id	sid	tid	token	lemma	pos
ajird-1636	1	1	american	american	PROPN
ajird-1636	1	2	journal	journal	PROPN
ajird-1636	1	3	of	of	ADP
ajird-1636	1	4	interdisciplinary	interdisciplinary	ADJ
ajird-1636	1	5	research	research	NOUN
ajird-1636	1	6	and	and	CCONJ
ajird-1636	1	7	development	development	NOUN
ajird-1636	1	8	issn	issn	PROPN
ajird-1636	1	9	online	online	NOUN
ajird-1636	1	10	:	:	PUNCT
ajird-1636	1	11	2771	2771	NUM
ajird-1636	1	12	-	-	SYM
ajird-1636	1	13	8948	8948	NUM
ajird-1636	1	14	website	website	NOUN
ajird-1636	1	15	:	:	PUNCT
ajird-1636	1	16	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-1636	1	17	volume	volume	NOUN
ajird-1636	1	18	46	46	NUM
ajird-1636	1	19	,	,	PUNCT
ajird-1636	1	20	november2025	november2025	PROPN
ajird-1636	1	21	37	37	NUM
ajird-1636	2	1	|	|	ADV
ajird-1636	2	2	p	p	NOUN
ajird-1636	2	3	a	a	DET
ajird-1636	2	4	g	g	NOUN
ajird-1636	2	5	e	e	NOUN
ajird-1636	2	6	the	the	DET
ajird-1636	2	7	role	role	NOUN
ajird-1636	2	8	of	of	ADP
ajird-1636	2	9	markers	marker	NOUN
ajird-1636	2	10	galectin-3	galectin-3	PROPN
ajird-1636	2	11	and	and	CCONJ
ajird-1636	2	12	h	h	NOUN
ajird-1636	2	13	-	-	PUNCT
ajird-1636	2	14	fabr	fabr	ADJ
ajird-1636	2	15	in	in	ADP
ajird-1636	2	16	current	current	ADJ
ajird-1636	2	17	forecast	forecast	NOUN
ajird-1636	2	18	chronic	chronic	ADJ
ajird-1636	2	19	heart	heart	NOUN
ajird-1636	2	20	failure	failure	NOUN
ajird-1636	2	21	in	in	ADP
ajird-1636	2	22	patients	patient	NOUN
ajird-1636	2	23	undergoing	undergo	VERB
ajird-1636	2	24	stenting	stente	VERB
ajird-1636	2	25	and	and	CCONJ
ajird-1636	2	26	coronary	coronary	ADJ
ajird-1636	2	27	artery	artery	NOUN
ajird-1636	2	28	bypass	bypass	NOUN
ajird-1636	2	29	grafting	grafting	NOUN
ajird-1636	2	30	,	,	PUNCT
ajird-1636	2	31	with	with	ADP
ajird-1636	2	32	and	and	CCONJ
ajird-1636	2	33	without	without	ADP
ajird-1636	2	34	type	type	NOUN
ajird-1636	2	35	2	2	NUM
ajird-1636	2	36	diabetes	diabetes	NOUN
ajird-1636	2	37	khaidarova	khaidarova	PROPN
ajird-1636	2	38	f.	f.	PROPN
ajird-1636	2	39	a.	a.	PROPN
ajird-1636	2	40	inogamova	inogamova	PROPN
ajird-1636	3	1	d.	d.	PROPN
ajird-1636	3	2	t.	t.	PROPN
ajird-1636	3	3	republican	republican	PROPN
ajird-1636	3	4	specialized	specialize	VERB
ajird-1636	3	5	scientific	scientific	ADJ
ajird-1636	3	6	and	and	CCONJ
ajird-1636	3	7	practical	practical	ADJ
ajird-1636	3	8	medical	medical	ADJ
ajird-1636	3	9	center	center	NOUN
ajird-1636	3	10	of	of	ADP
ajird-1636	3	11	endocrinology	endocrinology	NOUN
ajird-1636	3	12	of	of	ADP
ajird-1636	3	13	the	the	DET
ajird-1636	3	14	ministry	ministry	PROPN
ajird-1636	3	15	of	of	ADP
ajird-1636	3	16	health	health	PROPN
ajird-1636	3	17	of	of	ADP
ajird-1636	3	18	the	the	DET
ajird-1636	3	19	republic	republic	NOUN
ajird-1636	3	20	of	of	ADP
ajird-1636	3	21	uzbekistan	uzbekistan	PROPN
ajird-1636	3	22	named	name	VERB
ajird-1636	3	23	after	after	ADP
ajird-1636	3	24	acad	acad	PROPN
ajird-1636	3	25	.	.	PUNCT
ajird-1636	4	1	y.h	y.h	PROPN
ajird-1636	4	2	.	.	PROPN
ajird-1636	4	3	turakulova	turakulova	PROPN
ajird-1636	4	4	,	,	PUNCT
ajird-1636	4	5	diabetic	diabetic	ADJ
ajird-1636	4	6	foot	foot	NOUN
ajird-1636	4	7	department	department	NOUN
ajird-1636	4	8	,	,	PUNCT
ajird-1636	4	9	republic	republic	NOUN
ajird-1636	4	10	of	of	ADP
ajird-1636	4	11	uzbekistan	uzbekistan	PROPN
ajird-1636	4	12	,	,	PUNCT
ajird-1636	4	13	100125	100125	NUM
ajird-1636	4	14	,	,	PUNCT
ajird-1636	4	15	tashkent	tashkent	PROPN
ajird-1636	4	16	,	,	PUNCT
ajird-1636	4	17	st	st	PROPN
ajird-1636	4	18	.	.	PROPN
ajird-1636	4	19	mirzo	mirzo	PROPN
ajird-1636	4	20	ulugbek	ulugbek	ADJ
ajird-1636	4	21	56	56	NUM
ajird-1636	4	22	abstract	abstract	ADJ
ajird-1636	4	23	cardiovascular	cardiovascular	ADJ
ajird-1636	4	24	diseases	disease	NOUN
ajird-1636	4	25	remain	remain	VERB
ajird-1636	4	26	the	the	DET
ajird-1636	4	27	main	main	ADJ
ajird-1636	4	28	cause	cause	NOUN
ajird-1636	4	29	of	of	ADP
ajird-1636	4	30	death	death	NOUN
ajird-1636	4	31	and	and	CCONJ
ajird-1636	4	32	disability	disability	NOUN
ajird-1636	4	33	in	in	ADP
ajird-1636	4	34	patients	patient	NOUN
ajird-1636	4	35	with	with	ADP
ajird-1636	4	36	type	type	NOUN
ajird-1636	4	37	2	2	NUM
ajird-1636	4	38	diabetes	diabetes	NOUN
ajird-1636	4	39	mellitus	mellitus	NOUN
ajird-1636	4	40	(	(	PUNCT
ajird-1636	4	41	dm2	dm2	PROPN
ajird-1636	4	42	)	)	PUNCT
ajird-1636	4	43	dm2	dm2	PROPN
ajird-1636	4	44	aggravates	aggravate	VERB
ajird-1636	4	45	the	the	DET
ajird-1636	4	46	underlying	underlie	VERB
ajird-1636	4	47	mechanisms	mechanism	NOUN
ajird-1636	4	48	of	of	ADP
ajird-1636	4	49	atherosclerosis	atherosclerosis	NOUN
ajird-1636	4	50	and	and	CCONJ
ajird-1636	4	51	heart	heart	NOUN
ajird-1636	4	52	failure	failure	NOUN
ajird-1636	4	53	.	.	PUNCT
ajird-1636	5	1	to	to	PART
ajird-1636	5	2	study	study	VERB
ajird-1636	5	3	the	the	DET
ajird-1636	5	4	role	role	NOUN
ajird-1636	5	5	of	of	ADP
ajird-1636	5	6	galelectin-3	galelectin-3	PROPN
ajird-1636	5	7	and	and	CCONJ
ajird-1636	5	8	h	h	NOUN
ajird-1636	5	9	-	-	PUNCT
ajird-1636	5	10	fabr	fabr	ADJ
ajird-1636	5	11	markers	marker	NOUN
ajird-1636	5	12	in	in	ADP
ajird-1636	5	13	the	the	DET
ajird-1636	5	14	forecast	forecast	NOUN
ajird-1636	5	15	of	of	ADP
ajird-1636	5	16	chf	chf	NOUN
ajird-1636	5	17	in	in	ADP
ajird-1636	5	18	patients	patient	NOUN
ajird-1636	5	19	with	with	ADP
ajird-1636	5	20	type	type	NOUN
ajird-1636	5	21	2	2	NUM
ajird-1636	5	22	diabetes	diabetes	NOUN
ajird-1636	5	23	mellitus	mellitus	NOUN
ajird-1636	5	24	and	and	CCONJ
ajird-1636	5	25	stenting	stente	VERB
ajird-1636	5	26	80	80	NUM
ajird-1636	5	27	patients	patient	NOUN
ajird-1636	5	28	(	(	PUNCT
ajird-1636	5	29	prospectively	prospectively	ADV
ajird-1636	5	30	)	)	PUNCT
ajird-1636	5	31	with	with	ADP
ajird-1636	5	32	type	type	NOUN
ajird-1636	5	33	2	2	NUM
ajird-1636	5	34	diabetes	diabetes	NOUN
ajird-1636	5	35	were	be	AUX
ajird-1636	5	36	examined	examine	VERB
ajird-1636	5	37	at	at	ADP
ajird-1636	5	38	the	the	DET
ajird-1636	5	39	acad	acad	NOUN
ajird-1636	5	40	.	.	PUNCT
ajird-1636	6	1	vv	vv	ADP
ajird-1636	6	2	vakhidov	vakhidov	PROPN
ajird-1636	6	3	.	.	PUNCT
ajird-1636	7	1	of	of	ADP
ajird-1636	7	2	these	these	PRON
ajird-1636	7	3	,	,	PUNCT
ajird-1636	7	4	there	there	PRON
ajird-1636	7	5	were	be	VERB
ajird-1636	7	6	29	29	NUM
ajird-1636	7	7	women	woman	NOUN
ajird-1636	7	8	and	and	CCONJ
ajird-1636	7	9	51	51	NUM
ajird-1636	7	10	men	man	NOUN
ajird-1636	7	11	.	.	PUNCT
ajird-1636	8	1	the	the	DET
ajird-1636	8	2	average	average	ADJ
ajird-1636	8	3	age	age	NOUN
ajird-1636	8	4	of	of	ADP
ajird-1636	8	5	men	man	NOUN
ajird-1636	8	6	was	be	AUX
ajird-1636	8	7	67	67	NUM
ajird-1636	8	8	±	±	NUM
ajird-1636	8	9	4.2	4.2	NUM
ajird-1636	8	10	years	year	NOUN
ajird-1636	8	11	,	,	PUNCT
ajird-1636	8	12	and	and	CCONJ
ajird-1636	8	13	the	the	DET
ajird-1636	8	14	average	average	ADJ
ajird-1636	8	15	age	age	NOUN
ajird-1636	8	16	of	of	ADP
ajird-1636	8	17	women	woman	NOUN
ajird-1636	8	18	was	be	AUX
ajird-1636	8	19	64	64	NUM
ajird-1636	8	20	±	±	NUM
ajird-1636	8	21	5.6	5.6	NUM
ajird-1636	8	22	years	year	NOUN
ajird-1636	8	23	.	.	PUNCT
ajird-1636	9	1	10	10	NUM
ajird-1636	9	2	patients	patient	NOUN
ajird-1636	9	3	with	with	ADP
ajird-1636	9	4	dm	dm	PROPN
ajird-1636	9	5	2	2	NUM
ajird-1636	9	6	without	without	ADP
ajird-1636	9	7	coronary	coronary	ADJ
ajird-1636	9	8	artery	artery	NOUN
ajird-1636	9	9	disease	disease	NOUN
ajird-1636	9	10	of	of	ADP
ajird-1636	9	11	the	the	DET
ajird-1636	9	12	corresponding	corresponding	ADJ
ajird-1636	9	13	age	age	NOUN
ajird-1636	9	14	made	make	VERB
ajird-1636	9	15	up	up	ADP
ajird-1636	9	16	the	the	DET
ajird-1636	9	17	control	control	NOUN
ajird-1636	9	18	group	group	NOUN
ajird-1636	9	19	.	.	PUNCT
ajird-1636	10	1	the	the	DET
ajird-1636	10	2	study	study	NOUN
ajird-1636	10	3	used	use	VERB
ajird-1636	10	4	clinical	clinical	ADJ
ajird-1636	10	5	and	and	CCONJ
ajird-1636	10	6	biochemical	biochemical	ADJ
ajird-1636	10	7	research	research	NOUN
ajird-1636	10	8	methods	method	NOUN
ajird-1636	10	9	(	(	PUNCT
ajird-1636	10	10	glycemia	glycemia	NOUN
ajird-1636	10	11	,	,	PUNCT
ajird-1636	10	12	glycated	glycate	VERB
ajird-1636	10	13	hemoglobin	hemoglobin	NOUN
ajird-1636	10	14	,	,	PUNCT
ajird-1636	10	15	alt	alt	ADJ
ajird-1636	10	16	,	,	PUNCT
ajird-1636	10	17	ast	ast	NOUN
ajird-1636	10	18	,	,	PUNCT
ajird-1636	10	19	bilirubin	bilirubin	NOUN
ajird-1636	10	20	,	,	PUNCT
ajird-1636	10	21	urea	urea	NOUN
ajird-1636	10	22	,	,	PUNCT
ajird-1636	10	23	creatinine	creatinine	NOUN
ajird-1636	10	24	,	,	PUNCT
ajird-1636	10	25	pti	pti	PROPN
ajird-1636	10	26	,	,	PUNCT
ajird-1636	10	27	studies	study	NOUN
ajird-1636	10	28	of	of	ADP
ajird-1636	10	29	chf	chf	NOUN
ajird-1636	10	30	biomarkers	biomarker	NOUN
ajird-1636	10	31	(	(	PUNCT
ajird-1636	10	32	galectin-3	galectin-3	PROPN
ajird-1636	10	33	,	,	PUNCT
ajird-1636	10	34	h	h	NOUN
ajird-1636	10	35	-	-	PUNCT
ajird-1636	10	36	fabr	fabr	ADJ
ajird-1636	10	37	)	)	PUNCT
ajird-1636	10	38	,	,	PUNCT
ajird-1636	10	39	as	as	ADV
ajird-1636	10	40	well	well	ADV
ajird-1636	10	41	as	as	ADP
ajird-1636	10	42	instrumental	instrumental	ADJ
ajird-1636	10	43	methods	method	NOUN
ajird-1636	10	44	of	of	ADP
ajird-1636	10	45	examination	examination	NOUN
ajird-1636	10	46	-	-	PUNCT
ajird-1636	10	47	ultrasound	ultrasound	NOUN
ajird-1636	10	48	of	of	ADP
ajird-1636	10	49	internal	internal	ADJ
ajird-1636	10	50	organs	organ	NOUN
ajird-1636	10	51	,	,	PUNCT
ajird-1636	10	52	ecg	ecg	PROPN
ajird-1636	10	53	,	,	PUNCT
ajird-1636	10	54	echo	echo	NOUN
ajird-1636	10	55	-	-	PUNCT
ajird-1636	10	56	ecg	ecg	PROPN
ajird-1636	10	57	,	,	PUNCT
ajird-1636	10	58	as	as	ADV
ajird-1636	10	59	well	well	ADV
ajird-1636	10	60	as	as	ADP
ajird-1636	10	61	statistical	statistical	ADJ
ajird-1636	10	62	techniques	technique	NOUN
ajird-1636	10	63	.	.	PUNCT
ajird-1636	11	1	the	the	DET
ajird-1636	11	2	mean	mean	ADJ
ajird-1636	11	3	values	value	NOUN
ajird-1636	11	4	of	of	ADP
ajird-1636	11	5	galectin	galectin	NOUN
ajird-1636	11	6	3	3	NUM
ajird-1636	11	7	and	and	CCONJ
ajird-1636	11	8	h	h	NOUN
ajird-1636	11	9	-	-	PUNCT
ajird-1636	11	10	fabr	fabr	ADJ
ajird-1636	11	11	in	in	ADP
ajird-1636	11	12	the	the	DET
ajird-1636	11	13	preoperative	preoperative	ADJ
ajird-1636	11	14	period	period	NOUN
ajird-1636	11	15	were	be	AUX
ajird-1636	11	16	normal	normal	ADJ
ajird-1636	11	17	in	in	ADP
ajird-1636	11	18	patients	patient	NOUN
ajird-1636	11	19	of	of	ADP
ajird-1636	11	20	groups	group	NOUN
ajird-1636	11	21	2	2	NUM
ajird-1636	11	22	and	and	CCONJ
ajird-1636	11	23	4	4	NUM
ajird-1636	11	24	,	,	PUNCT
ajird-1636	11	25	but	but	CCONJ
ajird-1636	11	26	were	be	AUX
ajird-1636	11	27	significantly	significantly	ADV
ajird-1636	11	28	high	high	ADJ
ajird-1636	11	29	in	in	ADP
ajird-1636	11	30	patients	patient	NOUN
ajird-1636	11	31	of	of	ADP
ajird-1636	11	32	groups	group	NOUN
ajird-1636	11	33	1	1	NUM
ajird-1636	11	34	and	and	CCONJ
ajird-1636	11	35	3	3	NUM
ajird-1636	11	36	,	,	PUNCT
ajird-1636	11	37	that	that	ADV
ajird-1636	11	38	is	is	ADV
ajird-1636	11	39	,	,	PUNCT
ajird-1636	11	40	with	with	ADP
ajird-1636	11	41	a	a	DET
ajird-1636	11	42	combination	combination	NOUN
ajird-1636	11	43	of	of	ADP
ajird-1636	11	44	dm	dm	NUM
ajird-1636	11	45	2	2	NUM
ajird-1636	11	46	and	and	CCONJ
ajird-1636	11	47	chf	chf	NOUN
ajird-1636	11	48	,	,	PUNCT
ajird-1636	11	49	approaching	approach	VERB
ajird-1636	11	50	critical	critical	ADJ
ajird-1636	11	51	threshold	threshold	NOUN
ajird-1636	11	52	values	value	NOUN
ajird-1636	11	53	.	.	PUNCT
ajird-1636	12	1	thus	thus	ADV
ajird-1636	12	2	,	,	PUNCT
ajird-1636	12	3	the	the	DET
ajird-1636	12	4	average	average	ADJ
ajird-1636	12	5	values	value	NOUN
ajird-1636	12	6	of	of	ADP
ajird-1636	12	7	galectin-3	galectin-3	PROPN
ajird-1636	12	8	in	in	ADP
ajird-1636	12	9	the	the	DET
ajird-1636	12	10	1st	1st	ADJ
ajird-1636	12	11	group	group	NOUN
ajird-1636	12	12	of	of	ADP
ajird-1636	12	13	patients	patient	NOUN
ajird-1636	12	14	were	be	AUX
ajird-1636	12	15	within	within	ADP
ajird-1636	12	16	8.68±0.04	8.68±0.04	PROPN
ajird-1636	12	17	ng	ng	PROPN
ajird-1636	12	18	/	/	SYM
ajird-1636	12	19	ml	ml	PROPN
ajird-1636	12	20	,	,	PUNCT
ajird-1636	12	21	and	and	CCONJ
ajird-1636	12	22	in	in	ADP
ajird-1636	12	23	the	the	DET
ajird-1636	12	24	group	group	NOUN
ajird-1636	12	25	7.62±0.08	7.62±0.08	PROPN
ajird-1636	12	26	ng	ng	PROPN
ajird-1636	12	27	/	/	SYM
ajird-1636	12	28	ml	ml	PROPN
ajird-1636	12	29	.	.	PUNCT
ajird-1636	13	1	the	the	DET
ajird-1636	13	2	average	average	ADJ
ajird-1636	13	3	h	h	ADJ
ajird-1636	13	4	-	-	PUNCT
ajird-1636	13	5	fabr	fabr	ADJ
ajird-1636	13	6	data	datum	NOUN
ajird-1636	13	7	in	in	ADP
ajird-1636	13	8	group	group	NOUN
ajird-1636	13	9	1	1	NUM
ajird-1636	13	10	reached	reach	VERB
ajird-1636	13	11	17.1±0.4	17.1±0.4	NUM
ajird-1636	13	12	ng	ng	PROPN
ajird-1636	13	13	/	/	SYM
ajird-1636	13	14	ml	ml	PROPN
ajird-1636	13	15	,	,	PUNCT
ajird-1636	13	16	and	and	CCONJ
ajird-1636	13	17	in	in	ADP
ajird-1636	13	18	the	the	DET
ajird-1636	13	19	group	group	NOUN
ajird-1636	13	20	13.5±0.7ng	13.5±0.7ng	NUM
ajird-1636	13	21	/	/	SYM
ajird-1636	13	22	ml	ml	NOUN
ajird-1636	13	23	.	.	PUNCT
ajird-1636	14	1	the	the	DET
ajird-1636	14	2	increase	increase	NOUN
ajird-1636	14	3	in	in	ADP
ajird-1636	14	4	the	the	DET
ajird-1636	14	5	concentration	concentration	NOUN
ajird-1636	14	6	of	of	ADP
ajird-1636	14	7	galectin-3	galectin-3	PROPN
ajird-1636	14	8	and	and	CCONJ
ajird-1636	14	9	h	h	NOUN
ajird-1636	14	10	-	-	PUNCT
ajird-1636	14	11	fabr	fabr	ADJ
ajird-1636	14	12	in	in	ADP
ajird-1636	14	13	all	all	DET
ajird-1636	14	14	patients	patient	NOUN
ajird-1636	14	15	with	with	ADP
ajird-1636	14	16	type	type	NOUN
ajird-1636	14	17	2	2	NUM
ajird-1636	14	18	dm	dm	NOUN
ajird-1636	14	19	with	with	ADP
ajird-1636	14	20	concomitant	concomitant	ADJ
ajird-1636	14	21	chf	chf	NOUN
ajird-1636	14	22	,	,	PUNCT
ajird-1636	14	23	as	as	ADV
ajird-1636	14	24	well	well	ADV
ajird-1636	14	25	as	as	ADP
ajird-1636	14	26	the	the	DET
ajird-1636	14	27	high	high	ADJ
ajird-1636	14	28	sensitivity	sensitivity	NOUN
ajird-1636	14	29	and	and	CCONJ
ajird-1636	14	30	specificity	specificity	NOUN
ajird-1636	14	31	of	of	ADP
ajird-1636	14	32	the	the	DET
ajird-1636	14	33	test	test	NOUN
ajird-1636	14	34	,	,	PUNCT
ajird-1636	14	35	prove	prove	VERB
ajird-1636	14	36	the	the	DET
ajird-1636	14	37	value	value	NOUN
ajird-1636	14	38	of	of	ADP
ajird-1636	14	39	this	this	DET
ajird-1636	14	40	marker	marker	NOUN
ajird-1636	14	41	for	for	ADP
ajird-1636	14	42	diagnosing	diagnose	VERB
ajird-1636	14	43	chf	chf	NOUN
ajird-1636	14	44	in	in	ADP
ajird-1636	14	45	patients	patient	NOUN
ajird-1636	14	46	with	with	ADP
ajird-1636	14	47	type	type	NOUN
ajird-1636	14	48	2	2	NUM
ajird-1636	14	49	dm	dm	NOUN
ajird-1636	14	50	.	.	PUNCT
ajird-1636	15	1	keywords	keyword	NOUN
ajird-1636	15	2	:	:	PUNCT
ajird-1636	15	3	galectin-3	galectin-3	PROPN
ajird-1636	15	4	,	,	PUNCT
ajird-1636	15	5	h	h	NOUN
ajird-1636	15	6	-	-	PUNCT
ajird-1636	15	7	fabr	fabr	ADJ
ajird-1636	15	8	,	,	PUNCT
ajird-1636	15	9	type	type	NOUN
ajird-1636	15	10	2	2	NUM
ajird-1636	15	11	diabetes	diabetes	NOUN
ajird-1636	15	12	mellitus	mellitus	NOUN
ajird-1636	15	13	,	,	PUNCT
ajird-1636	15	14	chronic	chronic	ADJ
ajird-1636	15	15	heart	heart	NOUN
ajird-1636	15	16	failure	failure	NOUN
ajird-1636	15	17	.	.	PUNCT
ajird-1636	16	1	american	american	ADJ
ajird-1636	16	2	journal	journal	PROPN
ajird-1636	16	3	of	of	ADP
ajird-1636	16	4	interdisciplinary	interdisciplinary	ADJ
ajird-1636	16	5	research	research	NOUN
ajird-1636	16	6	and	and	CCONJ
ajird-1636	16	7	development	development	NOUN
ajird-1636	16	8	issn	issn	PROPN
ajird-1636	16	9	online	online	NOUN
ajird-1636	16	10	:	:	PUNCT
ajird-1636	16	11	2771	2771	NUM
ajird-1636	16	12	-	-	SYM
ajird-1636	16	13	8948	8948	NUM
ajird-1636	16	14	website	website	NOUN
ajird-1636	16	15	:	:	PUNCT
ajird-1636	16	16	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-1636	16	17	volume	volume	NOUN
ajird-1636	16	18	46	46	NUM
ajird-1636	16	19	,	,	PUNCT
ajird-1636	16	20	november2025	november2025	PROPN
ajird-1636	16	21	38	38	NUM
ajird-1636	17	1	|	|	ADV
ajird-1636	17	2	p	p	NOUN
ajird-1636	17	3	a	a	DET
ajird-1636	17	4	g	g	NOUN
ajird-1636	17	5	e	e	NOUN
ajird-1636	17	6	introduction	introduction	NOUN
ajird-1636	17	7	type	type	NOUN
ajird-1636	17	8	2	2	NUM
ajird-1636	17	9	diabetes	diabetes	NOUN
ajird-1636	17	10	mellitus	mellitus	NOUN
ajird-1636	17	11	(	(	PUNCT
ajird-1636	17	12	t2	t2	NOUN
ajird-1636	17	13	dm	dm	NOUN
ajird-1636	17	14	)	)	PUNCT
ajird-1636	17	15	is	be	AUX
ajird-1636	17	16	an	an	DET
ajird-1636	17	17	epidemic	epidemic	NOUN
ajird-1636	17	18	metabolic	metabolic	NOUN
ajird-1636	17	19	disease	disease	NOUN
ajird-1636	17	20	with	with	ADP
ajird-1636	17	21	increasing	increase	VERB
ajird-1636	17	22	prevalence	prevalence	NOUN
ajird-1636	17	23	,	,	PUNCT
ajird-1636	17	24	affecting	affect	VERB
ajird-1636	17	25	more	more	ADJ
ajird-1636	17	26	than	than	ADP
ajird-1636	17	27	463	463	NUM
ajird-1636	17	28	million	million	NUM
ajird-1636	17	29	people	people	NOUN
ajird-1636	17	30	today	today	NOUN
ajird-1636	17	31	.	.	PUNCT
ajird-1636	18	1	it	it	PRON
ajird-1636	18	2	has	have	AUX
ajird-1636	18	3	been	be	AUX
ajird-1636	18	4	estimated	estimate	VERB
ajird-1636	18	5	that	that	SCONJ
ajird-1636	18	6	approximately	approximately	ADV
ajird-1636	18	7	700	700	NUM
ajird-1636	18	8	million	million	NUM
ajird-1636	18	9	people	people	NOUN
ajird-1636	18	10	will	will	AUX
ajird-1636	18	11	have	have	VERB
ajird-1636	18	12	type	type	NOUN
ajird-1636	18	13	2	2	NUM
ajird-1636	18	14	diabetes	diabetes	NOUN
ajird-1636	18	15	in	in	ADP
ajird-1636	18	16	2045.[1	2045.[1	NUM
ajird-1636	18	17	]	]	PUNCT
ajird-1636	18	18	.the	.the	PRON
ajird-1636	18	19	main	main	ADJ
ajird-1636	18	20	reasons	reason	NOUN
ajird-1636	18	21	for	for	ADP
ajird-1636	18	22	this	this	DET
ajird-1636	18	23	marked	mark	VERB
ajird-1636	18	24	increase	increase	NOUN
ajird-1636	18	25	are	be	AUX
ajird-1636	18	26	altered	alter	VERB
ajird-1636	18	27	living	living	NOUN
ajird-1636	18	28	conditions	condition	NOUN
ajird-1636	18	29	with	with	ADP
ajird-1636	18	30	a	a	DET
ajird-1636	18	31	sedentary	sedentary	ADJ
ajird-1636	18	32	lifestyle	lifestyle	NOUN
ajird-1636	18	33	and	and	CCONJ
ajird-1636	18	34	less	less	ADV
ajird-1636	18	35	physical	physical	ADJ
ajird-1636	18	36	activity	activity	NOUN
ajird-1636	18	37	leading	lead	VERB
ajird-1636	18	38	to	to	ADP
ajird-1636	18	39	an	an	DET
ajird-1636	18	40	increase	increase	NOUN
ajird-1636	18	41	in	in	ADP
ajird-1636	18	42	obesity	obesity	NOUN
ajird-1636	18	43	among	among	ADP
ajird-1636	18	44	a	a	DET
ajird-1636	18	45	growing	grow	VERB
ajird-1636	18	46	world	world	NOUN
ajird-1636	18	47	population	population	NOUN
ajird-1636	18	48	with	with	ADP
ajird-1636	18	49	longevity.[2].since	longevity.[2].since	NOUN
ajird-1636	18	50	type	type	NOUN
ajird-1636	18	51	2	2	NUM
ajird-1636	18	52	diabetes	diabetes	NOUN
ajird-1636	18	53	increases	increase	VERB
ajird-1636	18	54	the	the	DET
ajird-1636	18	55	risk	risk	NOUN
ajird-1636	18	56	of	of	ADP
ajird-1636	18	57	developing	develop	VERB
ajird-1636	18	58	various	various	ADJ
ajird-1636	18	59	diseases	disease	NOUN
ajird-1636	18	60	,	,	PUNCT
ajird-1636	18	61	such	such	ADJ
ajird-1636	18	62	as	as	ADP
ajird-1636	18	63	cancer	cancer	NOUN
ajird-1636	18	64	and	and	CCONJ
ajird-1636	18	65	cardiovascular	cardiovascular	ADJ
ajird-1636	18	66	disease	disease	NOUN
ajird-1636	18	67	(	(	PUNCT
ajird-1636	18	68	cvd	cvd	PROPN
ajird-1636	18	69	)	)	PUNCT
ajird-1636	18	70	,	,	PUNCT
ajird-1636	18	71	the	the	DET
ajird-1636	18	72	duration	duration	NOUN
ajird-1636	18	73	and	and	CCONJ
ajird-1636	18	74	quality	quality	NOUN
ajird-1636	18	75	of	of	ADP
ajird-1636	18	76	life	life	NOUN
ajird-1636	18	77	of	of	ADP
ajird-1636	18	78	patients	patient	NOUN
ajird-1636	18	79	are	be	AUX
ajird-1636	18	80	significantly	significantly	ADV
ajird-1636	18	81	reduced.[3	reduced.[3	NOUN
ajird-1636	18	82	-	-	SYM
ajird-1636	18	83	5].due	5].due	NUM
ajird-1636	18	84	to	to	PART
ajird-1636	18	85	microvascular	microvascular	VERB
ajird-1636	18	86	and	and	CCONJ
ajird-1636	18	87	macrovascular	macrovascular	ADJ
ajird-1636	18	88	changes	change	NOUN
ajird-1636	18	89	,	,	PUNCT
ajird-1636	18	90	the	the	DET
ajird-1636	18	91	risk	risk	NOUN
ajird-1636	18	92	of	of	ADP
ajird-1636	18	93	cardiovascular	cardiovascular	ADJ
ajird-1636	18	94	disease	disease	NOUN
ajird-1636	18	95	in	in	ADP
ajird-1636	18	96	patients	patient	NOUN
ajird-1636	18	97	with	with	ADP
ajird-1636	18	98	type	type	NOUN
ajird-1636	18	99	2	2	NUM
ajird-1636	18	100	diabetes	diabetes	NOUN
ajird-1636	18	101	is	be	AUX
ajird-1636	18	102	twice	twice	ADV
ajird-1636	18	103	as	as	ADV
ajird-1636	18	104	high	high	ADJ
ajird-1636	18	105	as	as	ADP
ajird-1636	18	106	in	in	ADP
ajird-1636	18	107	those	those	PRON
ajird-1636	18	108	with	with	ADP
ajird-1636	18	109	euglycemia	euglycemia	NOUN
ajird-1636	18	110	.	.	PUNCT
ajird-1636	19	1	approximately	approximately	ADV
ajird-1636	19	2	80	80	NUM
ajird-1636	19	3	%	%	NOUN
ajird-1636	19	4	of	of	ADP
ajird-1636	19	5	t2dm	t2dm	ADJ
ajird-1636	19	6	-	-	PUNCT
ajird-1636	19	7	related	relate	VERB
ajird-1636	19	8	deaths	death	NOUN
ajird-1636	19	9	are	be	AUX
ajird-1636	19	10	associated	associate	VERB
ajird-1636	19	11	with	with	ADP
ajird-1636	19	12	the	the	DET
ajird-1636	19	13	progression	progression	NOUN
ajird-1636	19	14	of	of	ADP
ajird-1636	19	15	cvd	cvd	PROPN
ajird-1636	19	16	and	and	CCONJ
ajird-1636	19	17	the	the	DET
ajird-1636	19	18	occurrence	occurrence	NOUN
ajird-1636	19	19	of	of	ADP
ajird-1636	19	20	its	its	PRON
ajird-1636	19	21	acute	acute	ADJ
ajird-1636	19	22	manifestations	manifestation	NOUN
ajird-1636	19	23	,	,	PUNCT
ajird-1636	19	24	including	include	VERB
ajird-1636	19	25	heart	heart	NOUN
ajird-1636	19	26	failure	failure	NOUN
ajird-1636	19	27	,	,	PUNCT
ajird-1636	19	28	myocardial	myocardial	ADJ
ajird-1636	19	29	infarction	infarction	NOUN
ajird-1636	19	30	and	and	CCONJ
ajird-1636	19	31	stroke[6	stroke[6	NOUN
ajird-1636	19	32	-	-	PUNCT
ajird-1636	19	33	8].an	8].an	NUM
ajird-1636	19	34	increased	increase	VERB
ajird-1636	19	35	risk	risk	NOUN
ajird-1636	19	36	of	of	ADP
ajird-1636	19	37	cardiovascular	cardiovascular	ADJ
ajird-1636	19	38	disease	disease	NOUN
ajird-1636	19	39	is	be	AUX
ajird-1636	19	40	present	present	ADJ
ajird-1636	19	41	not	not	PART
ajird-1636	19	42	only	only	ADV
ajird-1636	19	43	in	in	ADP
ajird-1636	19	44	t2	t2	PROPN
ajird-1636	19	45	dm	dm	NOUN
ajird-1636	19	46	,	,	PUNCT
ajird-1636	19	47	but	but	CCONJ
ajird-1636	19	48	also	also	ADV
ajird-1636	19	49	in	in	ADP
ajird-1636	19	50	early	early	ADJ
ajird-1636	19	51	pre	pre	ADJ
ajird-1636	19	52	-	-	ADJ
ajird-1636	19	53	diabetic	diabetic	ADJ
ajird-1636	19	54	form.[9	form.[9	NOUN
ajird-1636	19	55	]	]	PUNCT
ajird-1636	19	56	.	.	PUNCT
ajird-1636	20	1	in	in	ADP
ajird-1636	20	2	the	the	DET
ajird-1636	20	3	diagnosis	diagnosis	NOUN
ajird-1636	20	4	of	of	ADP
ajird-1636	20	5	heart	heart	NOUN
ajird-1636	20	6	failure	failure	NOUN
ajird-1636	20	7	(	(	PUNCT
ajird-1636	20	8	hf	hf	NOUN
ajird-1636	20	9	)	)	PUNCT
ajird-1636	20	10	,	,	PUNCT
ajird-1636	20	11	nt	not	PART
ajird-1636	20	12	-	-	PUNCT
ajird-1636	20	13	probnp	probnp	NOUN
ajird-1636	20	14	represents	represent	VERB
ajird-1636	20	15	the	the	DET
ajird-1636	20	16	gold	gold	ADJ
ajird-1636	20	17	standard	standard	ADJ
ajird-1636	20	18	laboratory	laboratory	NOUN
ajird-1636	20	19	parameter	parameter	NOUN
ajird-1636	20	20	,	,	PUNCT
ajird-1636	20	21	but	but	CCONJ
ajird-1636	20	22	also	also	ADV
ajird-1636	20	23	galectin-3	galectin-3	PROPN
ajird-1636	20	24	has	have	AUX
ajird-1636	20	25	shown	show	VERB
ajird-1636	20	26	promising	promising	ADJ
ajird-1636	20	27	results	result	NOUN
ajird-1636	20	28	in	in	ADP
ajird-1636	20	29	relation	relation	NOUN
ajird-1636	20	30	to	to	ADP
ajird-1636	20	31	the	the	DET
ajird-1636	20	32	presence	presence	NOUN
ajird-1636	20	33	of	of	ADP
ajird-1636	20	34	cardiac	cardiac	ADJ
ajird-1636	20	35	dysfunction.[10,11].since	dysfunction.[10,11].since	NOUN
ajird-1636	20	36	galectin-3	galectin-3	PROPN
ajird-1636	20	37	has	have	AUX
ajird-1636	20	38	been	be	AUX
ajird-1636	20	39	shown	show	VERB
ajird-1636	20	40	to	to	PART
ajird-1636	20	41	be	be	AUX
ajird-1636	20	42	involved	involve	VERB
ajird-1636	20	43	in	in	ADP
ajird-1636	20	44	inflammatory	inflammatory	ADJ
ajird-1636	20	45	and	and	CCONJ
ajird-1636	20	46	fibrotic	fibrotic	ADJ
ajird-1636	20	47	processes	process	NOUN
ajird-1636	20	48	,	,	PUNCT
ajird-1636	20	49	as	as	ADV
ajird-1636	20	50	well	well	ADV
ajird-1636	20	51	as	as	ADP
ajird-1636	20	52	in	in	ADP
ajird-1636	20	53	cardiac	cardiac	ADJ
ajird-1636	20	54	remodeling[12	remodeling[12	PROPN
ajird-1636	20	55	,	,	PUNCT
ajird-1636	20	56	13],the	13],the	DET
ajird-1636	20	57	authors	author	NOUN
ajird-1636	20	58	showed	show	VERB
ajird-1636	20	59	that	that	SCONJ
ajird-1636	20	60	galectin-3	galectin-3	PROPN
ajird-1636	20	61	may	may	AUX
ajird-1636	20	62	be	be	AUX
ajird-1636	20	63	a	a	DET
ajird-1636	20	64	specific	specific	ADJ
ajird-1636	20	65	and	and	CCONJ
ajird-1636	20	66	additional	additional	ADJ
ajird-1636	20	67	biomarker	biomarker	NOUN
ajird-1636	20	68	,	,	PUNCT
ajird-1636	20	69	especially	especially	ADV
ajird-1636	20	70	for	for	ADP
ajird-1636	20	71	heart	heart	NOUN
ajird-1636	20	72	failure	failure	NOUN
ajird-1636	20	73	caused	cause	VERB
ajird-1636	20	74	by	by	ADP
ajird-1636	20	75	hyperglycemia[14	hyperglycemia[14	PROPN
ajird-1636	20	76	]	]	PUNCT
ajird-1636	20	77	.the	.the	DET
ajird-1636	20	78	authors	author	NOUN
ajird-1636	20	79	concluded	conclude	VERB
ajird-1636	20	80	that	that	SCONJ
ajird-1636	20	81	,	,	PUNCT
ajird-1636	20	82	in	in	ADP
ajird-1636	20	83	a	a	DET
ajird-1636	20	84	large	large	ADJ
ajird-1636	20	85	population	population	NOUN
ajird-1636	20	86	cohort	cohort	NOUN
ajird-1636	20	87	,	,	PUNCT
ajird-1636	20	88	galectin-3	galectin-3	PROPN
ajird-1636	20	89	was	be	AUX
ajird-1636	20	90	superior	superior	ADJ
ajird-1636	20	91	to	to	ADP
ajird-1636	20	92	nt	nt	NOUN
ajird-1636	20	93	-	-	PUNCT
ajird-1636	20	94	probnp	probnp	NOUN
ajird-1636	20	95	in	in	ADP
ajird-1636	20	96	predicting	predict	VERB
ajird-1636	20	97	heart	heart	NOUN
ajird-1636	20	98	function	function	NOUN
ajird-1636	20	99	over	over	ADP
ajird-1636	20	100	a	a	DET
ajird-1636	20	101	five	five	NUM
ajird-1636	20	102	-	-	PUNCT
ajird-1636	20	103	year	year	NOUN
ajird-1636	20	104	period	period	NOUN
ajird-1636	20	105	in	in	ADP
ajird-1636	20	106	patients	patient	NOUN
ajird-1636	20	107	with	with	ADP
ajird-1636	20	108	t2	t2	NOUN
ajird-1636	20	109	dm	dm	NOUN
ajird-1636	20	110	.	.	PUNCT
ajird-1636	21	1	although	although	SCONJ
ajird-1636	21	2	galectin-3	galectin-3	PROPN
ajird-1636	21	3	is	be	AUX
ajird-1636	21	4	inferior	inferior	ADJ
ajird-1636	21	5	to	to	ADP
ajird-1636	21	6	nt	nt	NOUN
ajird-1636	21	7	-	-	PUNCT
ajird-1636	21	8	probnp	probnp	NOUN
ajird-1636	21	9	in	in	ADP
ajird-1636	21	10	predicting	predict	VERB
ajird-1636	21	11	survival	survival	NOUN
ajird-1636	21	12	,	,	PUNCT
ajird-1636	21	13	it	it	PRON
ajird-1636	21	14	may	may	AUX
ajird-1636	21	15	represent	represent	VERB
ajird-1636	21	16	a	a	DET
ajird-1636	21	17	valuable	valuable	ADJ
ajird-1636	21	18	tool	tool	NOUN
ajird-1636	21	19	to	to	PART
ajird-1636	21	20	provide	provide	VERB
ajird-1636	21	21	additional	additional	ADJ
ajird-1636	21	22	information	information	NOUN
ajird-1636	21	23	in	in	ADP
ajird-1636	21	24	monitoring	monitoring	NOUN
ajird-1636	21	25	and	and	CCONJ
ajird-1636	21	26	predicting	predict	VERB
ajird-1636	21	27	cardiac	cardiac	ADJ
ajird-1636	21	28	function	function	NOUN
ajird-1636	21	29	in	in	ADP
ajird-1636	21	30	high	high	ADJ
ajird-1636	21	31	-	-	PUNCT
ajird-1636	21	32	risk	risk	NOUN
ajird-1636	21	33	patients	patient	NOUN
ajird-1636	21	34	with	with	ADP
ajird-1636	21	35	t2	t2	PROPN
ajird-1636	21	36	dm	dm	PROPN
ajird-1636	21	37	.	.	PUNCT
ajird-1636	22	1	the	the	DET
ajird-1636	22	2	standard	standard	ADJ
ajird-1636	22	3	deviation	deviation	NOUN
ajird-1636	22	4	of	of	ADP
ajird-1636	22	5	galectin-3	galectin-3	PROPN
ajird-1636	22	6	was	be	AUX
ajird-1636	22	7	5	5	NUM
ajird-1636	22	8	ng	ng	PROPN
ajird-1636	22	9	/	/	SYM
ajird-1636	22	10	ml	ml	PROPN
ajird-1636	22	11	.	.	PUNCT
ajird-1636	23	1	the	the	DET
ajird-1636	23	2	first	first	ADJ
ajird-1636	23	3	tertile	tertile	NOUN
ajird-1636	23	4	(	(	PUNCT
ajird-1636	23	5	galectin-3	galectin-3	PROPN
ajird-1636	23	6	≤	≤	PROPN
ajird-1636	23	7	12.2	12.2	NUM
ajird-1636	23	8	ng	ng	NOUN
ajird-1636	23	9	/	/	SYM
ajird-1636	23	10	ml	ml	VERB
ajird-1636	23	11	)	)	PUNCT
ajird-1636	23	12	included	include	VERB
ajird-1636	23	13	4925	4925	NUM
ajird-1636	23	14	subjects	subject	NOUN
ajird-1636	23	15	,	,	PUNCT
ajird-1636	23	16	the	the	DET
ajird-1636	23	17	second	second	ADJ
ajird-1636	23	18	tertile	tertile	NOUN
ajird-1636	23	19	(	(	PUNCT
ajird-1636	23	20	galectin-3	galectin-3	PROPN
ajird-1636	23	21	>	>	X
ajird-1636	23	22	12.2	12.2	NUM
ajird-1636	23	23	to	to	ADP
ajird-1636	23	24	≤	≤	NUM
ajird-1636	23	25	15.3	15.3	NUM
ajird-1636	23	26	ng	ng	NOUN
ajird-1636	23	27	/	/	SYM
ajird-1636	23	28	ml	ml	VERB
ajird-1636	23	29	)	)	PUNCT
ajird-1636	23	30	included	include	VERB
ajird-1636	23	31	4934	4934	NUM
ajird-1636	23	32	subjects	subject	NOUN
ajird-1636	23	33	,	,	PUNCT
ajird-1636	23	34	and	and	CCONJ
ajird-1636	23	35	the	the	DET
ajird-1636	23	36	third	third	ADJ
ajird-1636	23	37	tertile	tertile	NOUN
ajird-1636	23	38	(	(	PUNCT
ajird-1636	23	39	galectin-3	galectin-3	PROPN
ajird-1636	23	40	>	>	X
ajird-1636	23	41	15.3	15.3	NUM
ajird-1636	23	42	ng	ng	PROPN
ajird-1636	23	43	/	/	SYM
ajird-1636	23	44	ml	ml	VERB
ajird-1636	23	45	)	)	PUNCT
ajird-1636	23	46	included	include	VERB
ajird-1636	23	47	4934	4934	NUM
ajird-1636	23	48	people	people	NOUN
ajird-1636	23	49	.	.	PUNCT
ajird-1636	24	1	4924	4924	NUM
ajird-1636	24	2	people	people	NOUN
ajird-1636	24	3	participated	participate	VERB
ajird-1636	24	4	.	.	PUNCT
ajird-1636	25	1	lower	low	ADJ
ajird-1636	25	2	levels	level	NOUN
ajird-1636	25	3	of	of	ADP
ajird-1636	25	4	galectin-3	galectin-3	PROPN
ajird-1636	25	5	have	have	AUX
ajird-1636	25	6	been	be	AUX
ajird-1636	25	7	associated	associate	VERB
ajird-1636	25	8	with	with	ADP
ajird-1636	25	9	a	a	DET
ajird-1636	25	10	euglycemic	euglycemic	ADJ
ajird-1636	25	11	state	state	NOUN
ajird-1636	25	12	,	,	PUNCT
ajird-1636	25	13	while	while	SCONJ
ajird-1636	25	14	higher	high	ADJ
ajird-1636	25	15	levels	level	NOUN
ajird-1636	25	16	of	of	ADP
ajird-1636	25	17	galectin-3	galectin-3	PROPN
ajird-1636	25	18	were	be	AUX
ajird-1636	25	19	associated	associate	VERB
ajird-1636	25	20	with	with	ADP
ajird-1636	25	21	a	a	DET
ajird-1636	25	22	higher	high	ADJ
ajird-1636	25	23	prevalence	prevalence	NOUN
ajird-1636	25	24	of	of	ADP
ajird-1636	25	25	prediabetes	prediabete	NOUN
ajird-1636	25	26	(	(	PUNCT
ajird-1636	25	27	an	an	DET
ajird-1636	25	28	increase	increase	NOUN
ajird-1636	25	29	of	of	ADP
ajird-1636	25	30	about	about	ADV
ajird-1636	25	31	50	50	NUM
ajird-1636	25	32	%	%	NOUN
ajird-1636	25	33	from	from	ADP
ajird-1636	25	34	the	the	DET
ajird-1636	25	35	first	first	ADJ
ajird-1636	25	36	to	to	ADP
ajird-1636	25	37	the	the	DET
ajird-1636	25	38	third	third	ADJ
ajird-1636	25	39	tertile	tertile	NOUN
ajird-1636	25	40	)	)	PUNCT
ajird-1636	25	41	and	and	CCONJ
ajird-1636	25	42	t2	t2	NOUN
ajird-1636	25	43	dm	dm	X
ajird-1636	25	44	(	(	PUNCT
ajird-1636	25	45	almost	almost	ADV
ajird-1636	25	46	a	a	DET
ajird-1636	25	47	tripling	tripling	NOUN
ajird-1636	25	48	of	of	ADP
ajird-1636	25	49	the	the	DET
ajird-1636	25	50	prevalence	prevalence	NOUN
ajird-1636	25	51	from	from	ADP
ajird-1636	25	52	the	the	DET
ajird-1636	25	53	first	first	ADJ
ajird-1636	25	54	to	to	ADP
ajird-1636	25	55	the	the	DET
ajird-1636	25	56	third	third	NOUN
ajird-1636	25	57	)	)	PUNCT
ajird-1636	25	58	.	.	PUNCT
ajird-1636	26	1	with	with	ADP
ajird-1636	26	2	increasing	increase	VERB
ajird-1636	26	3	levels	level	NOUN
ajird-1636	26	4	of	of	ADP
ajird-1636	26	5	galectin-3	galectin-3	PROPN
ajird-1636	26	6	,	,	PUNCT
ajird-1636	26	7	individuals	individual	NOUN
ajird-1636	26	8	were	be	AUX
ajird-1636	26	9	older	old	ADJ
ajird-1636	26	10	and	and	CCONJ
ajird-1636	26	11	more	more	ADV
ajird-1636	26	12	often	often	ADV
ajird-1636	26	13	female	female	ADJ
ajird-1636	26	14	,	,	PUNCT
ajird-1636	26	15	and	and	CCONJ
ajird-1636	26	16	there	there	PRON
ajird-1636	26	17	was	be	VERB
ajird-1636	26	18	also	also	ADV
ajird-1636	26	19	a	a	DET
ajird-1636	26	20	higher	high	ADJ
ajird-1636	26	21	prevalence	prevalence	NOUN
ajird-1636	26	22	of	of	ADP
ajird-1636	26	23	arterial	arterial	ADJ
ajird-1636	26	24	hypertension	hypertension	NOUN
ajird-1636	26	25	,	,	PUNCT
ajird-1636	26	26	dyslipidemia	dyslipidemia	NOUN
ajird-1636	26	27	,	,	PUNCT
ajird-1636	26	28	obesity	obesity	NOUN
ajird-1636	26	29	,	,	PUNCT
ajird-1636	26	30	and	and	CCONJ
ajird-1636	26	31	all	all	DET
ajird-1636	26	32	assessed	assessed	ADJ
ajird-1636	26	33	comorbidities	comorbiditie	NOUN
ajird-1636	26	34	.	.	PUNCT
ajird-1636	27	1	as	as	SCONJ
ajird-1636	27	2	expected	expect	VERB
ajird-1636	27	3	,	,	PUNCT
ajird-1636	27	4	higher	high	ADJ
ajird-1636	27	5	galectin-3	galectin-3	PROPN
ajird-1636	27	6	levels	level	NOUN
ajird-1636	27	7	were	be	AUX
ajird-1636	27	8	associated	associate	VERB
ajird-1636	27	9	with	with	ADP
ajird-1636	27	10	a	a	DET
ajird-1636	27	11	higher	high	ADJ
ajird-1636	27	12	prevalence	prevalence	NOUN
ajird-1636	27	13	of	of	ADP
ajird-1636	27	14	hf	hf	NOUN
ajird-1636	27	15	.	.	PUNCT
ajird-1636	28	1	and	and	CCONJ
ajird-1636	28	2	there	there	PRON
ajird-1636	28	3	was	be	VERB
ajird-1636	28	4	also	also	ADV
ajird-1636	28	5	a	a	DET
ajird-1636	28	6	higher	high	ADJ
ajird-1636	28	7	prevalence	prevalence	NOUN
ajird-1636	28	8	of	of	ADP
ajird-1636	28	9	hypertension	hypertension	NOUN
ajird-1636	28	10	,	,	PUNCT
ajird-1636	28	11	dyslipidemia	dyslipidemia	NOUN
ajird-1636	28	12	,	,	PUNCT
ajird-1636	28	13	obesity	obesity	NOUN
ajird-1636	28	14	,	,	PUNCT
ajird-1636	28	15	and	and	CCONJ
ajird-1636	28	16	all	all	DET
ajird-1636	28	17	comorbidities	comorbiditie	NOUN
ajird-1636	28	18	assessed	assess	VERB
ajird-1636	28	19	.	.	PUNCT
ajird-1636	29	1	as	as	SCONJ
ajird-1636	29	2	expected	expect	VERB
ajird-1636	29	3	,	,	PUNCT
ajird-1636	29	4	higher	high	ADJ
ajird-1636	29	5	galectin-3	galectin-3	PROPN
ajird-1636	29	6	levels	level	NOUN
ajird-1636	29	7	were	be	AUX
ajird-1636	29	8	associated	associate	VERB
ajird-1636	29	9	with	with	ADP
ajird-1636	29	10	a	a	DET
ajird-1636	29	11	higher	high	ADJ
ajird-1636	29	12	prevalence	prevalence	NOUN
ajird-1636	29	13	of	of	ADP
ajird-1636	29	14	hf	hf	NOUN
ajird-1636	29	15	.	.	PUNCT
ajird-1636	30	1	and	and	CCONJ
ajird-1636	30	2	there	there	PRON
ajird-1636	30	3	was	be	VERB
ajird-1636	30	4	also	also	ADV
ajird-1636	30	5	a	a	DET
ajird-1636	30	6	higher	high	ADJ
ajird-1636	30	7	prevalence	prevalence	NOUN
ajird-1636	30	8	of	of	ADP
ajird-1636	30	9	hypertension	hypertension	NOUN
ajird-1636	30	10	,	,	PUNCT
ajird-1636	30	11	dyslipidemia	dyslipidemia	NOUN
ajird-1636	30	12	,	,	PUNCT
ajird-1636	30	13	obesity	obesity	NOUN
ajird-1636	30	14	,	,	PUNCT
ajird-1636	30	15	and	and	CCONJ
ajird-1636	30	16	all	all	DET
ajird-1636	30	17	comorbidities	comorbiditie	NOUN
ajird-1636	30	18	assessed	assess	VERB
ajird-1636	30	19	.	.	PUNCT
ajird-1636	31	1	as	as	SCONJ
ajird-1636	31	2	expected	expect	VERB
ajird-1636	31	3	,	,	PUNCT
ajird-1636	31	4	higher	high	ADJ
ajird-1636	31	5	galectin-3	galectin-3	PROPN
ajird-1636	31	6	levels	level	NOUN
ajird-1636	31	7	were	be	AUX
ajird-1636	31	8	associated	associate	VERB
ajird-1636	31	9	with	with	ADP
ajird-1636	31	10	a	a	DET
ajird-1636	31	11	higher	high	ADJ
ajird-1636	31	12	prevalence	prevalence	NOUN
ajird-1636	31	13	of	of	ADP
ajird-1636	31	14	hf.[14	hf.[14	PROPN
ajird-1636	31	15	]	]	PUNCT
ajird-1636	31	16	.in	.in	PUNCT
ajird-1636	31	17	t2	t2	PROPN
ajird-1636	31	18	dm	dm	PROPN
ajird-1636	31	19	,	,	PUNCT
ajird-1636	31	20	the	the	DET
ajird-1636	31	21	risk	risk	NOUN
ajird-1636	31	22	of	of	ADP
ajird-1636	31	23	all	all	DET
ajird-1636	31	24	-	-	PUNCT
ajird-1636	31	25	cause	cause	NOUN
ajird-1636	31	26	mortality	mortality	NOUN
ajird-1636	31	27	was	be	AUX
ajird-1636	31	28	comparable	comparable	ADJ
ajird-1636	31	29	at	at	ADP
ajird-1636	31	30	low	low	ADJ
ajird-1636	31	31	and	and	CCONJ
ajird-1636	31	32	intermediate	intermediate	ADJ
ajird-1636	31	33	levels	level	NOUN
ajird-1636	31	34	,	,	PUNCT
ajird-1636	31	35	but	but	CCONJ
ajird-1636	31	36	nearly	nearly	ADV
ajird-1636	31	37	doubled	double	VERB
ajird-1636	31	38	in	in	ADP
ajird-1636	31	39	subjects	subject	NOUN
ajird-1636	31	40	with	with	ADP
ajird-1636	31	41	high	high	ADJ
ajird-1636	31	42	galectin-3	galectin-3	PROPN
ajird-1636	31	43	levels	level	NOUN
ajird-1636	31	44	(	(	PUNCT
ajird-1636	31	45	first	first	ADJ
ajird-1636	31	46	and	and	CCONJ
ajird-1636	31	47	second	second	ADJ
ajird-1636	31	48	tertile	tertile	NOUN
ajird-1636	31	49	versus	versus	ADP
ajird-1636	31	50	american	american	ADJ
ajird-1636	31	51	journal	journal	PROPN
ajird-1636	31	52	of	of	ADP
ajird-1636	31	53	interdisciplinary	interdisciplinary	ADJ
ajird-1636	31	54	research	research	NOUN
ajird-1636	31	55	and	and	CCONJ
ajird-1636	31	56	development	development	NOUN
ajird-1636	31	57	issn	issn	PROPN
ajird-1636	31	58	online	online	NOUN
ajird-1636	31	59	:	:	PUNCT
ajird-1636	31	60	2771	2771	NUM
ajird-1636	31	61	-	-	SYM
ajird-1636	31	62	8948	8948	NUM
ajird-1636	31	63	website	website	NOUN
ajird-1636	31	64	:	:	PUNCT
ajird-1636	31	65	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-1636	31	66	volume	volume	NOUN
ajird-1636	31	67	46	46	NUM
ajird-1636	31	68	,	,	PUNCT
ajird-1636	31	69	november2025	november2025	PROPN
ajird-1636	31	70	39	39	NUM
ajird-1636	32	1	|	|	ADV
ajird-1636	32	2	p	p	ADP
ajird-1636	32	3	a	a	DET
ajird-1636	32	4	g	g	NOUN
ajird-1636	32	5	e	e	NOUN
ajird-1636	32	6	third	third	ADJ
ajird-1636	32	7	tertile	tertile	NOUN
ajird-1636	32	8	)	)	PUNCT
ajird-1636	32	9	.	.	PUNCT
ajird-1636	33	1	in	in	ADP
ajird-1636	33	2	contrast	contrast	NOUN
ajird-1636	33	3	,	,	PUNCT
ajird-1636	33	4	cv	cv	PROPN
ajird-1636	33	5	mortality	mortality	NOUN
ajird-1636	33	6	was	be	AUX
ajird-1636	33	7	approximately	approximately	ADV
ajird-1636	33	8	tripled	triple	VERB
ajird-1636	33	9	at	at	ADP
ajird-1636	33	10	intermediate	intermediate	ADJ
ajird-1636	33	11	levels	level	NOUN
ajird-1636	33	12	(	(	PUNCT
ajird-1636	33	13	first	first	ADJ
ajird-1636	33	14	vs.	vs.	ADP
ajird-1636	33	15	second	second	ADJ
ajird-1636	33	16	tertile	tertile	NOUN
ajird-1636	33	17	)	)	PUNCT
ajird-1636	33	18	and	and	CCONJ
ajird-1636	33	19	increased	increase	VERB
ajird-1636	33	20	to	to	ADP
ajird-1636	33	21	a	a	DET
ajird-1636	33	22	six	six	NUM
ajird-1636	33	23	-	-	ADJ
ajird-1636	33	24	fold	fold	ADJ
ajird-1636	33	25	risk	risk	NOUN
ajird-1636	33	26	at	at	ADP
ajird-1636	33	27	high	high	ADJ
ajird-1636	33	28	levels	level	NOUN
ajird-1636	33	29	of	of	ADP
ajird-1636	33	30	galectin-3	galectin-3	PROPN
ajird-1636	33	31	(	(	PUNCT
ajird-1636	33	32	first	first	ADJ
ajird-1636	33	33	vs.	vs.	X
ajird-1636	33	34	third	third	ADJ
ajird-1636	33	35	tertile	tertile	NOUN
ajird-1636	33	36	)	)	PUNCT
ajird-1636	33	37	.	.	PUNCT
ajird-1636	34	1	in	in	ADP
ajird-1636	34	2	general	general	ADJ
ajird-1636	34	3	,	,	PUNCT
ajird-1636	34	4	the	the	DET
ajird-1636	34	5	level	level	NOUN
ajird-1636	34	6	of	of	ADP
ajird-1636	34	7	galectin3	galectin3	NOUN
ajird-1636	34	8	significantly	significantly	ADV
ajird-1636	34	9	correlated	correlate	VERB
ajird-1636	34	10	with	with	ADP
ajird-1636	34	11	the	the	DET
ajird-1636	34	12	risk	risk	NOUN
ajird-1636	34	13	of	of	ADP
ajird-1636	34	14	cardiovascular	cardiovascular	ADJ
ajird-1636	34	15	and	and	CCONJ
ajird-1636	34	16	overall	overall	ADJ
ajird-1636	34	17	mortality	mortality	NOUN
ajird-1636	34	18	.	.	PUNCT
ajird-1636	35	1	in	in	ADP
ajird-1636	35	2	addition	addition	NOUN
ajird-1636	35	3	,	,	PUNCT
ajird-1636	35	4	galectin-3	galectin-3	PROPN
ajird-1636	35	5	has	have	AUX
ajird-1636	35	6	shown	show	VERB
ajird-1636	35	7	prospective	prospective	ADJ
ajird-1636	35	8	value	value	NOUN
ajird-1636	35	9	for	for	ADP
ajird-1636	35	10	cardiovascular	cardiovascular	ADJ
ajird-1636	35	11	and	and	CCONJ
ajird-1636	35	12	all	all	DET
ajird-1636	35	13	-	-	PUNCT
ajird-1636	35	14	cause	cause	NOUN
ajird-1636	35	15	mortality	mortality	NOUN
ajird-1636	35	16	in	in	ADP
ajird-1636	35	17	individuals	individual	NOUN
ajird-1636	35	18	with	with	ADP
ajird-1636	35	19	t2dm.[14	t2dm.[14	PROPN
ajird-1636	35	20	]	]	PUNCT
ajird-1636	35	21	.	.	PUNCT
ajird-1636	36	1	thus	thus	ADV
ajird-1636	36	2	,	,	PUNCT
ajird-1636	36	3	diabetic	diabetic	ADJ
ajird-1636	36	4	patients	patient	NOUN
ajird-1636	36	5	with	with	ADP
ajird-1636	36	6	known	know	VERB
ajird-1636	36	7	cardiovascular	cardiovascular	ADJ
ajird-1636	36	8	diseases	disease	NOUN
ajird-1636	36	9	,	,	PUNCT
ajird-1636	36	10	including	include	VERB
ajird-1636	36	11	atherosclerosis	atherosclerosis	NOUN
ajird-1636	36	12	,	,	PUNCT
ajird-1636	36	13	stable	stable	ADJ
ajird-1636	36	14	coronary	coronary	ADJ
ajird-1636	36	15	artery	artery	NOUN
ajird-1636	36	16	disease	disease	NOUN
ajird-1636	36	17	(	(	PUNCT
ajird-1636	36	18	chd	chd	NOUN
ajird-1636	36	19	)	)	PUNCT
ajird-1636	36	20	,	,	PUNCT
ajird-1636	36	21	acute	acute	ADJ
ajird-1636	36	22	coronary	coronary	ADJ
ajird-1636	36	23	syndrome	syndrome	NOUN
ajird-1636	36	24	/	/	SYM
ajird-1636	36	25	myocardial	myocardial	ADJ
ajird-1636	36	26	infarction	infarction	NOUN
ajird-1636	36	27	(	(	PUNCT
ajird-1636	36	28	mi	mi	NOUN
ajird-1636	36	29	)	)	PUNCT
ajird-1636	36	30	,	,	PUNCT
ajird-1636	36	31	heart	heart	NOUN
ajird-1636	36	32	failure	failure	NOUN
ajird-1636	36	33	(	(	PUNCT
ajird-1636	36	34	hf	hf	NOUN
ajird-1636	36	35	)	)	PUNCT
ajird-1636	36	36	,	,	PUNCT
ajird-1636	36	37	arrhythmias	arrhythmia	NOUN
ajird-1636	36	38	(	(	PUNCT
ajird-1636	36	39	atrial	atrial	ADJ
ajird-1636	36	40	fibrillation	fibrillation	NOUN
ajird-1636	36	41	and	and	CCONJ
ajird-1636	36	42	flutter	flutter	NOUN
ajird-1636	36	43	)	)	PUNCT
ajird-1636	36	44	,	,	PUNCT
ajird-1636	36	45	and	and	CCONJ
ajird-1636	36	46	cardiomyopathies	cardiomyopathy	NOUN
ajird-1636	36	47	,	,	PUNCT
ajird-1636	36	48	have	have	VERB
ajird-1636	36	49	higher	high	ADJ
ajird-1636	36	50	risk	risk	NOUN
ajird-1636	36	51	of	of	ADP
ajird-1636	36	52	mortality	mortality	NOUN
ajird-1636	36	53	than	than	ADP
ajird-1636	36	54	non	non	ADJ
ajird-1636	36	55	-	-	NOUN
ajird-1636	36	56	diabetics	diabetic	NOUN
ajird-1636	36	57	with	with	ADP
ajird-1636	36	58	cardiovascular	cardiovascular	ADJ
ajird-1636	36	59	disease	disease	NOUN
ajird-1636	36	60	[	[	X
ajird-1636	36	61	15	15	NUM
ajird-1636	36	62	-	-	SYM
ajird-1636	36	63	17	17	NUM
ajird-1636	36	64	]	]	PUNCT
ajird-1636	36	65	.	.	PUNCT
ajird-1636	37	1	in	in	ADP
ajird-1636	37	2	2019	2019	NUM
ajird-1636	37	3	,	,	PUNCT
ajird-1636	37	4	the	the	DET
ajird-1636	37	5	european	european	ADJ
ajird-1636	37	6	society	society	PROPN
ajird-1636	37	7	of	of	ADP
ajird-1636	37	8	cardiology	cardiology	NOUN
ajird-1636	37	9	(	(	PUNCT
ajird-1636	37	10	esc	esc	NOUN
ajird-1636	37	11	)	)	PUNCT
ajird-1636	37	12	announced	announce	VERB
ajird-1636	37	13	a	a	DET
ajird-1636	37	14	new	new	ADJ
ajird-1636	37	15	clinical	clinical	ADJ
ajird-1636	37	16	guideline	guideline	NOUN
ajird-1636	37	17	for	for	ADP
ajird-1636	37	18	diabetes	diabetes	NOUN
ajird-1636	37	19	,	,	PUNCT
ajird-1636	37	20	prediabetes	prediabete	NOUN
ajird-1636	37	21	and	and	CCONJ
ajird-1636	37	22	cardiovascular	cardiovascular	ADJ
ajird-1636	37	23	disease	disease	NOUN
ajird-1636	37	24	[	[	X
ajird-1636	37	25	18	18	NUM
ajird-1636	37	26	]	]	PUNCT
ajird-1636	37	27	.	.	PUNCT
ajird-1636	38	1	this	this	DET
ajird-1636	38	2	recommendation	recommendation	NOUN
ajird-1636	38	3	contains	contain	VERB
ajird-1636	38	4	a	a	DET
ajird-1636	38	5	section	section	NOUN
ajird-1636	38	6	on	on	ADP
ajird-1636	38	7	circulating	circulate	VERB
ajird-1636	38	8	cardiac	cardiac	ADJ
ajird-1636	38	9	biomarkers	biomarker	NOUN
ajird-1636	38	10	that	that	PRON
ajird-1636	38	11	are	be	AUX
ajird-1636	38	12	promising	promise	VERB
ajird-1636	38	13	predictors	predictor	NOUN
ajird-1636	38	14	of	of	ADP
ajird-1636	38	15	cad	cad	PROPN
ajird-1636	38	16	,	,	PUNCT
ajird-1636	38	17	hf	hf	NOUN
ajird-1636	38	18	,	,	PUNCT
ajird-1636	38	19	and	and	CCONJ
ajird-1636	38	20	major	major	ADJ
ajird-1636	38	21	adverse	adverse	ADJ
ajird-1636	38	22	cardiovascular	cardiovascular	ADJ
ajird-1636	38	23	events	event	NOUN
ajird-1636	38	24	(	(	PUNCT
ajird-1636	38	25	maces	mace	NOUN
ajird-1636	38	26	)	)	PUNCT
ajird-1636	38	27	in	in	ADP
ajird-1636	38	28	patients	patient	NOUN
ajird-1636	38	29	with	with	ADP
ajird-1636	38	30	dm	dm	PROPN
ajird-1636	38	31	.	.	PUNCT
ajird-1636	39	1	notably	notably	ADV
ajird-1636	39	2	,	,	PUNCT
ajird-1636	39	3	dm2	dm2	PROPN
ajird-1636	39	4	and	and	CCONJ
ajird-1636	39	5	diabetes	diabetes	NOUN
ajird-1636	39	6	-	-	PUNCT
ajird-1636	39	7	induced	induce	VERB
ajird-1636	39	8	target	target	NOUN
ajird-1636	39	9	organ	organ	NOUN
ajird-1636	39	10	damage	damage	NOUN
ajird-1636	39	11	are	be	AUX
ajird-1636	39	12	considered	consider	VERB
ajird-1636	39	13	factors	factor	NOUN
ajird-1636	39	14	hindering	hinder	VERB
ajird-1636	39	15	the	the	DET
ajird-1636	39	16	clinical	clinical	ADJ
ajird-1636	39	17	interpretation	interpretation	NOUN
ajird-1636	39	18	of	of	ADP
ajird-1636	39	19	peak	peak	NOUN
ajird-1636	39	20	levels	level	NOUN
ajird-1636	39	21	of	of	ADP
ajird-1636	39	22	circulating	circulate	VERB
ajird-1636	39	23	biomarkers	biomarker	NOUN
ajird-1636	39	24	[	[	X
ajird-1636	39	25	19	19	NUM
ajird-1636	39	26	]	]	PUNCT
ajird-1636	39	27	.	.	PUNCT
ajird-1636	40	1	evidence	evidence	NOUN
ajird-1636	40	2	shows	show	VERB
ajird-1636	40	3	that	that	SCONJ
ajird-1636	40	4	traditional	traditional	ADJ
ajird-1636	40	5	cvd	cvd	PROPN
ajird-1636	40	6	risk	risk	NOUN
ajird-1636	40	7	factors	factor	NOUN
ajird-1636	40	8	negatively	negatively	ADV
ajird-1636	40	9	affect	affect	VERB
ajird-1636	40	10	mortality	mortality	NOUN
ajird-1636	40	11	and	and	CCONJ
ajird-1636	40	12	quality	quality	NOUN
ajird-1636	40	13	of	of	ADP
ajird-1636	40	14	life	life	NOUN
ajird-1636	40	15	in	in	ADP
ajird-1636	40	16	t2	t2	NOUN
ajird-1636	40	17	dm	dm	PROPN
ajird-1636	40	18	patients	patient	NOUN
ajird-1636	40	19	,	,	PUNCT
ajird-1636	40	20	and	and	CCONJ
ajird-1636	40	21	it	it	PRON
ajird-1636	40	22	is	be	AUX
ajird-1636	40	23	suggested	suggest	VERB
ajird-1636	40	24	that	that	SCONJ
ajird-1636	40	25	cardiac	cardiac	ADJ
ajird-1636	40	26	biomarkers	biomarker	NOUN
ajird-1636	40	27	reflecting	reflect	VERB
ajird-1636	40	28	various	various	ADJ
ajird-1636	40	29	pathophysiological	pathophysiological	ADJ
ajird-1636	40	30	stages	stage	NOUN
ajird-1636	40	31	of	of	ADP
ajird-1636	40	32	cardiac	cardiac	ADJ
ajird-1636	40	33	remodeling	remodeling	NOUN
ajird-1636	40	34	such	such	ADJ
ajird-1636	40	35	as	as	ADP
ajird-1636	40	36	biomechanical	biomechanical	ADJ
ajird-1636	40	37	stress	stress	NOUN
ajird-1636	40	38	,	,	PUNCT
ajird-1636	40	39	inflammation	inflammation	NOUN
ajird-1636	40	40	,	,	PUNCT
ajird-1636	40	41	necrosis	necrosis	NOUN
ajird-1636	40	42	/	/	SYM
ajird-1636	40	43	apoptosis	apoptosis	NOUN
ajird-1636	40	44	,	,	PUNCT
ajird-1636	40	45	fibrosis	fibrosis	NOUN
ajird-1636	40	46	,	,	PUNCT
ajird-1636	40	47	ecm	ecm	NOUN
ajird-1636	40	48	hypertrophy	hypertrophy	NOUN
ajird-1636	40	49	and	and	CCONJ
ajird-1636	40	50	remodeling	remodeling	NOUN
ajird-1636	40	51	will	will	AUX
ajird-1636	40	52	be	be	AUX
ajird-1636	40	53	of	of	ADP
ajird-1636	40	54	additional	additional	ADJ
ajird-1636	40	55	value	value	NOUN
ajird-1636	40	56	in	in	ADP
ajird-1636	40	57	predicting	predict	VERB
ajird-1636	40	58	clinical	clinical	ADJ
ajird-1636	40	59	outcomes	outcome	NOUN
ajird-1636	40	60	(	(	PUNCT
ajird-1636	40	61	death	death	NOUN
ajird-1636	40	62	,	,	PUNCT
ajird-1636	40	63	maces	mace	NOUN
ajird-1636	40	64	,	,	PUNCT
ajird-1636	40	65	hospitalization	hospitalization	NOUN
ajird-1636	40	66	,	,	PUNCT
ajird-1636	40	67	onset	onset	NOUN
ajird-1636	40	68	of	of	ADP
ajird-1636	40	69	hf	hf	NOUN
ajird-1636	40	70	)	)	PUNCT
ajird-1636	40	71	in	in	ADP
ajird-1636	40	72	a	a	DET
ajird-1636	40	73	patient	patient	ADJ
ajird-1636	40	74	population	population	NOUN
ajird-1636	40	75	.	.	PUNCT
ajird-1636	41	1	in	in	ADP
ajird-1636	41	2	addition	addition	NOUN
ajird-1636	41	3	,	,	PUNCT
ajird-1636	41	4	measurement	measurement	NOUN
ajird-1636	41	5	of	of	ADP
ajird-1636	41	6	circulating	circulate	VERB
ajird-1636	41	7	levels	level	NOUN
ajird-1636	41	8	of	of	ADP
ajird-1636	41	9	cardiac	cardiac	ADJ
ajird-1636	41	10	biomarkers	biomarker	NOUN
ajird-1636	41	11	may	may	AUX
ajird-1636	41	12	demonstrate	demonstrate	VERB
ajird-1636	41	13	new	new	ADJ
ajird-1636	41	14	individual	individual	ADJ
ajird-1636	41	15	prognostic	prognostic	ADJ
ajird-1636	41	16	information	information	NOUN
ajird-1636	41	17	that	that	PRON
ajird-1636	41	18	may	may	AUX
ajird-1636	41	19	be	be	AUX
ajird-1636	41	20	of	of	ADP
ajird-1636	41	21	greater	great	ADJ
ajird-1636	41	22	predictive	predictive	ADJ
ajird-1636	41	23	power	power	NOUN
ajird-1636	41	24	than	than	ADP
ajird-1636	41	25	conventional	conventional	ADJ
ajird-1636	41	26	cardiovascular	cardiovascular	ADJ
ajird-1636	41	27	risk	risk	NOUN
ajird-1636	41	28	factors	factor	NOUN
ajird-1636	41	29	.	.	PUNCT
ajird-1636	42	1	however	however	ADV
ajird-1636	42	2	,	,	PUNCT
ajird-1636	42	3	each	each	DET
ajird-1636	42	4	biomarker	biomarker	NOUN
ajird-1636	42	5	has	have	VERB
ajird-1636	42	6	strengths	strength	NOUN
ajird-1636	42	7	and	and	CCONJ
ajird-1636	42	8	weaknesses	weakness	NOUN
ajird-1636	42	9	,	,	PUNCT
ajird-1636	42	10	which	which	PRON
ajird-1636	42	11	affect	affect	VERB
ajird-1636	42	12	cost	cost	NOUN
ajird-1636	42	13	,	,	PUNCT
ajird-1636	42	14	specificity	specificity	NOUN
ajird-1636	42	15	,	,	PUNCT
ajird-1636	42	16	sensitivity	sensitivity	NOUN
ajird-1636	42	17	,	,	PUNCT
ajird-1636	42	18	predictive	predictive	ADJ
ajird-1636	42	19	value	value	NOUN
ajird-1636	42	20	,	,	PUNCT
ajird-1636	42	21	and	and	CCONJ
ajird-1636	42	22	head	head	NOUN
ajird-1636	42	23	-	-	PUNCT
ajird-1636	42	24	to	to	ADP
ajird-1636	42	25	-	-	PUNCT
ajird-1636	42	26	head	head	NOUN
ajird-1636	42	27	superiority	superiority	NOUN
ajird-1636	42	28	.	.	PUNCT
ajird-1636	43	1	since	since	SCONJ
ajird-1636	43	2	there	there	PRON
ajird-1636	43	3	are	be	VERB
ajird-1636	43	4	many	many	ADJ
ajird-1636	43	5	circulating	circulate	VERB
ajird-1636	43	6	biomarkers	biomarker	NOUN
ajird-1636	43	7	with	with	ADP
ajird-1636	43	8	unproven	unproven	ADJ
ajird-1636	43	9	ability	ability	NOUN
ajird-1636	43	10	to	to	PART
ajird-1636	43	11	predict	predict	VERB
ajird-1636	43	12	clinical	clinical	ADJ
ajird-1636	43	13	outcomes	outcome	NOUN
ajird-1636	43	14	in	in	ADP
ajird-1636	43	15	individuals	individual	NOUN
ajird-1636	43	16	before	before	ADV
ajird-1636	43	17	and	and	CCONJ
ajird-1636	43	18	with	with	ADP
ajird-1636	43	19	dm[20	dm[20	PROPN
ajird-1636	43	20	]	]	PUNCT
ajird-1636	43	21	.	.	PUNCT
ajird-1636	44	1	galectin-3	galectin-3	PROPN
ajird-1636	44	2	(	(	PUNCT
ajird-1636	44	3	gal-3	gal-3	NUM
ajird-1636	44	4	)	)	PUNCT
ajird-1636	44	5	is	be	AUX
ajird-1636	44	6	a	a	DET
ajird-1636	44	7	versatile	versatile	ADJ
ajird-1636	44	8	protein	protein	NOUN
ajird-1636	44	9	that	that	PRON
ajird-1636	44	10	belongs	belong	VERB
ajird-1636	44	11	to	to	ADP
ajird-1636	44	12	the	the	DET
ajird-1636	44	13	lectin	lectin	NOUN
ajird-1636	44	14	family	family	NOUN
ajird-1636	44	15	and	and	CCONJ
ajird-1636	44	16	is	be	AUX
ajird-1636	44	17	predominantly	predominantly	ADV
ajird-1636	44	18	involved	involve	VERB
ajird-1636	44	19	in	in	ADP
ajird-1636	44	20	fibrosis	fibrosis	NOUN
ajird-1636	44	21	and	and	CCONJ
ajird-1636	44	22	inflammation	inflammation	NOUN
ajird-1636	44	23	of	of	ADP
ajird-1636	44	24	the	the	DET
ajird-1636	44	25	heart	heart	NOUN
ajird-1636	44	26	,	,	PUNCT
ajird-1636	44	27	liver	liver	NOUN
ajird-1636	44	28	,	,	PUNCT
ajird-1636	44	29	and	and	CCONJ
ajird-1636	44	30	kidneys	kidney	NOUN
ajird-1636	45	1	[	[	X
ajird-1636	45	2	21,22	21,22	NOUN
ajird-1636	45	3	]	]	X
ajird-1636	45	4	.	.	PUNCT
ajird-1636	46	1	overexpression	overexpression	NOUN
ajird-1636	46	2	of	of	ADP
ajird-1636	46	3	gal-3	gal-3	PUNCT
ajird-1636	46	4	is	be	AUX
ajird-1636	46	5	associated	associate	VERB
ajird-1636	46	6	with	with	ADP
ajird-1636	46	7	the	the	DET
ajird-1636	46	8	accumulation	accumulation	NOUN
ajird-1636	46	9	of	of	ADP
ajird-1636	46	10	advanced	advanced	ADJ
ajird-1636	46	11	glycation	glycation	NOUN
ajird-1636	46	12	end	end	NOUN
ajird-1636	46	13	products	product	NOUN
ajird-1636	46	14	(	(	PUNCT
ajird-1636	46	15	ages	age	NOUN
ajird-1636	46	16	)	)	PUNCT
ajird-1636	46	17	,	,	PUNCT
ajird-1636	46	18	products	product	NOUN
ajird-1636	46	19	of	of	ADP
ajird-1636	46	20	oxidative	oxidative	ADJ
ajird-1636	46	21	stress	stress	NOUN
ajird-1636	46	22	.	.	PUNCT
ajird-1636	47	1	gal-3	gal-3	PUNCT
ajird-1636	47	2	predicts	predict	VERB
ajird-1636	47	3	cardiac	cardiac	ADJ
ajird-1636	47	4	remodeling	remodeling	NOUN
ajird-1636	47	5	and	and	CCONJ
ajird-1636	47	6	cardiovascular	cardiovascular	ADJ
ajird-1636	47	7	events	event	NOUN
ajird-1636	47	8	that	that	PRON
ajird-1636	47	9	are	be	AUX
ajird-1636	47	10	independently	independently	ADV
ajird-1636	47	11	associated	associate	VERB
ajird-1636	47	12	with	with	ADP
ajird-1636	47	13	it	it	PRON
ajird-1636	47	14	,	,	PUNCT
ajird-1636	47	15	such	such	ADJ
ajird-1636	47	16	as	as	ADP
ajird-1636	47	17	hf	hf	ADJ
ajird-1636	47	18	and	and	CCONJ
ajird-1636	47	19	atrial	atrial	ADJ
ajird-1636	47	20	fibrillation	fibrillation	NOUN
ajird-1636	47	21	[	[	X
ajird-1636	47	22	23.24	23.24	NUM
ajird-1636	47	23	]	]	PUNCT
ajird-1636	47	24	.	.	PUNCT
ajird-1636	48	1	serum	serum	NOUN
ajird-1636	48	2	gal-3	gal-3	PUNCT
ajird-1636	48	3	levels	level	NOUN
ajird-1636	48	4	in	in	ADP
ajird-1636	48	5	t2	t2	NOUN
ajird-1636	49	1	dm	dm	PROPN
ajird-1636	49	2	patients	patient	NOUN
ajird-1636	49	3	showed	show	VERB
ajird-1636	49	4	a	a	DET
ajird-1636	49	5	modest	modest	ADJ
ajird-1636	49	6	increase	increase	NOUN
ajird-1636	49	7	from	from	ADP
ajird-1636	49	8	baseline	baseline	NOUN
ajird-1636	49	9	with	with	ADP
ajird-1636	49	10	the	the	DET
ajird-1636	49	11	sglt2	sglt2	ADJ
ajird-1636	49	12	inhibitor	inhibitor	NOUN
ajird-1636	49	13	canagliflozin	canagliflozin	PROPN
ajird-1636	49	14	compared	compare	VERB
ajird-1636	49	15	with	with	ADP
ajird-1636	49	16	placebo	placebo	NOUN
ajird-1636	49	17	,	,	PUNCT
ajird-1636	49	18	while	while	SCONJ
ajird-1636	49	19	both	both	PRON
ajird-1636	49	20	ntprobnp	ntprobnp	NOUN
ajird-1636	49	21	and	and	CCONJ
ajird-1636	49	22	hs	hs	ADJ
ajird-1636	49	23	-	-	ADJ
ajird-1636	49	24	ctni	ctni	ADJ
ajird-1636	49	25	concentrations	concentration	NOUN
ajird-1636	49	26	showed	show	VERB
ajird-1636	49	27	a	a	DET
ajird-1636	49	28	downward	downward	ADJ
ajird-1636	49	29	trend	trend	NOUN
ajird-1636	49	30	for	for	ADP
ajird-1636	49	31	>	>	SYM
ajird-1636	49	32	2	2	NUM
ajird-1636	49	33	years	year	NOUN
ajird-1636	49	34	[	[	X
ajird-1636	49	35	25	25	NUM
ajird-1636	49	36	]	]	PUNCT
ajird-1636	49	37	.	.	PUNCT
ajird-1636	50	1	all	all	PRON
ajird-1636	50	2	of	of	ADP
ajird-1636	50	3	the	the	DET
ajird-1636	50	4	above	above	ADJ
ajird-1636	50	5	emphasizes	emphasize	VERB
ajird-1636	50	6	the	the	DET
ajird-1636	50	7	relevance	relevance	NOUN
ajird-1636	50	8	of	of	ADP
ajird-1636	50	9	this	this	DET
ajird-1636	50	10	study	study	NOUN
ajird-1636	50	11	.	.	PUNCT
ajird-1636	51	1	in	in	ADP
ajird-1636	51	2	this	this	DET
ajird-1636	51	3	regard	regard	NOUN
ajird-1636	51	4	,	,	PUNCT
ajird-1636	51	5	we	we	PRON
ajird-1636	51	6	formulated	formulate	VERB
ajird-1636	51	7	the	the	DET
ajird-1636	51	8	following	follow	VERB
ajird-1636	51	9	goal	goal	NOUN
ajird-1636	51	10	of	of	ADP
ajird-1636	51	11	the	the	DET
ajird-1636	51	12	research	research	NOUN
ajird-1636	51	13	work	work	NOUN
ajird-1636	51	14	.	.	PUNCT
ajird-1636	52	1	purpose	purpose	NOUN
ajird-1636	52	2	of	of	ADP
ajird-1636	52	3	the	the	DET
ajird-1636	52	4	study	study	NOUN
ajird-1636	52	5	-to	-to	INTJ
ajird-1636	52	6	study	study	VERB
ajird-1636	52	7	the	the	DET
ajird-1636	52	8	role	role	NOUN
ajird-1636	52	9	of	of	ADP
ajird-1636	52	10	galectin-3	galectin-3	PROPN
ajird-1636	52	11	and	and	CCONJ
ajird-1636	52	12	h	h	NOUN
ajird-1636	52	13	-	-	PUNCT
ajird-1636	52	14	fabr	fabr	ADJ
ajird-1636	52	15	markers	marker	NOUN
ajird-1636	52	16	in	in	ADP
ajird-1636	52	17	the	the	DET
ajird-1636	52	18	prognosis	prognosis	NOUN
ajird-1636	52	19	of	of	ADP
ajird-1636	52	20	chf	chf	NOUN
ajird-1636	52	21	in	in	ADP
ajird-1636	52	22	patients	patient	NOUN
ajird-1636	52	23	with	with	ADP
ajird-1636	52	24	type	type	NOUN
ajird-1636	52	25	2	2	NUM
ajird-1636	52	26	diabetes	diabetes	NOUN
ajird-1636	52	27	mellitus	mellitus	NOUN
ajird-1636	52	28	undergoing	undergo	VERB
ajird-1636	52	29	cabg	cabg	NOUN
ajird-1636	52	30	and	and	CCONJ
ajird-1636	52	31	stenting	stenting	NOUN
ajird-1636	52	32	.	.	PUNCT
ajird-1636	53	1	american	american	PROPN
ajird-1636	53	2	journal	journal	PROPN
ajird-1636	53	3	of	of	ADP
ajird-1636	53	4	interdisciplinary	interdisciplinary	ADJ
ajird-1636	53	5	research	research	NOUN
ajird-1636	53	6	and	and	CCONJ
ajird-1636	53	7	development	development	NOUN
ajird-1636	53	8	issn	issn	PROPN
ajird-1636	53	9	online	online	NOUN
ajird-1636	53	10	:	:	PUNCT
ajird-1636	53	11	2771	2771	NUM
ajird-1636	53	12	-	-	SYM
ajird-1636	53	13	8948	8948	NUM
ajird-1636	53	14	website	website	NOUN
ajird-1636	53	15	:	:	PUNCT
ajird-1636	53	16	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-1636	53	17	volume	volume	NOUN
ajird-1636	53	18	46	46	NUM
ajird-1636	53	19	,	,	PUNCT
ajird-1636	53	20	november2025	november2025	PROPN
ajird-1636	53	21	40	40	NUM
ajird-1636	54	1	|	|	ADV
ajird-1636	54	2	p	p	X
ajird-1636	54	3	a	a	DET
ajird-1636	54	4	g	g	NOUN
ajird-1636	54	5	e	e	NOUN
ajird-1636	54	6	materials	material	NOUN
ajird-1636	54	7	and	and	CCONJ
ajird-1636	54	8	methods	method	NOUN
ajird-1636	54	9	80	80	NUM
ajird-1636	54	10	patients	patient	NOUN
ajird-1636	54	11	(	(	PUNCT
ajird-1636	54	12	prospectively	prospectively	ADV
ajird-1636	54	13	)	)	PUNCT
ajird-1636	54	14	with	with	ADP
ajird-1636	54	15	type	type	NOUN
ajird-1636	54	16	2	2	NUM
ajird-1636	54	17	diabetes	diabetes	NOUN
ajird-1636	54	18	were	be	AUX
ajird-1636	54	19	examined	examine	VERB
ajird-1636	54	20	at	at	ADP
ajird-1636	54	21	the	the	DET
ajird-1636	54	22	acad	acad	NOUN
ajird-1636	54	23	.	.	PUNCT
ajird-1636	55	1	v.v	v.v	PROPN
ajird-1636	55	2	.	.	PROPN
ajird-1636	55	3	vakhidov	vakhidov	PROPN
ajird-1636	55	4	on	on	ADP
ajird-1636	55	5	the	the	DET
ajird-1636	55	6	basis	basis	NOUN
ajird-1636	55	7	of	of	ADP
ajird-1636	55	8	a	a	DET
ajird-1636	55	9	scientific	scientific	ADJ
ajird-1636	55	10	agreement	agreement	NOUN
ajird-1636	55	11	together	together	ADV
ajird-1636	55	12	with	with	ADP
ajird-1636	55	13	the	the	DET
ajird-1636	55	14	rsnpmtse	rsnpmtse	NOUN
ajird-1636	55	15	of	of	ADP
ajird-1636	55	16	the	the	DET
ajird-1636	55	17	ministry	ministry	PROPN
ajird-1636	55	18	of	of	ADP
ajird-1636	55	19	health	health	PROPN
ajird-1636	55	20	of	of	ADP
ajird-1636	55	21	the	the	DET
ajird-1636	55	22	republic	republic	NOUN
ajird-1636	55	23	of	of	ADP
ajird-1636	55	24	uzbekistan	uzbekistan	PROPN
ajird-1636	55	25	named	name	VERB
ajird-1636	55	26	after	after	ADP
ajird-1636	55	27	acad	acad	PROPN
ajird-1636	55	28	.	.	PUNCT
ajird-1636	56	1	y.h	y.h	PROPN
ajird-1636	56	2	.	.	PROPN
ajird-1636	56	3	turakulova	turakulova	PROPN
ajird-1636	56	4	.	.	PUNCT
ajird-1636	57	1	at	at	ADP
ajird-1636	57	2	the	the	DET
ajird-1636	57	3	same	same	ADJ
ajird-1636	57	4	time	time	NOUN
ajird-1636	57	5	,	,	PUNCT
ajird-1636	57	6	300	300	NUM
ajird-1636	57	7	case	case	NOUN
ajird-1636	57	8	histories	history	NOUN
ajird-1636	57	9	of	of	ADP
ajird-1636	57	10	patients	patient	NOUN
ajird-1636	57	11	with	with	ADP
ajird-1636	57	12	type	type	NOUN
ajird-1636	57	13	2	2	NUM
ajird-1636	57	14	diabetes	diabete	NOUN
ajird-1636	57	15	who	who	PRON
ajird-1636	57	16	underwent	undergo	VERB
ajird-1636	57	17	cabg	cabg	NOUN
ajird-1636	57	18	in	in	ADP
ajird-1636	57	19	this	this	DET
ajird-1636	57	20	center	center	NOUN
ajird-1636	57	21	were	be	AUX
ajird-1636	57	22	retrospectively	retrospectively	ADV
ajird-1636	57	23	analyzed	analyze	VERB
ajird-1636	57	24	.	.	PUNCT
ajird-1636	58	1	all	all	PRON
ajird-1636	58	2	observed	observe	VERB
ajird-1636	58	3	80	80	NUM
ajird-1636	58	4	patients	patient	NOUN
ajird-1636	58	5	were	be	AUX
ajird-1636	58	6	divided	divide	VERB
ajird-1636	58	7	into	into	ADP
ajird-1636	58	8	4	4	NUM
ajird-1636	58	9	groups	group	NOUN
ajird-1636	58	10	:	:	PUNCT
ajird-1636	58	11	gr	gr	X
ajird-1636	58	12	.	.	PROPN
ajird-1636	58	13	–	–	PUNCT
ajird-1636	58	14	25	25	NUM
ajird-1636	58	15	patients	patient	NOUN
ajird-1636	58	16	with	with	ADP
ajird-1636	58	17	chf	chf	NOUN
ajird-1636	58	18	and	and	CCONJ
ajird-1636	58	19	type	type	NOUN
ajird-1636	58	20	2	2	NUM
ajird-1636	58	21	diabetes	diabetes	NOUN
ajird-1636	58	22	,	,	PUNCT
ajird-1636	58	23	stent	stent	NOUN
ajird-1636	58	24	gr	gr	NOUN
ajird-1636	58	25	.	.	PUNCT
ajird-1636	59	1	–	–	PUNCT
ajird-1636	59	2	25	25	NUM
ajird-1636	59	3	patients	patient	NOUN
ajird-1636	59	4	with	with	ADP
ajird-1636	59	5	chf	chf	NOUN
ajird-1636	59	6	without	without	ADP
ajird-1636	59	7	type	type	NOUN
ajird-1636	59	8	2	2	NUM
ajird-1636	59	9	diabetes	diabetes	NOUN
ajird-1636	59	10	,	,	PUNCT
ajird-1636	59	11	stent	stent	NOUN
ajird-1636	59	12	gr	gr	NOUN
ajird-1636	59	13	.	.	PUNCT
ajird-1636	59	14	–	–	PUNCT
ajird-1636	59	15	10	10	NUM
ajird-1636	59	16	patients	patient	NOUN
ajird-1636	59	17	with	with	ADP
ajird-1636	59	18	chf	chf	PROPN
ajird-1636	59	19	and	and	CCONJ
ajird-1636	59	20	dm2	dm2	PROPN
ajird-1636	59	21	,	,	PUNCT
ajird-1636	59	22	cabg	cabg	VERB
ajird-1636	59	23	gr	gr	PROPN
ajird-1636	59	24	.	.	PROPN
ajird-1636	59	25	–	–	PUNCT
ajird-1636	59	26	20	20	NUM
ajird-1636	59	27	patients	patient	NOUN
ajird-1636	59	28	with	with	ADP
ajird-1636	59	29	chf	chf	NOUN
ajird-1636	59	30	without	without	ADP
ajird-1636	59	31	dm	dm	PROPN
ajird-1636	59	32	2	2	NUM
ajird-1636	59	33	,	,	PUNCT
ajird-1636	59	34	cabg	cabg	VERB
ajird-1636	59	35	the	the	DET
ajird-1636	59	36	control	control	PROPN
ajird-1636	59	37	group	group	NOUN
ajird-1636	59	38	consisted	consist	VERB
ajird-1636	59	39	of	of	ADP
ajird-1636	59	40	10	10	NUM
ajird-1636	59	41	patients	patient	NOUN
ajird-1636	59	42	with	with	ADP
ajird-1636	59	43	type	type	NOUN
ajird-1636	59	44	2	2	NUM
ajird-1636	59	45	diabetes	diabetes	NOUN
ajird-1636	59	46	without	without	ADP
ajird-1636	59	47	chf	chf	PROPN
ajird-1636	59	48	.	.	PROPN
ajird-1636	60	1	of	of	ADP
ajird-1636	60	2	these	these	PRON
ajird-1636	60	3	,	,	PUNCT
ajird-1636	60	4	there	there	PRON
ajird-1636	60	5	were	be	VERB
ajird-1636	60	6	29	29	NUM
ajird-1636	60	7	women	woman	NOUN
ajird-1636	60	8	,	,	PUNCT
ajird-1636	60	9	51	51	NUM
ajird-1636	60	10	men	man	NOUN
ajird-1636	60	11	.	.	PUNCT
ajird-1636	61	1	the	the	DET
ajird-1636	61	2	average	average	ADJ
ajird-1636	61	3	age	age	NOUN
ajird-1636	61	4	of	of	ADP
ajird-1636	61	5	men	man	NOUN
ajird-1636	61	6	was	be	AUX
ajird-1636	61	7	67	67	NUM
ajird-1636	61	8	±	±	NUM
ajird-1636	61	9	4.2	4.2	NUM
ajird-1636	61	10	years	year	NOUN
ajird-1636	61	11	,	,	PUNCT
ajird-1636	61	12	and	and	CCONJ
ajird-1636	61	13	the	the	DET
ajird-1636	61	14	average	average	ADJ
ajird-1636	61	15	age	age	NOUN
ajird-1636	61	16	of	of	ADP
ajird-1636	61	17	women	woman	NOUN
ajird-1636	61	18	was	be	AUX
ajird-1636	61	19	64	64	NUM
ajird-1636	61	20	±	±	NUM
ajird-1636	61	21	5.6	5.6	NUM
ajird-1636	61	22	years	year	NOUN
ajird-1636	61	23	.	.	PUNCT
ajird-1636	62	1	the	the	DET
ajird-1636	62	2	study	study	NOUN
ajird-1636	62	3	used	use	VERB
ajird-1636	62	4	clinical	clinical	ADJ
ajird-1636	62	5	and	and	CCONJ
ajird-1636	62	6	biochemical	biochemical	ADJ
ajird-1636	62	7	research	research	NOUN
ajird-1636	62	8	methods	method	NOUN
ajird-1636	62	9	(	(	PUNCT
ajird-1636	62	10	glycemia	glycemia	NOUN
ajird-1636	62	11	,	,	PUNCT
ajird-1636	62	12	glycated	glycate	VERB
ajird-1636	62	13	hemoglobin	hemoglobin	NOUN
ajird-1636	62	14	,	,	PUNCT
ajird-1636	62	15	alt	alt	ADJ
ajird-1636	62	16	,	,	PUNCT
ajird-1636	62	17	ast	ast	NOUN
ajird-1636	62	18	,	,	PUNCT
ajird-1636	62	19	bilirubin	bilirubin	NOUN
ajird-1636	62	20	,	,	PUNCT
ajird-1636	62	21	urea	urea	NOUN
ajird-1636	62	22	,	,	PUNCT
ajird-1636	62	23	creatinine	creatinine	NOUN
ajird-1636	62	24	,	,	PUNCT
ajird-1636	62	25	pti	pti	PROPN
ajird-1636	62	26	,	,	PUNCT
ajird-1636	62	27	studies	study	NOUN
ajird-1636	62	28	of	of	ADP
ajird-1636	62	29	chf	chf	NOUN
ajird-1636	62	30	biomarkers	biomarker	NOUN
ajird-1636	62	31	(	(	PUNCT
ajird-1636	62	32	galectin-3	galectin-3	PROPN
ajird-1636	62	33	,	,	PUNCT
ajird-1636	62	34	hfabr	hfabr	PROPN
ajird-1636	62	35	)	)	PUNCT
ajird-1636	62	36	,	,	PUNCT
ajird-1636	62	37	as	as	ADV
ajird-1636	62	38	well	well	ADV
ajird-1636	62	39	as	as	ADP
ajird-1636	62	40	instrumental	instrumental	ADJ
ajird-1636	62	41	methods	method	NOUN
ajird-1636	62	42	of	of	ADP
ajird-1636	62	43	examination	examination	NOUN
ajird-1636	62	44	ultrasound	ultrasound	NOUN
ajird-1636	62	45	of	of	ADP
ajird-1636	62	46	internal	internal	ADJ
ajird-1636	62	47	organs	organ	NOUN
ajird-1636	62	48	,	,	PUNCT
ajird-1636	62	49	ecg	ecg	PROPN
ajird-1636	62	50	,	,	PUNCT
ajird-1636	62	51	echo	echo	NOUN
ajird-1636	62	52	-	-	PUNCT
ajird-1636	62	53	ecg	ecg	PROPN
ajird-1636	62	54	,	,	PUNCT
ajird-1636	62	55	as	as	ADV
ajird-1636	62	56	well	well	ADV
ajird-1636	62	57	as	as	ADP
ajird-1636	62	58	statistical	statistical	ADJ
ajird-1636	62	59	methods	method	NOUN
ajird-1636	62	60	.	.	PUNCT
ajird-1636	63	1	used	use	VERB
ajird-1636	63	2	for	for	ADP
ajird-1636	63	3	echocardiographyvivid	echocardiographyvivid	PROPN
ajird-1636	63	4	e9	e9	PROPN
ajird-1636	63	5	or	or	CCONJ
ajird-1636	63	6	vivid	vivid	ADJ
ajird-1636	63	7	i	i	NOUN
ajird-1636	63	8	(	(	PUNCT
ajird-1636	63	9	general	general	PROPN
ajird-1636	63	10	electric	electric	PROPN
ajird-1636	63	11	,	,	PUNCT
ajird-1636	63	12	fairfield	fairfield	PROPN
ajird-1636	63	13	,	,	PUNCT
ajird-1636	63	14	ct)with	ct)with	ADP
ajird-1636	63	15	m4s	m4s	PROPN
ajird-1636	63	16	-	-	PUNCT
ajird-1636	63	17	rs	rs	ADJ
ajird-1636	63	18	transducer	transducer	NOUN
ajird-1636	63	19	(	(	PUNCT
ajird-1636	63	20	1.5	1.5	NUM
ajird-1636	63	21	-	-	SYM
ajird-1636	63	22	3.6	3.6	NUM
ajird-1636	63	23	mhz	mhz	NOUN
ajird-1636	63	24	)	)	PUNCT
ajird-1636	63	25	.	.	PUNCT
ajird-1636	64	1	all	all	DET
ajird-1636	64	2	measurements	measurement	NOUN
ajird-1636	64	3	in	in	ADP
ajird-1636	64	4	m	m	NOUN
ajird-1636	64	5	-	-	NOUN
ajird-1636	64	6	mode	mode	NOUN
ajird-1636	64	7	were	be	AUX
ajird-1636	64	8	performed	perform	VERB
ajird-1636	64	9	in	in	ADP
ajird-1636	64	10	accordance	accordance	NOUN
ajird-1636	64	11	with	with	ADP
ajird-1636	64	12	the	the	DET
ajird-1636	64	13	recommendations	recommendation	NOUN
ajird-1636	64	14	of	of	ADP
ajird-1636	64	15	the	the	DET
ajird-1636	64	16	american	american	ADJ
ajird-1636	64	17	society	society	NOUN
ajird-1636	64	18	of	of	ADP
ajird-1636	64	19	echocardiography	echocardiography	NOUN
ajird-1636	64	20	.	.	PUNCT
ajird-1636	65	1	results	result	NOUN
ajird-1636	65	2	and	and	CCONJ
ajird-1636	65	3	discussion	discussion	NOUN
ajird-1636	65	4	table	table	NOUN
ajird-1636	65	5	1	1	NUM
ajird-1636	65	6	shows	show	VERB
ajird-1636	65	7	the	the	DET
ajird-1636	65	8	distribution	distribution	NOUN
ajird-1636	65	9	of	of	ADP
ajird-1636	65	10	patients	patient	NOUN
ajird-1636	65	11	by	by	ADP
ajird-1636	65	12	sex	sex	NOUN
ajird-1636	65	13	and	and	CCONJ
ajird-1636	65	14	age	age	NOUN
ajird-1636	65	15	.	.	PUNCT
ajird-1636	66	1	as	as	SCONJ
ajird-1636	66	2	can	can	AUX
ajird-1636	66	3	be	be	AUX
ajird-1636	66	4	seen	see	VERB
ajird-1636	66	5	from	from	ADP
ajird-1636	66	6	table	table	NOUN
ajird-1636	66	7	1	1	NUM
ajird-1636	66	8	,	,	PUNCT
ajird-1636	66	9	patients	patient	NOUN
ajird-1636	66	10	in	in	ADP
ajird-1636	66	11	the	the	DET
ajird-1636	66	12	age	age	NOUN
ajird-1636	66	13	group	group	NOUN
ajird-1636	66	14	from	from	ADP
ajird-1636	66	15	45	45	NUM
ajird-1636	66	16	to	to	PART
ajird-1636	66	17	59	59	NUM
ajird-1636	66	18	years	year	NOUN
ajird-1636	66	19	old	old	ADJ
ajird-1636	66	20	both	both	CCONJ
ajird-1636	66	21	among	among	ADP
ajird-1636	66	22	men	man	NOUN
ajird-1636	66	23	and	and	CCONJ
ajird-1636	66	24	women	woman	NOUN
ajird-1636	66	25	predominated	predominate	VERB
ajird-1636	66	26	44	44	NUM
ajird-1636	66	27	out	out	ADP
ajird-1636	66	28	of	of	ADP
ajird-1636	66	29	80	80	NUM
ajird-1636	66	30	patients	patient	NOUN
ajird-1636	66	31	(	(	PUNCT
ajird-1636	66	32	55.0	55.0	NUM
ajird-1636	66	33	%	%	NOUN
ajird-1636	66	34	)	)	PUNCT
ajird-1636	66	35	.	.	PUNCT
ajird-1636	67	1	table	table	NOUN
ajird-1636	67	2	1	1	NUM
ajird-1636	67	3	.	.	PUNCT
ajird-1636	68	1	indicators	indicator	NOUN
ajird-1636	68	2	number	number	NOUN
ajird-1636	68	3	of	of	ADP
ajird-1636	68	4	patients	patient	NOUN
ajird-1636	68	5	(	(	PUNCT
ajird-1636	68	6	n=80	n=80	PROPN
ajird-1636	68	7	)	)	PUNCT
ajird-1636	68	8	1	1	NUM
ajird-1636	68	9	group	group	NOUN
ajird-1636	68	10	(	(	PUNCT
ajird-1636	68	11	n=25	n=25	NOUN
ajird-1636	68	12	)	)	PUNCT
ajird-1636	68	13	2	2	NUM
ajird-1636	68	14	group	group	NOUN
ajird-1636	68	15	(	(	PUNCT
ajird-1636	68	16	n=25	n=25	NOUN
ajird-1636	68	17	)	)	PUNCT
ajird-1636	68	18	3	3	NUM
ajird-1636	68	19	group	group	NOUN
ajird-1636	68	20	(	(	PUNCT
ajird-1636	68	21	n=10	n=10	NOUN
ajird-1636	68	22	)	)	PUNCT
ajird-1636	68	23	4	4	NUM
ajird-1636	68	24	group	group	NOUN
ajird-1636	68	25	(	(	PUNCT
ajird-1636	68	26	n=20	n=20	PROPN
ajird-1636	68	27	)	)	PUNCT
ajird-1636	68	28	control	control	NOUN
ajird-1636	68	29	(	(	PUNCT
ajird-1636	68	30	n=10	n=10	NOUN
ajird-1636	68	31	)	)	PUNCT
ajird-1636	68	32	abs	ab	VERB
ajird-1636	69	1	%	%	NOUN
ajird-1636	69	2	abs	ab	NOUN
ajird-1636	69	3	%	%	NOUN
ajird-1636	69	4	abs	ab	NOUN
ajird-1636	69	5	%	%	NOUN
ajird-1636	69	6	abs	ab	NOUN
ajird-1636	69	7	%	%	NOUN
ajird-1636	69	8	abs	ab	NOUN
ajird-1636	69	9	%	%	NOUN
ajird-1636	69	10	age	age	NOUN
ajird-1636	69	11	periods	period	NOUN
ajird-1636	69	12	,	,	PUNCT
ajird-1636	69	13	years	year	NOUN
ajird-1636	69	14	18	18	NUM
ajird-1636	69	15	-	-	SYM
ajird-1636	69	16	44	44	NUM
ajird-1636	69	17	45	45	NUM
ajird-1636	69	18	-	-	SYM
ajird-1636	69	19	59	59	NUM
ajird-1636	69	20	15	15	NUM
ajird-1636	69	21	60.0	60.0	NUM
ajird-1636	69	22	14	14	NUM
ajird-1636	69	23	56.0	56.0	NUM
ajird-1636	69	24	6	6	NUM
ajird-1636	69	25	60.0	60.0	NUM
ajird-1636	69	26	9	9	NUM
ajird-1636	69	27	45.0	45.0	NUM
ajird-1636	69	28	4	4	NUM
ajird-1636	69	29	40	40	NUM
ajird-1636	69	30	60	60	NUM
ajird-1636	69	31	-	-	SYM
ajird-1636	69	32	74	74	NUM
ajird-1636	69	33	10	10	NUM
ajird-1636	69	34	40.0	40.0	NUM
ajird-1636	69	35	eleven	eleven	NUM
ajird-1636	69	36	44.0	44.0	NUM
ajird-1636	69	37	4	4	NUM
ajird-1636	69	38	40.0	40.0	NUM
ajird-1636	69	39	eleven	eleven	NUM
ajird-1636	69	40	55.0	55.0	NUM
ajird-1636	69	41	6	6	NUM
ajird-1636	69	42	60	60	NUM
ajird-1636	69	43	75and	75and	NOUN
ajird-1636	69	44	>	>	PUNCT
ajird-1636	69	45	total	total	NOUN
ajird-1636	69	46	25	25	NUM
ajird-1636	69	47	31.25	31.25	NUM
ajird-1636	69	48	25	25	NUM
ajird-1636	69	49	31.25	31.25	NUM
ajird-1636	69	50	10	10	NUM
ajird-1636	69	51	12.5	12.5	NUM
ajird-1636	69	52	20	20	NUM
ajird-1636	69	53	25.0	25.0	NUM
ajird-1636	69	54	10	10	NUM
ajird-1636	69	55	12.5	12.5	NUM
ajird-1636	69	56	average	average	ADJ
ajird-1636	69	57	age	age	NOUN
ajird-1636	69	58	62.7±5.6	62.7±5.6	NUM
ajird-1636	69	59	61.6±7.8	61.6±7.8	NUM
ajird-1636	69	60	63.8±6.9	63.8±6.9	NUM
ajird-1636	69	61	64.7±3.6	64.7±3.6	NUM
ajird-1636	69	62	62.5±7.8	62.5±7.8	NUM
ajird-1636	69	63	sex	sex	NOUN
ajird-1636	69	64	male	male	NOUN
ajird-1636	69	65	19	19	NUM
ajird-1636	69	66	76.0	76.0	NUM
ajird-1636	69	67	18	18	NUM
ajird-1636	69	68	72.0	72.0	NUM
ajird-1636	69	69	6	6	NUM
ajird-1636	69	70	60	60	NUM
ajird-1636	69	71	13	13	NUM
ajird-1636	69	72	65	65	NUM
ajird-1636	69	73	5	5	NUM
ajird-1636	69	74	50.0	50.0	NUM
ajird-1636	69	75	female	female	NOUN
ajird-1636	69	76	6	6	NUM
ajird-1636	69	77	24.0	24.0	NUM
ajird-1636	69	78	7	7	NUM
ajird-1636	69	79	28.0	28.0	NUM
ajird-1636	69	80	4	4	NUM
ajird-1636	69	81	40	40	NUM
ajird-1636	69	82	7	7	NUM
ajird-1636	69	83	35	35	NUM
ajird-1636	69	84	5	5	NUM
ajird-1636	69	85	50.0	50.0	NUM
ajird-1636	69	86	total	total	NOUN
ajird-1636	69	87	25	25	NUM
ajird-1636	69	88	31.25	31.25	NUM
ajird-1636	69	89	15	15	NUM
ajird-1636	69	90	31.25	31.25	NUM
ajird-1636	69	91	15	15	NUM
ajird-1636	69	92	12.5	12.5	NUM
ajird-1636	69	93	20	20	NUM
ajird-1636	69	94	25.0	25.0	NUM
ajird-1636	69	95	10	10	NUM
ajird-1636	69	96	12.5	12.5	NUM
ajird-1636	69	97	american	american	ADJ
ajird-1636	69	98	journal	journal	PROPN
ajird-1636	69	99	of	of	ADP
ajird-1636	69	100	interdisciplinary	interdisciplinary	ADJ
ajird-1636	69	101	research	research	NOUN
ajird-1636	69	102	and	and	CCONJ
ajird-1636	69	103	development	development	NOUN
ajird-1636	69	104	issn	issn	PROPN
ajird-1636	69	105	online	online	NOUN
ajird-1636	69	106	:	:	PUNCT
ajird-1636	69	107	2771	2771	NUM
ajird-1636	69	108	-	-	SYM
ajird-1636	69	109	8948	8948	NUM
ajird-1636	69	110	website	website	NOUN
ajird-1636	69	111	:	:	PUNCT
ajird-1636	69	112	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-1636	69	113	volume	volume	NOUN
ajird-1636	69	114	46	46	NUM
ajird-1636	69	115	,	,	PUNCT
ajird-1636	69	116	november2025	november2025	PROPN
ajird-1636	69	117	41	41	NUM
ajird-1636	70	1	|	|	ADV
ajird-1636	70	2	p	p	X
ajird-1636	70	3	a	a	DET
ajird-1636	70	4	g	g	NOUN
ajird-1636	70	5	e	e	NOUN
ajird-1636	70	6	next	next	ADV
ajird-1636	70	7	,	,	PUNCT
ajird-1636	70	8	we	we	PRON
ajird-1636	70	9	studied	study	VERB
ajird-1636	70	10	the	the	DET
ajird-1636	70	11	clinical	clinical	ADJ
ajird-1636	70	12	and	and	CCONJ
ajird-1636	70	13	anamnestic	anamnestic	ADJ
ajird-1636	70	14	characteristics	characteristic	NOUN
ajird-1636	70	15	of	of	ADP
ajird-1636	70	16	patients	patient	NOUN
ajird-1636	70	17	by	by	ADP
ajird-1636	70	18	groups	group	NOUN
ajird-1636	70	19	(	(	PUNCT
ajird-1636	70	20	table	table	NOUN
ajird-1636	70	21	2	2	NUM
ajird-1636	70	22	)	)	PUNCT
ajird-1636	70	23	.	.	PUNCT
ajird-1636	71	1	table	table	NOUN
ajird-1636	71	2	2	2	NUM
ajird-1636	71	3	.	.	PUNCT
ajird-1636	71	4	clinical	clinical	ADJ
ajird-1636	71	5	and	and	CCONJ
ajird-1636	71	6	anamnestic	anamnestic	ADJ
ajird-1636	71	7	characteristics	characteristic	NOUN
ajird-1636	71	8	of	of	ADP
ajird-1636	71	9	patients	patient	NOUN
ajird-1636	71	10	included	include	VERB
ajird-1636	71	11	in	in	ADP
ajird-1636	71	12	the	the	DET
ajird-1636	71	13	study	study	NOUN
ajird-1636	71	14	(	(	PUNCT
ajird-1636	71	15	abs	ab	NOUN
ajird-1636	71	16	.	.	PUNCT
ajird-1636	71	17	number	number	NOUN
ajird-1636	71	18	)	)	PUNCT
ajird-1636	71	19	feature	feature	NOUN
ajird-1636	71	20	/	/	SYM
ajird-1636	71	21	indicator	indicator	NOUN
ajird-1636	71	22	1	1	NUM
ajird-1636	71	23	group	group	NOUN
ajird-1636	71	24	(	(	PUNCT
ajird-1636	71	25	n=25	n=25	NOUN
ajird-1636	71	26	)	)	PUNCT
ajird-1636	71	27	2	2	NUM
ajird-1636	71	28	group	group	NOUN
ajird-1636	71	29	(	(	PUNCT
ajird-1636	71	30	n=25	n=25	NOUN
ajird-1636	71	31	)	)	PUNCT
ajird-1636	71	32	3	3	NUM
ajird-1636	71	33	group	group	NOUN
ajird-1636	71	34	(	(	PUNCT
ajird-1636	71	35	n=10	n=10	NOUN
ajird-1636	71	36	)	)	PUNCT
ajird-1636	71	37	4	4	NUM
ajird-1636	71	38	group	group	NOUN
ajird-1636	71	39	(	(	PUNCT
ajird-1636	71	40	n=20	n=20	PROPN
ajird-1636	71	41	)	)	PUNCT
ajird-1636	71	42	control	control	NOUN
ajird-1636	71	43	(	(	PUNCT
ajird-1636	71	44	n=10	n=10	NOUN
ajird-1636	71	45	)	)	PUNCT
ajird-1636	71	46	women	woman	NOUN
ajird-1636	71	47	/	/	SYM
ajird-1636	71	48	men	man	NOUN
ajird-1636	72	1	19/6	19/6	NUM
ajird-1636	72	2	18/7	18/7	NUM
ajird-1636	72	3	6/4	6/4	NUM
ajird-1636	72	4	13/7	13/7	NUM
ajird-1636	72	5	5/5	5/5	NUM
ajird-1636	72	6	main	main	ADJ
ajird-1636	72	7	disease	disease	NOUN
ajird-1636	72	8	:	:	PUNCT
ajird-1636	72	9	sd	sd	ADP
ajird-1636	72	10	2	2	NUM
ajird-1636	72	11	,	,	PUNCT
ajird-1636	72	12	n=	n=	ADJ
ajird-1636	72	13	35	35	NUM
ajird-1636	72	14	19/6	19/6	NUM
ajird-1636	72	15	-/6/4	-/6/4	ADV
ajird-1636	72	16	-/5/5	-/5/5	PUNCT
ajird-1636	72	17	concomitant	concomitant	ADJ
ajird-1636	72	18	disease	disease	NOUN
ajird-1636	72	19	:	:	PUNCT
ajird-1636	72	20	obesity	obesity	NOUN
ajird-1636	72	21	1	1	NUM
ajird-1636	72	22	st	st	NOUN
ajird-1636	72	23	:	:	PUNCT
ajird-1636	72	24	n	n	PROPN
ajird-1636	72	25	=	=	NOUN
ajird-1636	72	26	14	14	NUM
ajird-1636	72	27	4/3	4/3	NUM
ajird-1636	72	28	1/4/2	1/4/2	NUM
ajird-1636	72	29	-/-/	-/-/	NOUN
ajird-1636	72	30	obesity	obesity	NOUN
ajird-1636	72	31	2	2	NUM
ajird-1636	72	32	st	st	NOUN
ajird-1636	72	33	:	:	PUNCT
ajird-1636	72	34	n	n	PROPN
ajird-1636	72	35	=	=	SYM
ajird-1636	72	36	5	5	NUM
ajird-1636	72	37	1/2/-/1	1/2/-/1	NUM
ajird-1636	72	38	-/1	-/1	NOUN
ajird-1636	72	39	-/	-/	PROPN
ajird-1636	72	40	—	—	PUNCT
ajird-1636	72	41	chf	chf	NOUN
ajird-1636	72	42	,	,	PUNCT
ajird-1636	72	43	n=80	n=80	PROPN
ajird-1636	72	44	19/6	19/6	PROPN
ajird-1636	72	45	18/7	18/7	NUM
ajird-1636	72	46	6/4	6/4	NUM
ajird-1636	72	47	13/7	13/7	NUM
ajird-1636	72	48	-/	-/	ADP
ajird-1636	72	49	complication	complication	NOUN
ajird-1636	72	50	of	of	ADP
ajird-1636	72	51	dm	dm	PROPN
ajird-1636	72	52	2	2	NUM
ajird-1636	72	53	:	:	PUNCT
ajird-1636	72	54	dnr	dnr	PROPN
ajird-1636	72	55	:	:	PUNCT
ajird-1636	72	56	n=11	n=11	INTJ
ajird-1636	72	57	(	(	PUNCT
ajird-1636	72	58	13.75	13.75	NUM
ajird-1636	72	59	%	%	NOUN
ajird-1636	72	60	)	)	PUNCT
ajird-1636	72	61	6/3	6/3	NUM
ajird-1636	72	62	-/3/2	-/3/2	PROPN
ajird-1636	72	63	-/-/	-/-/	PROPN
ajird-1636	72	64	dnp	dnp	PROPN
ajird-1636	72	65	:	:	PUNCT
ajird-1636	72	66	n	n	PROPN
ajird-1636	72	67	=	=	SYM
ajird-1636	72	68	20	20	NUM
ajird-1636	72	69	(	(	PUNCT
ajird-1636	72	70	25	25	NUM
ajird-1636	72	71	%	%	NOUN
ajird-1636	72	72	)	)	PUNCT
ajird-1636	72	73	8/4	8/4	NUM
ajird-1636	72	74	-/5/3	-/5/3	PUNCT
ajird-1636	72	75	-/2/2	-/2/2	PUNCT
ajird-1636	72	76	hereditary	hereditary	ADJ
ajird-1636	72	77	burden	burden	NOUN
ajird-1636	72	78	for	for	ADP
ajird-1636	72	79	dm2	dm2	PROPN
ajird-1636	72	80	n=8	n=8	PROPN
ajird-1636	72	81	(	(	PUNCT
ajird-1636	72	82	22.8	22.8	NUM
ajird-1636	72	83	%	%	NOUN
ajird-1636	72	84	)	)	PUNCT
ajird-1636	72	85	hereditary	hereditary	ADJ
ajird-1636	72	86	burden	burden	NOUN
ajird-1636	72	87	for	for	ADP
ajird-1636	72	88	cvd	cvd	PROPN
ajird-1636	72	89	:	:	PUNCT
ajird-1636	72	90	n=20	n=20	PROPN
ajird-1636	72	91	(	(	PUNCT
ajird-1636	72	92	25	25	NUM
ajird-1636	72	93	%	%	NOUN
ajird-1636	72	94	)	)	PUNCT
ajird-1636	72	95	3/1	3/1	NUM
ajird-1636	72	96	-/	-/	NUM
ajird-1636	72	97	2/2	2/2	NUM
ajird-1636	72	98	/	/	SYM
ajird-1636	72	99	1/1	1/1	NUM
ajird-1636	72	100	4/2	4/2	NUM
ajird-1636	72	101	2/3	2/3	NUM
ajird-1636	72	102	3/1	3/1	NUM
ajird-1636	72	103	1/4	1/4	NUM
ajird-1636	72	104	-/	-/	PROPN
ajird-1636	72	105	pics	pic	NOUN
ajird-1636	72	106	,	,	PUNCT
ajird-1636	72	107	n=17	n=17	NOUN
ajird-1636	72	108	(	(	PUNCT
ajird-1636	72	109	21.3	21.3	NUM
ajird-1636	72	110	%	%	NOUN
ajird-1636	72	111	)	)	PUNCT
ajird-1636	73	1	6/2	6/2	NUM
ajird-1636	73	2	3/3	3/3	NUM
ajird-1636	73	3	7/4	7/4	NUM
ajird-1636	73	4	7/5	7/5	NUM
ajird-1636	73	5	-/	-/	PUNCT
ajird-1636	73	6	stroke	stroke	NOUN
ajird-1636	73	7	,	,	PUNCT
ajird-1636	73	8	n	n	CCONJ
ajird-1636	73	9	=	=	SYM
ajird-1636	73	10	0	0	NUM
ajird-1636	73	11	-/-/-/-/-/	-/-/-/-/-/	NOUN
ajird-1636	73	12	prescription	prescription	NOUN
ajird-1636	73	13	of	of	ADP
ajird-1636	73	14	dm	dm	PROPN
ajird-1636	73	15	2	2	NUM
ajird-1636	73	16	,	,	PUNCT
ajird-1636	73	17	years	year	NOUN
ajird-1636	73	18	up	up	ADP
ajird-1636	73	19	to	to	PART
ajird-1636	73	20	5	5	NUM
ajird-1636	73	21	years	year	NOUN
ajird-1636	73	22	,	,	PUNCT
ajird-1636	73	23	n	n	NOUN
ajird-1636	73	24	=	=	SYM
ajird-1636	73	25	11	11	NUM
ajird-1636	73	26	(	(	PUNCT
ajird-1636	73	27	13.75	13.75	NUM
ajird-1636	73	28	%	%	NOUN
ajird-1636	73	29	)	)	PUNCT
ajird-1636	73	30	2/3	2/3	NUM
ajird-1636	73	31	1/1	1/1	NUM
ajird-1636	73	32	1/3	1/3	NUM
ajird-1636	73	33	from	from	ADP
ajird-1636	73	34	5	5	NUM
ajird-1636	73	35	to	to	PART
ajird-1636	73	36	10	10	NUM
ajird-1636	73	37	years	year	NOUN
ajird-1636	73	38	old	old	ADJ
ajird-1636	73	39	,	,	PUNCT
ajird-1636	73	40	n=17	n=17	NOUN
ajird-1636	73	41	(	(	PUNCT
ajird-1636	73	42	21.3	21.3	NUM
ajird-1636	73	43	%	%	NOUN
ajird-1636	73	44	)	)	PUNCT
ajird-1636	73	45	2/3	2/3	NUM
ajird-1636	73	46	-/3/3	-/3/3	NOUN
ajird-1636	73	47	-/4/2	-/4/2	NOUN
ajird-1636	73	48	over	over	ADP
ajird-1636	73	49	10	10	NUM
ajird-1636	73	50	years	year	NOUN
ajird-1636	73	51	,	,	PUNCT
ajird-1636	73	52	n=12	n=12	X
ajird-1636	73	53	(	(	PUNCT
ajird-1636	73	54	15	15	NUM
ajird-1636	73	55	%	%	NOUN
ajird-1636	73	56	)	)	PUNCT
ajird-1636	73	57	3/2	3/2	NUM
ajird-1636	73	58	7/	7/	NUM
ajird-1636	73	59	-/	-/	PUNCT
ajird-1636	73	60	sbp	sbp	NOUN
ajird-1636	73	61	,	,	PUNCT
ajird-1636	73	62	mm	mm	PROPN
ajird-1636	73	63	hg	hg	NOUN
ajird-1636	73	64	136.3±7.3	136.3±7.3	NUM
ajird-1636	73	65	*	*	PROPN
ajird-1636	73	66	141.7±8.2	141.7±8.2	PROPN
ajird-1636	73	67	*	*	SYM
ajird-1636	73	68	138.6±6.5	138.6±6.5	NUM
ajird-1636	73	69	*	*	PUNCT
ajird-1636	74	1	139.8±8.7	139.8±8.7	NUM
ajird-1636	74	2	*	*	SYM
ajird-1636	74	3	118.4±6.7	118.4±6.7	NUM
ajird-1636	74	4	dbp	dbp	PROPN
ajird-1636	74	5	,	,	PUNCT
ajird-1636	74	6	mm	mm	PROPN
ajird-1636	74	7	hg	hg	NOUN
ajird-1636	74	8	89.1±7.4	89.1±7.4	NUM
ajird-1636	74	9	*	*	NOUN
ajird-1636	74	10	90.1±3.8	90.1±3.8	NUM
ajird-1636	74	11	*	*	SYM
ajird-1636	74	12	87.1±9.8	87.1±9.8	NUM
ajird-1636	74	13	*	*	SYM
ajird-1636	74	14	86.1±6.8	86.1±6.8	NUM
ajird-1636	74	15	*	*	SYM
ajird-1636	74	16	73.1±3.9	73.1±3.9	NUM
ajird-1636	74	17	*	*	PUNCT
ajird-1636	74	18	heart	heart	NOUN
ajird-1636	74	19	rate	rate	NOUN
ajird-1636	74	20	,	,	PUNCT
ajird-1636	74	21	beats	beat	NOUN
ajird-1636	74	22	/	/	SYM
ajird-1636	74	23	min	min	NOUN
ajird-1636	74	24	86.6±8.3	86.6±8.3	NUM
ajird-1636	74	25	78.6±6.3	78.6±6.3	NUM
ajird-1636	74	26	78.6±5.7	78.6±5.7	NUM
ajird-1636	74	27	78.6±5.4	78.6±5.4	NUM
ajird-1636	74	28	70.6±1.3	70.6±1.3	NUM
ajird-1636	74	29	bmi	bmi	NOUN
ajird-1636	74	30	,	,	PUNCT
ajird-1636	74	31	kg	kg	PROPN
ajird-1636	74	32	/	/	SYM
ajird-1636	74	33	m2	m2	PROPN
ajird-1636	74	34	32.5±2.1	32.5±2.1	NUM
ajird-1636	74	35	*	*	SYM
ajird-1636	74	36	29.9±7.5	29.9±7.5	NUM
ajird-1636	74	37	*	*	SYM
ajird-1636	74	38	28.7±4.8	28.7±4.8	NUM
ajird-1636	74	39	*	*	SYM
ajird-1636	74	40	31.6±5.6	31.6±5.6	NUM
ajird-1636	74	41	*	*	NUM
ajird-1636	74	42	24.9±6.1	24.9±6.1	NUM
ajird-1636	74	43	*	*	NOUN
ajird-1636	74	44	note	note	NOUN
ajird-1636	74	45	:	:	PUNCT
ajird-1636	74	46	ah	ah	INTJ
ajird-1636	74	47	arterial	arterial	ADJ
ajird-1636	74	48	hypertension	hypertension	NOUN
ajird-1636	74	49	,	,	PUNCT
ajird-1636	74	50	dbp	dbp	PROPN
ajird-1636	74	51	=	=	SYM
ajird-1636	74	52	diastolic	diastolic	NOUN
ajird-1636	74	53	blood	blood	NOUN
ajird-1636	74	54	pressure	pressure	NOUN
ajird-1636	74	55	,	,	PUNCT
ajird-1636	74	56	sbp	sbp	NOUN
ajird-1636	74	57	=	=	SYM
ajird-1636	74	58	systolic	systolic	ADJ
ajird-1636	74	59	blood	blood	NOUN
ajird-1636	74	60	pressure	pressure	NOUN
ajird-1636	74	61	,	,	PUNCT
ajird-1636	74	62	dnr	dnr	PROPN
ajird-1636	74	63	=	=	PROPN
ajird-1636	74	64	diabetic	diabetic	ADJ
ajird-1636	74	65	non	non	ADJ
ajird-1636	74	66	-	-	ADJ
ajird-1636	74	67	proliferative	proliferative	ADJ
ajird-1636	74	68	retinopathy	retinopathy	NOUN
ajird-1636	74	69	–	–	PUNCT
ajird-1636	74	70	*	*	PUNCT
ajird-1636	74	71	–	–	PUNCT
ajird-1636	74	72	significance	significance	NOUN
ajird-1636	74	73	criterion	criterion	NOUN
ajird-1636	74	74	,	,	PUNCT
ajird-1636	74	75	where	where	SCONJ
ajird-1636	74	76	р	р	ADP
ajird-1636	74	77	<	<	X
ajird-1636	74	78	0.005	0.005	NUM
ajird-1636	74	79	,	,	PUNCT
ajird-1636	74	80	dnp	dnp	PROPN
ajird-1636	74	81	–	–	PUNCT
ajird-1636	74	82	diabetic	diabetic	ADJ
ajird-1636	74	83	neuropathy	neuropathy	ADJ
ajird-1636	74	84	as	as	SCONJ
ajird-1636	74	85	can	can	AUX
ajird-1636	74	86	be	be	AUX
ajird-1636	74	87	seen	see	VERB
ajird-1636	74	88	from	from	ADP
ajird-1636	74	89	table	table	NOUN
ajird-1636	74	90	2	2	NUM
ajird-1636	74	91	,	,	PUNCT
ajird-1636	74	92	the	the	DET
ajird-1636	74	93	significance	significance	NOUN
ajird-1636	74	94	of	of	ADP
ajird-1636	74	95	differences	difference	NOUN
ajird-1636	74	96	in	in	ADP
ajird-1636	74	97	comparison	comparison	NOUN
ajird-1636	74	98	with	with	ADP
ajird-1636	74	99	the	the	DET
ajird-1636	74	100	control	control	NOUN
ajird-1636	74	101	relative	relative	ADJ
ajird-1636	74	102	to	to	ADP
ajird-1636	74	103	sbp	sbp	PROPN
ajird-1636	74	104	,	,	PUNCT
ajird-1636	74	105	dbp	dbp	PROPN
ajird-1636	74	106	,	,	PUNCT
ajird-1636	74	107	bmi	bmi	VERB
ajird-1636	74	108	in	in	ADP
ajird-1636	74	109	the	the	DET
ajird-1636	74	110	studied	study	VERB
ajird-1636	74	111	patients	patient	NOUN
ajird-1636	74	112	was	be	AUX
ajird-1636	74	113	established	establish	VERB
ajird-1636	74	114	(	(	PUNCT
ajird-1636	74	115	p<0.05	p<0.05	NOUN
ajird-1636	74	116	)	)	PUNCT
ajird-1636	74	117	.	.	PUNCT
ajird-1636	75	1	it	it	PRON
ajird-1636	75	2	should	should	AUX
ajird-1636	75	3	be	be	AUX
ajird-1636	75	4	noted	note	VERB
ajird-1636	75	5	that	that	SCONJ
ajird-1636	75	6	out	out	ADP
ajird-1636	75	7	of	of	ADP
ajird-1636	75	8	35	35	NUM
ajird-1636	75	9	patients	patient	NOUN
ajird-1636	75	10	of	of	ADP
ajird-1636	75	11	the	the	DET
ajird-1636	75	12	main	main	ADJ
ajird-1636	75	13	group	group	NOUN
ajird-1636	75	14	with	with	ADP
ajird-1636	75	15	type	type	NOUN
ajird-1636	75	16	2	2	NUM
ajird-1636	75	17	dm	dm	NOUN
ajird-1636	75	18	,	,	PUNCT
ajird-1636	75	19	8	8	NUM
ajird-1636	75	20	(	(	PUNCT
ajird-1636	75	21	22.8	22.8	NUM
ajird-1636	75	22	%	%	NOUN
ajird-1636	75	23	)	)	PUNCT
ajird-1636	75	24	had	have	VERB
ajird-1636	75	25	a	a	DET
ajird-1636	75	26	hereditary	hereditary	ADJ
ajird-1636	75	27	american	american	ADJ
ajird-1636	75	28	journal	journal	PROPN
ajird-1636	75	29	of	of	ADP
ajird-1636	75	30	interdisciplinary	interdisciplinary	ADJ
ajird-1636	75	31	research	research	NOUN
ajird-1636	75	32	and	and	CCONJ
ajird-1636	75	33	development	development	NOUN
ajird-1636	75	34	issn	issn	PROPN
ajird-1636	75	35	online	online	NOUN
ajird-1636	75	36	:	:	PUNCT
ajird-1636	75	37	2771	2771	NUM
ajird-1636	75	38	-	-	SYM
ajird-1636	75	39	8948	8948	NUM
ajird-1636	75	40	website	website	NOUN
ajird-1636	75	41	:	:	PUNCT
ajird-1636	75	42	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-1636	75	43	volume	volume	NOUN
ajird-1636	75	44	46	46	NUM
ajird-1636	75	45	,	,	PUNCT
ajird-1636	75	46	november2025	november2025	PROPN
ajird-1636	75	47	42	42	NUM
ajird-1636	75	48	|	|	ADV
ajird-1636	75	49	p	p	ADP
ajird-1636	75	50	a	a	DET
ajird-1636	75	51	g	g	NOUN
ajird-1636	75	52	e	e	NOUN
ajird-1636	75	53	burden	burden	NOUN
ajird-1636	75	54	for	for	ADP
ajird-1636	75	55	dm2	dm2	PROPN
ajird-1636	75	56	,	,	PUNCT
ajird-1636	75	57	while	while	SCONJ
ajird-1636	75	58	in	in	ADP
ajird-1636	75	59	general	general	ADJ
ajird-1636	75	60	,	,	PUNCT
ajird-1636	75	61	among	among	ADP
ajird-1636	75	62	80	80	NUM
ajird-1636	75	63	examined	examine	VERB
ajird-1636	75	64	patients	patient	NOUN
ajird-1636	75	65	,	,	PUNCT
ajird-1636	75	66	hereditary	hereditary	ADJ
ajird-1636	75	67	burden	burden	NOUN
ajird-1636	75	68	for	for	ADP
ajird-1636	75	69	cvd	cvd	PROPN
ajird-1636	75	70	was	be	AUX
ajird-1636	75	71	only	only	ADV
ajird-1636	75	72	20	20	NUM
ajird-1636	75	73	cases	case	NOUN
ajird-1636	75	74	(	(	PUNCT
ajird-1636	75	75	25.0	25.0	NUM
ajird-1636	75	76	%	%	NOUN
ajird-1636	75	77	)	)	PUNCT
ajird-1636	75	78	.	.	PUNCT
ajird-1636	76	1	19	19	NUM
ajird-1636	76	2	(	(	PUNCT
ajird-1636	76	3	23.8	23.8	NUM
ajird-1636	76	4	%	%	NOUN
ajird-1636	76	5	)	)	PUNCT
ajird-1636	76	6	patients	patient	NOUN
ajird-1636	76	7	out	out	ADP
ajird-1636	76	8	of	of	ADP
ajird-1636	76	9	80	80	NUM
ajird-1636	76	10	had	have	VERB
ajird-1636	76	11	grade	grade	NOUN
ajird-1636	76	12	1	1	NUM
ajird-1636	76	13	-	-	SYM
ajird-1636	76	14	2	2	NUM
ajird-1636	76	15	obesity	obesity	NOUN
ajird-1636	76	16	.	.	PUNCT
ajird-1636	77	1	diabetic	diabetic	ADJ
ajird-1636	77	2	non	non	ADJ
ajird-1636	77	3	-	-	ADJ
ajird-1636	77	4	proliferative	proliferative	ADJ
ajird-1636	77	5	retinopathy	retinopathy	NOUN
ajird-1636	77	6	was	be	AUX
ajird-1636	77	7	detected	detect	VERB
ajird-1636	77	8	in	in	ADP
ajird-1636	77	9	11	11	NUM
ajird-1636	77	10	out	out	ADP
ajird-1636	77	11	of	of	ADP
ajird-1636	77	12	35	35	NUM
ajird-1636	77	13	patients	patient	NOUN
ajird-1636	77	14	with	with	ADP
ajird-1636	77	15	dm	dm	PROPN
ajird-1636	77	16	2	2	NUM
ajird-1636	77	17	(	(	PUNCT
ajird-1636	77	18	31.4	31.4	NUM
ajird-1636	77	19	%	%	NOUN
ajird-1636	77	20	)	)	PUNCT
ajird-1636	77	21	,	,	PUNCT
ajird-1636	77	22	that	that	ADV
ajird-1636	77	23	is	is	ADV
ajird-1636	77	24	,	,	PUNCT
ajird-1636	77	25	in	in	ADP
ajird-1636	77	26	a	a	DET
ajird-1636	77	27	third	third	NOUN
ajird-1636	77	28	of	of	ADP
ajird-1636	77	29	cases	case	NOUN
ajird-1636	77	30	,	,	PUNCT
ajird-1636	77	31	and	and	CCONJ
ajird-1636	77	32	diabetic	diabetic	ADJ
ajird-1636	77	33	nephropathy	nephropathy	NOUN
ajird-1636	77	34	-	-	PUNCT
ajird-1636	77	35	.	.	PUNCT
ajird-1636	78	1	in	in	ADP
ajird-1636	78	2	20	20	NUM
ajird-1636	78	3	(	(	PUNCT
ajird-1636	78	4	25	25	NUM
ajird-1636	78	5	%	%	NOUN
ajird-1636	78	6	)	)	PUNCT
ajird-1636	78	7	in	in	ADP
ajird-1636	78	8	one	one	NUM
ajird-1636	78	9	fourth	fourth	ADJ
ajird-1636	78	10	of	of	ADP
ajird-1636	78	11	patients	patient	NOUN
ajird-1636	78	12	.	.	PUNCT
ajird-1636	79	1	next	next	ADV
ajird-1636	79	2	,	,	PUNCT
ajird-1636	79	3	we	we	PRON
ajird-1636	79	4	studied	study	VERB
ajird-1636	79	5	the	the	DET
ajird-1636	79	6	biochemical	biochemical	ADJ
ajird-1636	79	7	characteristics	characteristic	NOUN
ajird-1636	79	8	of	of	ADP
ajird-1636	79	9	patients	patient	NOUN
ajird-1636	79	10	(	(	PUNCT
ajird-1636	79	11	table3	table3	PROPN
ajird-1636	79	12	)	)	PUNCT
ajird-1636	79	13	.	.	PUNCT
ajird-1636	80	1	table	table	NOUN
ajird-1636	80	2	3	3	NUM
ajird-1636	80	3	average	average	ADJ
ajird-1636	80	4	biochemical	biochemical	ADJ
ajird-1636	80	5	parameters	parameter	NOUN
ajird-1636	80	6	of	of	ADP
ajird-1636	80	7	blood	blood	NOUN
ajird-1636	80	8	of	of	ADP
ajird-1636	80	9	patients	patient	NOUN
ajird-1636	80	10	in	in	ADP
ajird-1636	80	11	the	the	DET
ajird-1636	80	12	studied	study	VERB
ajird-1636	80	13	groups	group	NOUN
ajird-1636	80	14	in	in	ADP
ajird-1636	80	15	the	the	DET
ajird-1636	80	16	preoperative	preoperative	ADJ
ajird-1636	80	17	period	period	NOUN
ajird-1636	80	18	index	index	NOUN
ajird-1636	80	19	1	1	NUM
ajird-1636	80	20	group	group	NOUN
ajird-1636	80	21	2	2	NUM
ajird-1636	80	22	group	group	NOUN
ajird-1636	80	23	(	(	PUNCT
ajird-1636	80	24	n=25	n=25	NOUN
ajird-1636	80	25	)	)	PUNCT
ajird-1636	80	26	,	,	PUNCT
ajird-1636	80	27	3	3	NUM
ajird-1636	80	28	group	group	NOUN
ajird-1636	80	29	(	(	PUNCT
ajird-1636	80	30	n=10	n=10	PROPN
ajird-1636	80	31	)	)	PUNCT
ajird-1636	80	32	,	,	PUNCT
ajird-1636	80	33	4	4	NUM
ajird-1636	80	34	group	group	NOUN
ajird-1636	80	35	control	control	NOUN
ajird-1636	80	36	(	(	PUNCT
ajird-1636	80	37	n=25	n=25	NOUN
ajird-1636	80	38	)	)	PUNCT
ajird-1636	80	39	,	,	PUNCT
ajird-1636	80	40	m	m	VERB
ajird-1636	80	41	±	±	NUM
ajird-1636	80	42	m	m	PROPN
ajird-1636	80	43	m	m	VERB
ajird-1636	80	44	±	±	NUM
ajird-1636	80	45	m	m	PROPN
ajird-1636	80	46	m	m	VERB
ajird-1636	80	47	±	±	NUM
ajird-1636	80	48	m	m	PROPN
ajird-1636	80	49	(	(	PUNCT
ajird-1636	80	50	n=20	n=20	PROPN
ajird-1636	80	51	)	)	PUNCT
ajird-1636	80	52	,	,	PUNCT
ajird-1636	80	53	m	m	VERB
ajird-1636	80	54	±	±	NUM
ajird-1636	80	55	m	m	VERB
ajird-1636	80	56	(	(	PUNCT
ajird-1636	80	57	n=10	n=10	NOUN
ajird-1636	80	58	)	)	PUNCT
ajird-1636	80	59	,	,	PUNCT
ajird-1636	80	60	m	m	VERB
ajird-1636	80	61	±	±	PROPN
ajird-1636	80	62	m	m	AUX
ajird-1636	80	63	fasting	fast	VERB
ajird-1636	80	64	glucose	glucose	NOUN
ajird-1636	80	65	,	,	PUNCT
ajird-1636	80	66	mmol	mmol	NOUN
ajird-1636	80	67	/	/	SYM
ajird-1636	80	68	l	l	NOUN
ajird-1636	80	69	9.4±2.6	9.4±2.6	NUM
ajird-1636	80	70	4.3±0.8	4.3±0.8	NUM
ajird-1636	80	71	8.2±0.7	8.2±0.7	NUM
ajird-1636	80	72	5.2±0.1	5.2±0.1	NUM
ajird-1636	81	1	6.2±0.7	6.2±0.7	NUM
ajird-1636	81	2	postprandial	postprandial	ADJ
ajird-1636	81	3	glycemia	glycemia	NOUN
ajird-1636	81	4	12.4±2.3	12.4±2.3	NUM
ajird-1636	81	5	7.5±1.2	7.5±1.2	NUM
ajird-1636	81	6	13.9±1.6	13.9±1.6	NUM
ajird-1636	81	7	7.7±1.2	7.7±1.2	NUM
ajird-1636	81	8	11.5±1.2	11.5±1.2	NUM
ajird-1636	81	9	hba1c	hba1c	NOUN
ajird-1636	81	10	,	,	PUNCT
ajird-1636	81	11	%	%	INTJ
ajird-1636	81	12	7.2±1.7	7.2±1.7	NUM
ajird-1636	81	13	5.5±0.9	5.5±0.9	NUM
ajird-1636	81	14	8.5±0.9	8.5±0.9	NUM
ajird-1636	81	15	5.5±0.9	5.5±0.9	NUM
ajird-1636	81	16	7.3±0.4	7.3±0.4	NUM
ajird-1636	81	17	bilirubin	bilirubin	NOUN
ajird-1636	81	18	total	total	NOUN
ajird-1636	81	19	,	,	PUNCT
ajird-1636	81	20	µmol	µmol	ADV
ajird-1636	81	21	/	/	SYM
ajird-1636	81	22	l	l	NOUN
ajird-1636	81	23	12.8±1.4	12.8±1.4	NUM
ajird-1636	81	24	13.5±2.1	13.5±2.1	NUM
ajird-1636	81	25	13.5±3.1	13.5±3.1	NUM
ajird-1636	81	26	14.3±2.4	14.3±2.4	NUM
ajird-1636	81	27	14.5±2.1	14.5±2.1	NUM
ajird-1636	81	28	urea	urea	NOUN
ajird-1636	81	29	,	,	PUNCT
ajird-1636	81	30	µmol	µmol	ADV
ajird-1636	81	31	/	/	SYM
ajird-1636	81	32	l	l	NOUN
ajird-1636	81	33	1.8±0.3	1.8±0.3	NUM
ajird-1636	81	34	2.6±0.4	2.6±0.4	NUM
ajird-1636	81	35	3.8±0.7	3.8±0.7	NUM
ajird-1636	81	36	2.6±0.6	2.6±0.6	NUM
ajird-1636	81	37	2.1±0.4	2.1±0.4	NUM
ajird-1636	81	38	creatinine	creatinine	NOUN
ajird-1636	81	39	,	,	PUNCT
ajird-1636	81	40	µmol	µmol	ADV
ajird-1636	81	41	/	/	SYM
ajird-1636	81	42	l	l	NOUN
ajird-1636	81	43	100±8.9	100±8.9	NUM
ajird-1636	81	44	87.6±6.2	87.6±6.2	NUM
ajird-1636	81	45	98.6±11.2	98.6±11.2	NUM
ajird-1636	81	46	79.6±9.2	79.6±9.2	NUM
ajird-1636	81	47	89.6±9.2	89.6±9.2	NUM
ajird-1636	81	48	total	total	ADJ
ajird-1636	81	49	cholesterol	cholesterol	NOUN
ajird-1636	81	50	,	,	PUNCT
ajird-1636	81	51	mmol	mmol	NOUN
ajird-1636	81	52	/	/	SYM
ajird-1636	81	53	l	l	NOUN
ajird-1636	81	54	7.6±1.6	7.6±1.6	NUM
ajird-1636	81	55	5.2±1.3	5.2±1.3	NUM
ajird-1636	81	56	5.2±1.2	5.2±1.2	NUM
ajird-1636	81	57	4.8±1.0	4.8±1.0	PROPN
ajird-1636	81	58	4.6±1.7	4.6±1.7	NUM
ajird-1636	81	59	ldl	ldl	NOUN
ajird-1636	81	60	,	,	PUNCT
ajird-1636	81	61	mmol	mmol	NOUN
ajird-1636	81	62	/	/	SYM
ajird-1636	81	63	l	l	NOUN
ajird-1636	81	64	0.78±0.08	0.78±0.08	NOUN
ajird-1636	81	65	*	*	X
ajird-1636	81	66	0.14±0.02	0.14±0.02	NOUN
ajird-1636	81	67	*	*	NOUN
ajird-1636	81	68	1.12±0.9	1.12±0.9	NUM
ajird-1636	81	69	*	*	SYM
ajird-1636	81	70	1.09±0.08	1.09±0.08	NUM
ajird-1636	81	71	*	*	SYM
ajird-1636	81	72	3.14±1.2	3.14±1.2	NUM
ajird-1636	81	73	hdl	hdl	NOUN
ajird-1636	81	74	,	,	PUNCT
ajird-1636	81	75	mmol	mmol	NOUN
ajird-1636	81	76	/	/	SYM
ajird-1636	81	77	l	l	NOUN
ajird-1636	81	78	1.1±0.04	1.1±0.04	NUM
ajird-1636	81	79	1.4±0.3	1.4±0.3	NUM
ajird-1636	81	80	1.2±0.7	1.2±0.7	NUM
ajird-1636	81	81	1.3±0.3	1.3±0.3	NUM
ajird-1636	81	82	1.5±0.31	1.5±0.31	NUM
ajird-1636	81	83	tg	tg	PROPN
ajird-1636	81	84	,	,	PUNCT
ajird-1636	81	85	mmol	mmol	NOUN
ajird-1636	81	86	/	/	SYM
ajird-1636	81	87	l	l	NOUN
ajird-1636	81	88	2.82±0.8	2.82±0.8	NUM
ajird-1636	81	89	*	*	SYM
ajird-1636	81	90	2.87±0.1	2.87±0.1	NUM
ajird-1636	81	91	*	*	VERB
ajird-1636	81	92	2.94±0.8	2.94±0.8	PROPN
ajird-1636	81	93	*	*	SYM
ajird-1636	81	94	2.88±0.5	2.88±0.5	PROPN
ajird-1636	81	95	*	*	SYM
ajird-1636	81	96	1.35±0.4	1.35±0.4	NUM
ajird-1636	81	97	galectin	galectin	NOUN
ajird-1636	81	98	3	3	NUM
ajird-1636	81	99	ng	ng	PROPN
ajird-1636	81	100	/	/	SYM
ajird-1636	81	101	ml	ml	NOUN
ajird-1636	81	102	8.68±0.04	8.68±0.04	NOUN
ajird-1636	81	103	*	*	NOUN
ajird-1636	81	104	*	*	NOUN
ajird-1636	81	105	0.59±0.03	0.59±0.03	NUM
ajird-1636	81	106	7.62±0.08	7.62±0.08	NUM
ajird-1636	81	107	*	*	PUNCT
ajird-1636	81	108	*	*	PUNCT
ajird-1636	81	109	0.73±0.09	0.73±0.09	NUM
ajird-1636	81	110	0.64±0.09	0.64±0.09	NUM
ajird-1636	81	111	h	h	ADJ
ajird-1636	81	112	-	-	PUNCT
ajird-1636	81	113	fabr	fabr	ADJ
ajird-1636	81	114	ng	ng	PROPN
ajird-1636	81	115	/	/	SYM
ajird-1636	81	116	ml	ml	NOUN
ajird-1636	81	117	17.1±0.4	17.1±0.4	NUM
ajird-1636	81	118	*	*	PUNCT
ajird-1636	81	119	2.8±0.3	2.8±0.3	NUM
ajird-1636	81	120	13.5±0.7	13.5±0.7	NUM
ajird-1636	81	121	*	*	SYM
ajird-1636	81	122	4.3±0.9	4.3±0.9	NUM
ajird-1636	81	123	3.3±0.31	3.3±0.31	NUM
ajird-1636	81	124	note	note	NOUN
ajird-1636	81	125	:	:	PUNCT
ajird-1636	81	126	hba1c	hba1c	PROPN
ajird-1636	81	127	—	—	PUNCT
ajird-1636	81	128	glycated	glycate	VERB
ajird-1636	81	129	hemoglobin	hemoglobin	NOUN
ajird-1636	81	130	,	,	PUNCT
ajird-1636	81	131	ldl	ldl	NOUN
ajird-1636	81	132	—	—	PUNCT
ajird-1636	81	133	low	low	ADJ
ajird-1636	81	134	density	density	NOUN
ajird-1636	81	135	lipoprotein	lipoprotein	ADJ
ajird-1636	81	136	,	,	PUNCT
ajird-1636	81	137	tg	tg	INTJ
ajird-1636	81	138	—	—	PUNCT
ajird-1636	81	139	triglycerides	triglyceride	NOUN
ajird-1636	81	140	,	,	PUNCT
ajird-1636	81	141	gfr	gfr	NOUN
ajird-1636	81	142	—	—	PUNCT
ajird-1636	81	143	glomerular	glomerular	ADJ
ajird-1636	81	144	filtration	filtration	NOUN
ajird-1636	81	145	rate	rate	NOUN
ajird-1636	81	146	.	.	PUNCT
ajird-1636	82	1	as	as	SCONJ
ajird-1636	82	2	can	can	AUX
ajird-1636	82	3	be	be	AUX
ajird-1636	82	4	seen	see	VERB
ajird-1636	82	5	from	from	ADP
ajird-1636	82	6	table	table	NOUN
ajird-1636	82	7	3	3	NUM
ajird-1636	82	8	,	,	PUNCT
ajird-1636	82	9	in	in	ADP
ajird-1636	82	10	patients	patient	NOUN
ajird-1636	82	11	of	of	ADP
ajird-1636	82	12	groups	group	NOUN
ajird-1636	82	13	1	1	NUM
ajird-1636	82	14	and	and	CCONJ
ajird-1636	82	15	3	3	NUM
ajird-1636	82	16	,	,	PUNCT
ajird-1636	82	17	a	a	DET
ajird-1636	82	18	significant	significant	ADJ
ajird-1636	82	19	increase	increase	NOUN
ajird-1636	82	20	in	in	ADP
ajird-1636	82	21	fasting	fast	VERB
ajird-1636	82	22	glycemia	glycemia	NOUN
ajird-1636	82	23	,	,	PUNCT
ajird-1636	82	24	postprandial	postprandial	ADJ
ajird-1636	82	25	glycemia	glycemia	NOUN
ajird-1636	82	26	,	,	PUNCT
ajird-1636	82	27	and	and	CCONJ
ajird-1636	82	28	glycated	glycate	VERB
ajird-1636	82	29	hemoglobin	hemoglobin	NOUN
ajird-1636	82	30	was	be	AUX
ajird-1636	82	31	found	find	VERB
ajird-1636	82	32	..	..	PUNCT
ajird-1636	82	33	(	(	PUNCT
ajird-1636	82	34	p	p	X
ajird-1636	82	35	<	<	X
ajird-1636	82	36	0.05	0.05	NUM
ajird-1636	82	37	)	)	PUNCT
ajird-1636	82	38	.	.	PUNCT
ajird-1636	83	1	mean	mean	VERB
ajird-1636	83	2	values	value	NOUN
ajird-1636	83	3	of	of	ADP
ajird-1636	83	4	total	total	ADJ
ajird-1636	83	5	bilirubin	bilirubin	NOUN
ajird-1636	83	6	,	,	PUNCT
ajird-1636	83	7	urea	urea	NOUN
ajird-1636	83	8	,	,	PUNCT
ajird-1636	83	9	blood	blood	NOUN
ajird-1636	83	10	creatinine	creatinine	NOUN
ajird-1636	83	11	levels	level	NOUN
ajird-1636	83	12	were	be	AUX
ajird-1636	83	13	normal	normal	ADJ
ajird-1636	83	14	(	(	PUNCT
ajird-1636	83	15	p<0.05	p<0.05	NOUN
ajird-1636	83	16	)	)	PUNCT
ajird-1636	83	17	against	against	ADP
ajird-1636	83	18	the	the	DET
ajird-1636	83	19	background	background	NOUN
ajird-1636	83	20	of	of	ADP
ajird-1636	83	21	dyslipidemia	dyslipidemia	NOUN
ajird-1636	83	22	(	(	PUNCT
ajird-1636	83	23	decrease	decrease	NOUN
ajird-1636	83	24	in	in	ADP
ajird-1636	83	25	ldl	ldl	NOUN
ajird-1636	83	26	,	,	PUNCT
ajird-1636	83	27	normal	normal	ADJ
ajird-1636	83	28	levels	level	NOUN
ajird-1636	83	29	of	of	ADP
ajird-1636	83	30	hdl	hdl	PROPN
ajird-1636	83	31	,	,	PUNCT
ajird-1636	83	32	increased	increase	VERB
ajird-1636	83	33	tg	tg	ADV
ajird-1636	83	34	in	in	ADP
ajird-1636	83	35	all	all	DET
ajird-1636	83	36	groups	group	NOUN
ajird-1636	83	37	and	and	CCONJ
ajird-1636	83	38	tc	tc	NOUN
ajird-1636	83	39	in	in	ADP
ajird-1636	83	40	group	group	NOUN
ajird-1636	83	41	1	1	NUM
ajird-1636	83	42	)	)	PUNCT
ajird-1636	83	43	.	.	PUNCT
ajird-1636	84	1	mean	mean	VERB
ajird-1636	84	2	values	value	NOUN
ajird-1636	84	3	of	of	ADP
ajird-1636	84	4	galectin	galectin	ADJ
ajird-1636	84	5	3	3	NUM
ajird-1636	84	6	andh	andh	NOUN
ajird-1636	84	7	-	-	PUNCT
ajird-1636	84	8	fabr	fabr	NOUN
ajird-1636	84	9	in	in	ADP
ajird-1636	84	10	the	the	DET
ajird-1636	84	11	preoperative	preoperative	ADJ
ajird-1636	84	12	period	period	NOUN
ajird-1636	84	13	were	be	AUX
ajird-1636	84	14	normal	normal	ADJ
ajird-1636	84	15	in	in	ADP
ajird-1636	84	16	patients	patient	NOUN
ajird-1636	84	17	of	of	ADP
ajird-1636	84	18	groups	group	NOUN
ajird-1636	84	19	2	2	NUM
ajird-1636	84	20	and	and	CCONJ
ajird-1636	84	21	4	4	NUM
ajird-1636	84	22	,	,	PUNCT
ajird-1636	84	23	but	but	CCONJ
ajird-1636	84	24	were	be	AUX
ajird-1636	84	25	significantly	significantly	ADV
ajird-1636	84	26	high	high	ADJ
ajird-1636	84	27	in	in	ADP
ajird-1636	84	28	patients	patient	NOUN
ajird-1636	84	29	of	of	ADP
ajird-1636	84	30	groups	group	NOUN
ajird-1636	84	31	1	1	NUM
ajird-1636	84	32	and	and	CCONJ
ajird-1636	84	33	3	3	NUM
ajird-1636	84	34	,	,	PUNCT
ajird-1636	84	35	that	that	ADV
ajird-1636	84	36	is	is	ADV
ajird-1636	84	37	,	,	PUNCT
ajird-1636	84	38	with	with	ADP
ajird-1636	84	39	a	a	DET
ajird-1636	84	40	combination	combination	NOUN
ajird-1636	84	41	of	of	ADP
ajird-1636	84	42	dm	dm	NUM
ajird-1636	84	43	2	2	NUM
ajird-1636	84	44	and	and	CCONJ
ajird-1636	84	45	chf	chf	NOUN
ajird-1636	84	46	,	,	PUNCT
ajird-1636	84	47	approaching	approach	VERB
ajird-1636	84	48	critical	critical	ADJ
ajird-1636	84	49	threshold	threshold	NOUN
ajird-1636	84	50	values	value	NOUN
ajird-1636	84	51	.	.	PUNCT
ajird-1636	85	1	so	so	ADV
ajird-1636	85	2	,	,	PUNCT
ajird-1636	85	3	the	the	DET
ajird-1636	85	4	average	average	ADJ
ajird-1636	85	5	values	value	NOUN
ajird-1636	85	6	of	of	ADP
ajird-1636	85	7	galectin	galectin	NOUN
ajird-1636	85	8	-3	-3	PUNCT
ajird-1636	85	9	in	in	ADP
ajird-1636	85	10	the	the	DET
ajird-1636	85	11	1st	1st	ADJ
ajird-1636	85	12	group	group	NOUN
ajird-1636	85	13	of	of	ADP
ajird-1636	85	14	patients	patient	NOUN
ajird-1636	85	15	were	be	AUX
ajird-1636	85	16	within8.68±0.04ng	within8.68±0.04ng	NOUN
ajird-1636	85	17	/	/	SYM
ajird-1636	85	18	ml	ml	NOUN
ajird-1636	85	19	,	,	PUNCT
ajird-1636	85	20	and	and	CCONJ
ajird-1636	85	21	in	in	ADP
ajird-1636	85	22	the	the	DET
ajird-1636	85	23	group7.62±0.08	group7.62±0.08	PROPN
ajird-1636	85	24	ng	ng	PROPN
ajird-1636	85	25	/	/	SYM
ajird-1636	85	26	ml	ml	PROPN
ajird-1636	85	27	.	.	PUNCT
ajird-1636	86	1	average	average	ADJ
ajird-1636	86	2	datah	datah	PROPN
ajird-1636	86	3	-	-	PUNCT
ajird-1636	86	4	fabr	fabr	NOUN
ajird-1636	86	5	in	in	ADP
ajird-1636	86	6	group	group	NOUN
ajird-1636	86	7	1	1	NUM
ajird-1636	86	8	reached	reach	VERB
ajird-1636	86	9	values17.1±0.4ng	values17.1±0.4ng	NOUN
ajird-1636	86	10	/	/	SYM
ajird-1636	86	11	ml	ml	ADJ
ajird-1636	86	12	,	,	PUNCT
ajird-1636	86	13	american	american	ADJ
ajird-1636	86	14	journal	journal	PROPN
ajird-1636	86	15	of	of	ADP
ajird-1636	86	16	interdisciplinary	interdisciplinary	ADJ
ajird-1636	86	17	research	research	NOUN
ajird-1636	86	18	and	and	CCONJ
ajird-1636	86	19	development	development	NOUN
ajird-1636	86	20	issn	issn	PROPN
ajird-1636	86	21	online	online	NOUN
ajird-1636	86	22	:	:	PUNCT
ajird-1636	86	23	2771	2771	NUM
ajird-1636	86	24	-	-	SYM
ajird-1636	86	25	8948	8948	NUM
ajird-1636	86	26	website	website	NOUN
ajird-1636	86	27	:	:	PUNCT
ajird-1636	86	28	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-1636	86	29	volume	volume	NOUN
ajird-1636	86	30	46	46	NUM
ajird-1636	86	31	,	,	PUNCT
ajird-1636	86	32	november2025	november2025	PROPN
ajird-1636	86	33	43	43	NUM
ajird-1636	87	1	|	|	ADV
ajird-1636	87	2	p	p	X
ajird-1636	87	3	a	a	DET
ajird-1636	87	4	g	g	NOUN
ajird-1636	87	5	e	e	NOUN
ajird-1636	87	6	and	and	CCONJ
ajird-1636	87	7	in	in	ADP
ajird-1636	87	8	the	the	DET
ajird-1636	87	9	group13.5±0.7ng	group13.5±0.7ng	X
ajird-1636	87	10	/	/	SYM
ajird-1636	87	11	ml.the	ml.the	PROPN
ajird-1636	87	12	next	next	ADJ
ajird-1636	87	13	stage	stage	NOUN
ajird-1636	87	14	of	of	ADP
ajird-1636	87	15	our	our	PRON
ajird-1636	87	16	work	work	NOUN
ajird-1636	87	17	was	be	AUX
ajird-1636	87	18	the	the	DET
ajird-1636	87	19	analysis	analysis	NOUN
ajird-1636	87	20	of	of	ADP
ajird-1636	87	21	echoecg	echoecg	ADJ
ajird-1636	87	22	data	datum	NOUN
ajird-1636	87	23	from	from	ADP
ajird-1636	87	24	our	our	PRON
ajird-1636	87	25	patients	patient	NOUN
ajird-1636	87	26	(	(	PUNCT
ajird-1636	87	27	table	table	NOUN
ajird-1636	87	28	4	4	NUM
ajird-1636	87	29	)	)	PUNCT
ajird-1636	87	30	.	.	PUNCT
ajird-1636	88	1	table	table	NOUN
ajird-1636	88	2	4	4	NUM
ajird-1636	88	3	echo	echo	NOUN
ajird-1636	88	4	-	-	PUNCT
ajird-1636	88	5	ecg	ecg	PROPN
ajird-1636	88	6	parameters	parameter	NOUN
ajird-1636	88	7	by	by	ADP
ajird-1636	88	8	groups	group	NOUN
ajird-1636	88	9	(	(	PUNCT
ajird-1636	88	10	m	m	PROPN
ajird-1636	88	11	±	±	NUM
ajird-1636	88	12	m	m	NOUN
ajird-1636	88	13	)	)	PUNCT
ajird-1636	88	14	indicators	indicator	NOUN
ajird-1636	88	15	1	1	NUM
ajird-1636	88	16	group	group	NOUN
ajird-1636	88	17	(	(	PUNCT
ajird-1636	88	18	n=25	n=25	NOUN
ajird-1636	88	19	)	)	PUNCT
ajird-1636	88	20	,	,	PUNCT
ajird-1636	88	21	m	m	VERB
ajird-1636	88	22	±	±	NUM
ajird-1636	88	23	m	m	PROPN
ajird-1636	88	24	2	2	NUM
ajird-1636	88	25	group	group	NOUN
ajird-1636	88	26	(	(	PUNCT
ajird-1636	88	27	n=25	n=25	NOUN
ajird-1636	88	28	)	)	PUNCT
ajird-1636	88	29	,	,	PUNCT
ajird-1636	88	30	m	m	VERB
ajird-1636	88	31	±	±	NUM
ajird-1636	88	32	m	m	PROPN
ajird-1636	88	33	3	3	NUM
ajird-1636	88	34	group	group	NOUN
ajird-1636	88	35	(	(	PUNCT
ajird-1636	88	36	n=10	n=10	PROPN
ajird-1636	88	37	)	)	PUNCT
ajird-1636	88	38	,	,	PUNCT
ajird-1636	88	39	m	m	VERB
ajird-1636	88	40	±	±	NUM
ajird-1636	88	41	m	m	PROPN
ajird-1636	88	42	4	4	NUM
ajird-1636	88	43	group	group	NOUN
ajird-1636	88	44	(	(	PUNCT
ajird-1636	88	45	n=20	n=20	PROPN
ajird-1636	88	46	)	)	PUNCT
ajird-1636	88	47	,	,	PUNCT
ajird-1636	88	48	m	m	VERB
ajird-1636	88	49	±	±	NUM
ajird-1636	88	50	m	m	PROPN
ajird-1636	88	51	norm	norm	NOUN
ajird-1636	88	52	kdr	kdr	PROPN
ajird-1636	88	53	lv	lv	PROPN
ajird-1636	88	54	,	,	PUNCT
ajird-1636	88	55	cm	cm	NOUN
ajird-1636	88	56	2.8±0.3	2.8±0.3	NUM
ajird-1636	88	57	*	*	PUNCT
ajird-1636	88	58	3.7±0.6	3.7±0.6	NUM
ajird-1636	89	1	2.6±0.5	2.6±0.5	NUM
ajird-1636	89	2	*	*	PROPN
ajird-1636	89	3	3.8±0.3	3.8±0.3	NUM
ajird-1636	89	4	4.6	4.6	NUM
ajird-1636	89	5	-	-	SYM
ajird-1636	89	6	5.7	5.7	NUM
ajird-1636	89	7	csr	csr	NOUN
ajird-1636	89	8	,	,	PUNCT
ajird-1636	89	9	ml	ml	PROPN
ajird-1636	89	10	26.9±4.5	26.9±4.5	NUM
ajird-1636	89	11	*	*	SYM
ajird-1636	89	12	32.3±7.6	32.3±7.6	NUM
ajird-1636	89	13	27.5±4.6	27.5±4.6	NUM
ajird-1636	89	14	*	*	SYM
ajird-1636	89	15	31.6±6.8	31.6±6.8	NUM
ajird-1636	89	16	33	33	NUM
ajird-1636	89	17	-	-	SYM
ajird-1636	89	18	68	68	NUM
ajird-1636	89	19	kdo	kdo	NOUN
ajird-1636	89	20	,	,	PUNCT
ajird-1636	89	21	ml	ml	ADP
ajird-1636	89	22	73.8±7.6	73.8±7.6	NUM
ajird-1636	89	23	*	*	PROPN
ajird-1636	89	24	82.4±6.4	82.4±6.4	NUM
ajird-1636	89	25	*	*	NOUN
ajird-1636	89	26	76.5±8.2	76.5±8.2	NUM
ajird-1636	89	27	*	*	SYM
ajird-1636	89	28	87.6±6.5	87.6±6.5	NUM
ajird-1636	89	29	*	*	SYM
ajird-1636	89	30	96	96	NUM
ajird-1636	89	31	-	-	SYM
ajird-1636	89	32	157	157	NUM
ajird-1636	89	33	lv	lv	PROPN
ajird-1636	89	34	cvd	cvd	PROPN
ajird-1636	89	35	,	,	PUNCT
ajird-1636	89	36	cm	cm	NOUN
ajird-1636	89	37	0.6±0.04	0.6±0.04	NOUN
ajird-1636	89	38	*	*	NOUN
ajird-1636	89	39	0.7±0.06	0.7±0.06	PROPN
ajird-1636	89	40	*	*	PROPN
ajird-1636	89	41	0.5±0.09	0.5±0.09	PROPN
ajird-1636	89	42	*	*	NOUN
ajird-1636	89	43	0.5±0.05	0.5±0.05	NOUN
ajird-1636	89	44	*	*	SYM
ajird-1636	89	45	0.95	0.95	NUM
ajird-1636	89	46	-2.05	-2.05	NUM
ajird-1636	89	47	lp	lp	NOUN
ajird-1636	89	48	,	,	PUNCT
ajird-1636	89	49	cm	cm	NOUN
ajird-1636	89	50	4.8±0.8	4.8±0.8	NUM
ajird-1636	89	51	4.7±0.2	4.7±0.2	NUM
ajird-1636	90	1	4.9±0.7	4.9±0.7	NUM
ajird-1636	91	1	3.9±0.2	3.9±0.2	NUM
ajird-1636	91	2	2.3–4.5	2.3–4.5	NUM
ajird-1636	92	1	tmzhp	tmzhp	ADJ
ajird-1636	92	2	,	,	PUNCT
ajird-1636	92	3	cm	cm	PROPN
ajird-1636	92	4	1.3±0.02	1.3±0.02	NUM
ajird-1636	92	5	1.2±0.07	1.2±0.07	NUM
ajird-1636	93	1	1.4±0.09	1.4±0.09	NUM
ajird-1636	93	2	1.3±0.06	1.3±0.06	NUM
ajird-1636	93	3	0.75	0.75	NUM
ajird-1636	93	4	-1.1	-1.1	ADJ
ajird-1636	93	5	sdla	sdla	NOUN
ajird-1636	93	6	mmhg	mmhg	NOUN
ajird-1636	93	7	.	.	PUNCT
ajird-1636	94	1	20.8±2.5	20.8±2.5	NUM
ajird-1636	94	2	*	*	PUNCT
ajird-1636	94	3	19.8±2.3	19.8±2.3	NUM
ajird-1636	94	4	22.7±2.8	22.7±2.8	NUM
ajird-1636	94	5	*	*	NOUN
ajird-1636	94	6	16.8±2.4	16.8±2.4	NUM
ajird-1636	94	7	12	12	NUM
ajird-1636	94	8	-	-	SYM
ajird-1636	94	9	15	15	NUM
ajird-1636	94	10	dt	dt	NOUN
ajird-1636	94	11	,	,	PUNCT
ajird-1636	94	12	ms	ms	PROPN
ajird-1636	94	13	114.8±10.2	114.8±10.2	PROPN
ajird-1636	94	14	*	*	PROPN
ajird-1636	94	15	101.2±8.6	101.2±8.6	NUM
ajird-1636	94	16	*	*	SYM
ajird-1636	95	1	120.2±8.9	120.2±8.9	NUM
ajird-1636	95	2	*	*	NOUN
ajird-1636	95	3	99.7±6.8	99.7±6.8	NUM
ajird-1636	95	4	*	*	SYM
ajird-1636	95	5	60	60	NUM
ajird-1636	95	6	-	-	SYM
ajird-1636	95	7	70	70	NUM
ajird-1636	95	8	tzslzh	tzslzh	NOUN
ajird-1636	95	9	,	,	PUNCT
ajird-1636	95	10	cm	cm	NOUN
ajird-1636	95	11	1.9±0.3	1.9±0.3	NUM
ajird-1636	95	12	*	*	PROPN
ajird-1636	95	13	1.7±0.6	1.7±0.6	NUM
ajird-1636	95	14	1.9±0.7	1.9±0.7	NUM
ajird-1636	95	15	*	*	SYM
ajird-1636	95	16	1.6±0.9	1.6±0.9	NUM
ajird-1636	95	17	0.6	0.6	NUM
ajird-1636	95	18	-	-	SYM
ajird-1636	95	19	1.1	1.1	NUM
ajird-1636	95	20	przh	przh	NOUN
ajird-1636	95	21	,	,	PUNCT
ajird-1636	95	22	mm	mm	PROPN
ajird-1636	95	23	22.6	22.6	NUM
ajird-1636	95	24	±	±	NUM
ajird-1636	95	25	2.1	2.1	NUM
ajird-1636	95	26	21.2±3.4	21.2±3.4	NUM
ajird-1636	95	27	23.6±3.2	23.6±3.2	NUM
ajird-1636	95	28	23.3±4.9	23.3±4.9	NUM
ajird-1636	95	29	9.5	9.5	NUM
ajird-1636	95	30	-20	-20	NUM
ajird-1636	95	31	ef	ef	PROPN
ajird-1636	95	32	,	,	PUNCT
ajird-1636	95	33	%	%	NOUN
ajird-1636	95	34	36.6±6.4	36.6±6.4	NUM
ajird-1636	95	35	*	*	NOUN
ajird-1636	95	36	39.2±3.3	39.2±3.3	NUM
ajird-1636	95	37	*	*	SYM
ajird-1636	95	38	33.6±5.8	33.6±5.8	NUM
ajird-1636	95	39	*	*	NOUN
ajird-1636	96	1	41.4±3.1	41.4±3.1	NUM
ajird-1636	96	2	*	*	SYM
ajird-1636	96	3	59	59	NUM
ajird-1636	96	4	±	±	NUM
ajird-1636	96	5	65	65	NUM
ajird-1636	96	6	e	e	NOUN
ajird-1636	96	7	/	/	SYM
ajird-1636	96	8	a	a	DET
ajird-1636	96	9	0.67±0.07	0.67±0.07	NOUN
ajird-1636	96	10	*	*	PUNCT
ajird-1636	96	11	0.99±0.05	0.99±0.05	NOUN
ajird-1636	96	12	*	*	SYM
ajird-1636	96	13	0.64±0.06	0.64±0.06	PROPN
ajird-1636	96	14	*	*	PUNCT
ajird-1636	96	15	0.71±0.09	0.71±0.09	PROPN
ajird-1636	96	16	*	*	PROPN
ajird-1636	96	17	1.5	1.5	NUM
ajird-1636	96	18	-	-	SYM
ajird-1636	96	19	1.7	1.7	NUM
ajird-1636	96	20	.	.	PUNCT
ajird-1636	97	1	ivrt	ivrt	NOUN
ajird-1636	97	2	,	,	PUNCT
ajird-1636	97	3	ms	ms	PROPN
ajird-1636	97	4	105.9±7.9	105.9±7.9	PROPN
ajird-1636	97	5	*	*	SYM
ajird-1636	97	6	98.6±8.3	98.6±8.3	NUM
ajird-1636	97	7	*	*	SYM
ajird-1636	97	8	108.8±7.9	108.8±7.9	NUM
ajird-1636	97	9	*	*	NUM
ajird-1636	97	10	95.6±5.9	95.6±5.9	NUM
ajird-1636	97	11	*	*	NOUN
ajird-1636	97	12	70	70	NUM
ajird-1636	97	13	-	-	SYM
ajird-1636	97	14	75	75	NUM
ajird-1636	97	15	mmlv	mmlv	NOUN
ajird-1636	97	16	,	,	PUNCT
ajird-1636	97	17	g	g	PROPN
ajird-1636	97	18	149.9±8.9	149.9±8.9	NUM
ajird-1636	97	19	*	*	NOUN
ajird-1636	98	1	142.8±8.8	142.8±8.8	NUM
ajird-1636	98	2	*	*	NOUN
ajird-1636	98	3	148.9±	148.9±	NUM
ajird-1636	98	4	11.5	11.5	NUM
ajird-1636	98	5	*	*	NUM
ajird-1636	98	6	141.9±	141.9±	NUM
ajird-1636	98	7	6.5	6.5	NUM
ajird-1636	98	8	*	*	SYM
ajird-1636	98	9	95	95	NUM
ajird-1636	98	10	-	-	SYM
ajird-1636	98	11	135	135	NUM
ajird-1636	98	12	lvmi	lvmi	NOUN
ajird-1636	98	13	,	,	PUNCT
ajird-1636	98	14	g	g	NOUN
ajird-1636	98	15	/	/	SYM
ajird-1636	98	16	m2	m2	PROPN
ajird-1636	98	17	143.5±11.5	143.5±11.5	PROPN
ajird-1636	98	18	*	*	PROPN
ajird-1636	98	19	128.9±11.4	128.9±11.4	PROPN
ajird-1636	98	20	138.9±10.7	138.9±10.7	NOUN
ajird-1636	98	21	*	*	ADJ
ajird-1636	98	22	136.3±12.3	136.3±12.3	NUM
ajird-1636	98	23	*	*	SYM
ajird-1636	98	24	109	109	NUM
ajird-1636	98	25	-	-	SYM
ajird-1636	98	26	124	124	NUM
ajird-1636	98	27	note	note	NOUN
ajird-1636	98	28	:	:	PUNCT
ajird-1636	98	29	*	*	PUNCT
ajird-1636	98	30	differences	difference	NOUN
ajird-1636	98	31	are	be	AUX
ajird-1636	98	32	significant	significant	ADJ
ajird-1636	98	33	,	,	PUNCT
ajird-1636	98	34	p	p	X
ajird-1636	98	35	<	<	X
ajird-1636	98	36	0.05.:edd	0.05.:edd	PROPN
ajird-1636	98	37	—	—	PUNCT
ajird-1636	98	38	end	end	NOUN
ajird-1636	98	39	diastolic	diastolic	ADJ
ajird-1636	98	40	size	size	NOUN
ajird-1636	98	41	,	,	PUNCT
ajird-1636	98	42	esr	esr	PROPN
ajird-1636	98	43	—	—	PUNCT
ajird-1636	98	44	end	end	VERB
ajird-1636	98	45	systolic	systolic	ADJ
ajird-1636	98	46	size	size	NOUN
ajird-1636	98	47	,	,	PUNCT
ajird-1636	98	48	la	la	ADJ
ajird-1636	98	49	—	—	PUNCT
ajird-1636	98	50	pulmonary	pulmonary	ADJ
ajird-1636	98	51	artery	artery	NOUN
ajird-1636	98	52	,	,	PUNCT
ajird-1636	98	53	lv	lv	PROPN
ajird-1636	98	54	—	—	PUNCT
ajird-1636	98	55	left	left	ADJ
ajird-1636	98	56	ventricle	ventricle	NOUN
ajird-1636	98	57	,	,	PUNCT
ajird-1636	98	58	la	la	NOUN
ajird-1636	98	59	—	—	PUNCT
ajird-1636	98	60	left	leave	VERB
ajird-1636	98	61	atrium	atrium	NOUN
ajird-1636	98	62	,	,	PUNCT
ajird-1636	98	63	n	n	CCONJ
ajird-1636	98	64	/	/	SYM
ajird-1636	98	65	a	a	PRON
ajird-1636	98	66	—	—	PUNCT
ajird-1636	98	67	unsignificant	unsignificant	ADJ
ajird-1636	98	68	difference	difference	NOUN
ajird-1636	98	69	between	between	ADP
ajird-1636	98	70	the	the	DET
ajird-1636	98	71	compared	compare	VERB
ajird-1636	98	72	parameters	parameter	NOUN
ajird-1636	98	73	,	,	PUNCT
ajird-1636	98	74	rv	rv	INTJ
ajird-1636	98	75	—	—	PUNCT
ajird-1636	98	76	right	right	ADJ
ajird-1636	98	77	ventricle	ventricle	NOUN
ajird-1636	98	78	,	,	PUNCT
ajird-1636	98	79	sbp	sbp	NOUN
ajird-1636	98	80	—	—	PUNCT
ajird-1636	98	81	systolic	systolic	ADJ
ajird-1636	98	82	blood	blood	NOUN
ajird-1636	98	83	pressure	pressure	NOUN
ajird-1636	98	84	,	,	PUNCT
ajird-1636	98	85	tzslv	tzslv	NOUN
ajird-1636	98	86	—	—	PUNCT
ajird-1636	98	87	thickness	thickness	NOUN
ajird-1636	98	88	posterior	posterior	ADJ
ajird-1636	98	89	wall	wall	NOUN
ajird-1636	98	90	of	of	ADP
ajird-1636	98	91	the	the	DET
ajird-1636	98	92	left	left	ADJ
ajird-1636	98	93	ventricle	ventricle	NOUN
ajird-1636	98	94	,	,	PUNCT
ajird-1636	98	95	vtrv	vtrv	NOUN
ajird-1636	98	96	—	—	PUNCT
ajird-1636	98	97	thickness	thickness	NOUN
ajird-1636	98	98	of	of	ADP
ajird-1636	98	99	the	the	DET
ajird-1636	98	100	interventricular	interventricular	ADJ
ajird-1636	98	101	septum	septum	NOUN
ajird-1636	98	102	,	,	PUNCT
ajird-1636	98	103	ef	ef	PROPN
ajird-1636	98	104	—	—	PUNCT
ajird-1636	98	105	ejection	ejection	NOUN
ajird-1636	98	106	fraction	fraction	NOUN
ajird-1636	98	107	,	,	PUNCT
ajird-1636	98	108	chf	chf	NOUN
ajird-1636	98	109	—	—	PUNCT
ajird-1636	98	110	chronic	chronic	ADJ
ajird-1636	98	111	heart	heart	NOUN
ajird-1636	98	112	failure	failure	NOUN
ajird-1636	98	113	,	,	PUNCT
ajird-1636	98	114	hr	hr	NOUN
ajird-1636	98	115	—	—	PUNCT
ajird-1636	98	116	heart	heart	NOUN
ajird-1636	98	117	rate	rate	NOUN
ajird-1636	98	118	,	,	PUNCT
ajird-1636	98	119	dt	dt	X
ajird-1636	98	120	—	—	PUNCT
ajird-1636	98	121	early	early	ADV
ajird-1636	98	122	diastolic	diastolic	NOUN
ajird-1636	98	123	filling	fill	VERB
ajird-1636	98	124	blood	blood	NOUN
ajird-1636	98	125	flow	flow	NOUN
ajird-1636	98	126	deceleration	deceleration	NOUN
ajird-1636	98	127	time	time	NOUN
ajird-1636	98	128	,	,	PUNCT
ajird-1636	98	129	ivrt	ivrt	INTJ
ajird-1636	98	130	—	—	PUNCT
ajird-1636	98	131	lv	lv	PROPN
ajird-1636	98	132	isovolumic	isovolumic	ADJ
ajird-1636	98	133	relaxation	relaxation	NOUN
ajird-1636	98	134	time	time	NOUN
ajird-1636	98	135	,	,	PUNCT
ajird-1636	98	136	e	e	NOUN
ajird-1636	98	137	/	/	SYM
ajird-1636	98	138	a	a	DET
ajird-1636	98	139	—	—	PUNCT
ajird-1636	98	140	peak	peak	NOUN
ajird-1636	98	141	ratio	ratio	NOUN
ajird-1636	98	142	e	e	NOUN
ajird-1636	98	143	and	and	CCONJ
ajird-1636	98	144	a	a	DET
ajird-1636	98	145	wave	wave	NOUN
ajird-1636	98	146	velocities	velocity	NOUN
ajird-1636	98	147	,	,	PUNCT
ajird-1636	98	148	edv	edv	NOUN
ajird-1636	98	149	–	–	PUNCT
ajird-1636	98	150	end	end	NOUN
ajird-1636	98	151	diastolic	diastolic	ADJ
ajird-1636	98	152	volume	volume	NOUN
ajird-1636	98	153	,	,	PUNCT
ajird-1636	98	154	esv	esv	PROPN
ajird-1636	98	155	–	–	PUNCT
ajird-1636	98	156	end	end	VERB
ajird-1636	98	157	systolic	systolic	ADJ
ajird-1636	98	158	volume	volume	NOUN
ajird-1636	98	159	,	,	PUNCT
ajird-1636	98	160	lvmi	lvmi	PROPN
ajird-1636	98	161	–	–	PUNCT
ajird-1636	98	162	lv	lv	PROPN
ajird-1636	98	163	myocardial	myocardial	ADJ
ajird-1636	98	164	mass	mass	NOUN
ajird-1636	98	165	,	,	PUNCT
ajird-1636	98	166	lvmi	lvmi	PROPN
ajird-1636	98	167	–	–	PUNCT
ajird-1636	98	168	lvmi	lvmi	PROPN
ajird-1636	98	169	index	index	NOUN
ajird-1636	98	170	,	,	PUNCT
ajird-1636	98	171	sppa	sppa	PROPN
ajird-1636	98	172	–	–	PUNCT
ajird-1636	98	173	mean	mean	VERB
ajird-1636	98	174	pulmonary	pulmonary	ADJ
ajird-1636	98	175	artery	artery	NOUN
ajird-1636	98	176	pressure	pressure	NOUN
ajird-1636	98	177	as	as	SCONJ
ajird-1636	98	178	can	can	AUX
ajird-1636	98	179	be	be	AUX
ajird-1636	98	180	seen	see	VERB
ajird-1636	98	181	from	from	ADP
ajird-1636	98	182	table	table	NOUN
ajird-1636	98	183	4	4	NUM
ajird-1636	98	184	,	,	PUNCT
ajird-1636	98	185	there	there	PRON
ajird-1636	98	186	is	be	VERB
ajird-1636	98	187	a	a	DET
ajird-1636	98	188	significant	significant	ADJ
ajird-1636	98	189	difference	difference	NOUN
ajird-1636	98	190	in	in	ADP
ajird-1636	98	191	the	the	DET
ajird-1636	98	192	parameters	parameter	NOUN
ajird-1636	98	193	of	of	ADP
ajird-1636	98	194	central	central	ADJ
ajird-1636	98	195	hemodynamics	hemodynamic	NOUN
ajird-1636	98	196	in	in	ADP
ajird-1636	98	197	the	the	DET
ajird-1636	98	198	studied	study	VERB
ajird-1636	98	199	groups	group	NOUN
ajird-1636	98	200	compared	compare	VERB
ajird-1636	98	201	with	with	ADP
ajird-1636	98	202	the	the	DET
ajird-1636	98	203	normal	normal	ADJ
ajird-1636	98	204	values	value	NOUN
ajird-1636	98	205	.	.	PUNCT
ajird-1636	99	1	indicators	indicator	NOUN
ajird-1636	99	2	such	such	ADJ
ajird-1636	99	3	as	as	ADP
ajird-1636	99	4	bww	bww	PROPN
ajird-1636	99	5	,	,	PUNCT
ajird-1636	99	6	dt	dt	PROPN
ajird-1636	99	7	,	,	PUNCT
ajird-1636	99	8	ef	ef	PROPN
ajird-1636	99	9	,	,	PUNCT
ajird-1636	99	10	e	e	NOUN
ajird-1636	99	11	/	/	SYM
ajird-1636	99	12	a	a	PRON
ajird-1636	99	13	,	,	PUNCT
ajird-1636	99	14	ivrt	ivrt	NOUN
ajird-1636	99	15	,	,	PUNCT
ajird-1636	99	16	lvmi	lvmi	PROPN
ajird-1636	99	17	,	,	PUNCT
ajird-1636	99	18	lvmi	lvmi	PROPN
ajird-1636	99	19	significantly	significantly	ADV
ajird-1636	99	20	differed	differ	VERB
ajird-1636	99	21	from	from	ADP
ajird-1636	99	22	the	the	DET
ajird-1636	99	23	norm	norm	NOUN
ajird-1636	99	24	in	in	ADP
ajird-1636	99	25	all	all	DET
ajird-1636	99	26	4	4	NUM
ajird-1636	99	27	observation	observation	NOUN
ajird-1636	99	28	groups(p<0.05).at	groups(p<0.05).at	VERB
ajird-1636	99	29	the	the	DET
ajird-1636	99	30	same	same	ADJ
ajird-1636	99	31	time	time	NOUN
ajird-1636	99	32	,	,	PUNCT
ajird-1636	99	33	the	the	DET
ajird-1636	99	34	average	average	ADJ
ajird-1636	99	35	values	value	NOUN
ajird-1636	99	36	end	end	VERB
ajird-1636	99	37	diastolic	diastolic	ADJ
ajird-1636	99	38	size	size	NOUN
ajird-1636	99	39	of	of	ADP
ajird-1636	99	40	the	the	DET
ajird-1636	99	41	left	left	ADJ
ajird-1636	99	42	ventricle	ventricle	NOUN
ajird-1636	99	43	(	(	PUNCT
ajird-1636	99	44	lv	lv	PROPN
ajird-1636	99	45	edd	edd	PROPN
ajird-1636	99	46	)	)	PUNCT
ajird-1636	99	47	,	,	PUNCT
ajird-1636	99	48	end	end	VERB
ajird-1636	99	49	systolic	systolic	ADJ
ajird-1636	99	50	volume	volume	NOUN
ajird-1636	99	51	(	(	PUNCT
ajird-1636	99	52	esv	esv	NOUN
ajird-1636	99	53	)	)	PUNCT
ajird-1636	99	54	,	,	PUNCT
ajird-1636	99	55	mean	mean	VERB
ajird-1636	99	56	pressure	pressure	NOUN
ajird-1636	99	57	in	in	ADP
ajird-1636	99	58	the	the	DET
ajird-1636	99	59	pulmonary	pulmonary	ADJ
ajird-1636	99	60	artery	artery	NOUN
ajird-1636	99	61	of	of	ADP
ajird-1636	99	62	sppa	sppa	PROPN
ajird-1636	99	63	,	,	PUNCT
ajird-1636	99	64	slowing	slow	VERB
ajird-1636	99	65	down	down	ADP
ajird-1636	99	66	time	time	NOUN
ajird-1636	99	67	of	of	ADP
ajird-1636	99	68	early	early	ADJ
ajird-1636	99	69	diastolic	diastolic	NOUN
ajird-1636	99	70	filling	fill	VERB
ajird-1636	99	71	blood	blood	NOUN
ajird-1636	99	72	flow	flow	NOUN
ajird-1636	99	73	(	(	PUNCT
ajird-1636	99	74	tzslv	tzslv	NOUN
ajird-1636	99	75	)	)	PUNCT
ajird-1636	99	76	,	,	PUNCT
ajird-1636	99	77	were	be	AUX
ajird-1636	99	78	significantly	significantly	ADV
ajird-1636	99	79	changed	change	VERB
ajird-1636	99	80	in	in	ADP
ajird-1636	99	81	groups	group	NOUN
ajird-1636	99	82	1	1	NUM
ajird-1636	99	83	and	and	CCONJ
ajird-1636	99	84	3	3	NUM
ajird-1636	99	85	(	(	PUNCT
ajird-1636	99	86	p	p	X
ajird-1636	99	87	<	<	X
ajird-1636	99	88	0.05	0.05	NUM
ajird-1636	99	89	)	)	PUNCT
ajird-1636	99	90	,	,	PUNCT
ajird-1636	99	91	and	and	CCONJ
ajird-1636	99	92	not	not	PART
ajird-1636	99	93	significantly	significantly	ADV
ajird-1636	99	94	changed	change	VERB
ajird-1636	99	95	in	in	ADP
ajird-1636	99	96	groups	group	NOUN
ajird-1636	99	97	2	2	NUM
ajird-1636	99	98	and	and	CCONJ
ajird-1636	99	99	4	4	NUM
ajird-1636	99	100	(	(	PUNCT
ajird-1636	99	101	p>0.05	p>0.05	PROPN
ajird-1636	99	102	)	)	PUNCT
ajird-1636	99	103	.	.	PUNCT
ajird-1636	100	1	the	the	DET
ajird-1636	100	2	average	average	ADJ
ajird-1636	100	3	values	value	NOUN
ajird-1636	100	4	of	of	ADP
ajird-1636	100	5	the	the	DET
ajird-1636	100	6	volume	volume	NOUN
ajird-1636	100	7	of	of	ADP
ajird-1636	100	8	the	the	DET
ajird-1636	100	9	left	left	ADJ
ajird-1636	100	10	atrium	atrium	NOUN
ajird-1636	100	11	(	(	PUNCT
ajird-1636	100	12	la	la	NOUN
ajird-1636	100	13	)	)	PUNCT
ajird-1636	100	14	and	and	CCONJ
ajird-1636	100	15	the	the	DET
ajird-1636	100	16	right	right	ADJ
ajird-1636	100	17	ventricle	ventricle	NOUN
ajird-1636	100	18	american	american	PROPN
ajird-1636	100	19	journal	journal	PROPN
ajird-1636	100	20	of	of	ADP
ajird-1636	100	21	interdisciplinary	interdisciplinary	ADJ
ajird-1636	100	22	research	research	NOUN
ajird-1636	100	23	and	and	CCONJ
ajird-1636	100	24	development	development	NOUN
ajird-1636	100	25	issn	issn	PROPN
ajird-1636	100	26	online	online	NOUN
ajird-1636	100	27	:	:	PUNCT
ajird-1636	100	28	2771	2771	NUM
ajird-1636	100	29	-	-	SYM
ajird-1636	100	30	8948	8948	NUM
ajird-1636	100	31	website	website	NOUN
ajird-1636	100	32	:	:	PUNCT
ajird-1636	100	33	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-1636	100	34	volume	volume	NOUN
ajird-1636	100	35	46	46	NUM
ajird-1636	100	36	,	,	PUNCT
ajird-1636	100	37	november2025	november2025	PROPN
ajird-1636	100	38	44	44	NUM
ajird-1636	100	39	|	|	ADV
ajird-1636	100	40	p	p	X
ajird-1636	100	41	a	a	DET
ajird-1636	100	42	g	g	NOUN
ajird-1636	100	43	e	e	X
ajird-1636	100	44	(	(	PUNCT
ajird-1636	100	45	rv	rv	PROPN
ajird-1636	100	46	)	)	PUNCT
ajird-1636	100	47	,	,	PUNCT
ajird-1636	100	48	the	the	DET
ajird-1636	100	49	thickness	thickness	NOUN
ajird-1636	100	50	of	of	ADP
ajird-1636	100	51	the	the	DET
ajird-1636	100	52	interventricular	interventricular	ADJ
ajird-1636	100	53	septum	septum	NOUN
ajird-1636	100	54	(	(	PUNCT
ajird-1636	100	55	vat	vat	NOUN
ajird-1636	100	56	)	)	PUNCT
ajird-1636	100	57	were	be	AUX
ajird-1636	100	58	insignificantly	insignificantly	ADV
ajird-1636	100	59	increased	increase	VERB
ajird-1636	100	60	in	in	ADP
ajird-1636	100	61	all	all	DET
ajird-1636	100	62	the	the	DET
ajird-1636	100	63	studied	studied	ADJ
ajird-1636	100	64	groups	group	NOUN
ajird-1636	100	65	(	(	PUNCT
ajird-1636	100	66	p>0.05	p>0.05	PROPN
ajird-1636	100	67	)	)	PUNCT
ajird-1636	100	68	.	.	PUNCT
ajird-1636	101	1	next	next	ADV
ajird-1636	101	2	,	,	PUNCT
ajird-1636	101	3	we	we	PRON
ajird-1636	101	4	evaluated	evaluate	VERB
ajird-1636	101	5	the	the	DET
ajird-1636	101	6	correlation	correlation	NOUN
ajird-1636	101	7	between	between	ADP
ajird-1636	101	8	the	the	DET
ajird-1636	101	9	biomarkers	biomarker	NOUN
ajird-1636	101	10	galectin-3	galectin-3	PROPN
ajird-1636	101	11	and	and	CCONJ
ajird-1636	101	12	h	h	NOUN
ajird-1636	101	13	-	-	PUNCT
ajird-1636	101	14	fabr	fabr	ADJ
ajird-1636	101	15	with	with	ADP
ajird-1636	101	16	various	various	ADJ
ajird-1636	101	17	laboratory	laboratory	NOUN
ajird-1636	101	18	instrumental	instrumental	ADJ
ajird-1636	101	19	data	datum	NOUN
ajird-1636	101	20	(	(	PUNCT
ajird-1636	101	21	tables	table	NOUN
ajird-1636	101	22	5	5	NUM
ajird-1636	101	23	and	and	CCONJ
ajird-1636	101	24	6	6	NUM
ajird-1636	101	25	)	)	PUNCT
ajird-1636	101	26	.	.	PUNCT
ajird-1636	102	1	table	table	NOUN
ajird-1636	102	2	5	5	NUM
ajird-1636	102	3	.	.	PUNCT
ajird-1636	103	1	correlation	correlation	NOUN
ajird-1636	103	2	(	(	PUNCT
ajird-1636	103	3	r	r	NOUN
ajird-1636	103	4	)	)	PUNCT
ajird-1636	103	5	of	of	ADP
ajird-1636	103	6	galectin-3	galectin-3	PROPN
ajird-1636	103	7	values	value	NOUN
ajird-1636	103	8	with	with	ADP
ajird-1636	103	9	laboratory	laboratory	NOUN
ajird-1636	103	10	and	and	CCONJ
ajird-1636	103	11	instrumental	instrumental	ADJ
ajird-1636	103	12	indicators	indicator	NOUN
ajird-1636	103	13	in	in	ADP
ajird-1636	103	14	the	the	DET
ajird-1636	103	15	studied	study	VERB
ajird-1636	103	16	groups	group	NOUN
ajird-1636	103	17	egfrml	egfrml	VERB
ajird-1636	103	18	/	/	SYM
ajird-1636	103	19	m	m	VERB
ajird-1636	103	20	in/1.73	in/1.73	PROPN
ajird-1636	103	21	m2	m2	PROPN
ajird-1636	103	22	glycemia	glycemia	NOUN
ajird-1636	103	23	on	on	ADP
ajird-1636	103	24	an	an	DET
ajird-1636	103	25	empty	empty	ADJ
ajird-1636	103	26	stomach	stomach	NOUN
ajird-1636	103	27	mmol	mmol	NOUN
ajird-1636	103	28	/	/	SYM
ajird-1636	103	29	l	l	NOUN
ajird-1636	104	1	hba1c	hba1c	NOUN
ajird-1636	104	2	%	%	INTJ
ajird-1636	104	3	ef	ef	X
ajird-1636	104	4	of	of	ADP
ajird-1636	104	5	the	the	DET
ajird-1636	104	6	left	left	ADJ
ajird-1636	104	7	ventricle	ventricle	NOUN
ajird-1636	104	8	mean	mean	VERB
ajird-1636	104	9	pressure	pressure	NOUN
ajird-1636	104	10	in	in	ADP
ajird-1636	104	11	the	the	DET
ajird-1636	104	12	pulmonary	pulmonary	ADJ
ajird-1636	104	13	artery	artery	NOUN
ajird-1636	104	14	ratio	ratio	NOUN
ajird-1636	104	15	of	of	ADP
ajird-1636	104	16	peak	peak	NOUN
ajird-1636	104	17	velocities	velocity	NOUN
ajird-1636	104	18	of	of	ADP
ajird-1636	104	19	waves	wave	NOUN
ajird-1636	104	20	e	e	NOUN
ajird-1636	104	21	and	and	CCONJ
ajird-1636	104	22	a(e	a(e	PROPN
ajird-1636	104	23	/	/	SYM
ajird-1636	104	24	a	a	NOUN
ajird-1636	104	25	)	)	PUNCT
ajird-1636	104	26	.	.	PUNCT
ajird-1636	105	1	gfr	gfr	PROPN
ajird-1636	105	2	,	,	PUNCT
ajird-1636	105	3	ml	ml	PROPN
ajird-1636	105	4	/	/	SYM
ajird-1636	105	5	min	min	NOUN
ajird-1636	105	6	1	1	NUM
ajird-1636	105	7	gr	gr	NUM
ajird-1636	105	8	0.65	0.65	NUM
ajird-1636	105	9	0.68	0.68	NUM
ajird-1636	105	10	0.67	0.67	NUM
ajird-1636	105	11	0.58	0.58	NUM
ajird-1636	105	12	0.57	0.57	NUM
ajird-1636	105	13	0.44	0.44	NUM
ajird-1636	105	14	2	2	NUM
ajird-1636	105	15	gr	gr	NUM
ajird-1636	105	16	0.67	0.67	NUM
ajird-1636	105	17	0.66	0.66	NUM
ajird-1636	105	18	0.69	0.69	NUM
ajird-1636	105	19	0.56	0.56	NUM
ajird-1636	105	20	0.71	0.71	NUM
ajird-1636	105	21	0.75	0.75	NUM
ajird-1636	105	22	note	note	NOUN
ajird-1636	105	23	:	:	PUNCT
ajird-1636	105	24	ef	ef	PROPN
ajird-1636	105	25	ejection	ejection	NOUN
ajird-1636	105	26	fraction	fraction	NOUN
ajird-1636	105	27	table	table	NOUN
ajird-1636	105	28	6	6	NUM
ajird-1636	105	29	.	.	PUNCT
ajird-1636	106	1	correlation	correlation	NOUN
ajird-1636	106	2	(	(	PUNCT
ajird-1636	106	3	r	r	NOUN
ajird-1636	106	4	)	)	PUNCT
ajird-1636	106	5	valuesh	valuesh	NOUN
ajird-1636	106	6	-	-	PUNCT
ajird-1636	106	7	fabrfrom	fabrfrom	NOUN
ajird-1636	106	8	laboratory	laboratory	NOUN
ajird-1636	106	9	and	and	CCONJ
ajird-1636	106	10	instrumental	instrumental	ADJ
ajird-1636	106	11	indicators	indicator	NOUN
ajird-1636	106	12	in	in	ADP
ajird-1636	106	13	the	the	DET
ajird-1636	106	14	studied	study	VERB
ajird-1636	106	15	groups	group	NOUN
ajird-1636	106	16	egfrml/	egfrml/	NUM
ajird-1636	106	17	m	m	NOUN
ajird-1636	106	18	in/1.73	in/1.73	PROPN
ajird-1636	106	19	m2	m2	PROPN
ajird-1636	106	20	glycemia	glycemia	NOUN
ajird-1636	106	21	on	on	ADP
ajird-1636	106	22	an	an	DET
ajird-1636	106	23	empty	empty	ADJ
ajird-1636	106	24	stomach	stomach	NOUN
ajird-1636	106	25	mmol	mmol	NOUN
ajird-1636	106	26	/	/	SYM
ajird-1636	106	27	l	l	NOUN
ajird-1636	106	28	hba1c	hba1c	NOUN
ajird-1636	106	29	%	%	INTJ
ajird-1636	106	30	ef	ef	X
ajird-1636	106	31	of	of	ADP
ajird-1636	106	32	the	the	DET
ajird-1636	106	33	left	left	ADJ
ajird-1636	106	34	ventricle	ventricle	NOUN
ajird-1636	106	35	mean	mean	VERB
ajird-1636	106	36	pressure	pressure	NOUN
ajird-1636	106	37	in	in	ADP
ajird-1636	106	38	the	the	DET
ajird-1636	106	39	pulmonary	pulmonary	ADJ
ajird-1636	106	40	artery	artery	NOUN
ajird-1636	106	41	ratio	ratio	NOUN
ajird-1636	106	42	of	of	ADP
ajird-1636	106	43	peak	peak	NOUN
ajird-1636	106	44	velocities	velocity	NOUN
ajird-1636	106	45	of	of	ADP
ajird-1636	106	46	waves	wave	NOUN
ajird-1636	106	47	e	e	NOUN
ajird-1636	106	48	and	and	CCONJ
ajird-1636	106	49	a	a	DET
ajird-1636	106	50	gfr	gfr	NOUN
ajird-1636	106	51	,	,	PUNCT
ajird-1636	106	52	ml	ml	PROPN
ajird-1636	106	53	/	/	SYM
ajird-1636	106	54	min	min	NOUN
ajird-1636	106	55	1	1	NUM
ajird-1636	106	56	gr	gr	NUM
ajird-1636	106	57	0.62	0.62	NUM
ajird-1636	106	58	0.71	0.71	NUM
ajird-1636	106	59	0.69	0.69	NUM
ajird-1636	106	60	0.58	0.58	NUM
ajird-1636	106	61	0.68	0.68	NUM
ajird-1636	106	62	0.74	0.74	NUM
ajird-1636	106	63	2	2	NUM
ajird-1636	106	64	gr	gr	NUM
ajird-1636	106	65	0.55	0.55	NUM
ajird-1636	106	66	0.59	0.59	NUM
ajird-1636	106	67	0.58	0.58	NUM
ajird-1636	106	68	0.74	0.74	NUM
ajird-1636	106	69	0.71	0.71	NUM
ajird-1636	106	70	0.76	0.76	NUM
ajird-1636	106	71	we	we	PRON
ajird-1636	106	72	see	see	VERB
ajird-1636	106	73	that	that	SCONJ
ajird-1636	106	74	the	the	DET
ajird-1636	106	75	correlation	correlation	NOUN
ajird-1636	106	76	between	between	ADP
ajird-1636	106	77	these	these	DET
ajird-1636	106	78	indicators	indicator	NOUN
ajird-1636	106	79	was	be	AUX
ajird-1636	106	80	significant	significant	ADJ
ajird-1636	106	81	.	.	PUNCT
ajird-1636	107	1	all	all	DET
ajird-1636	107	2	this	this	DET
ajird-1636	107	3	highlights	highlight	NOUN
ajird-1636	107	4	the	the	DET
ajird-1636	107	5	possibilities	possibility	NOUN
ajird-1636	107	6	of	of	ADP
ajird-1636	107	7	using	use	VERB
ajird-1636	107	8	biomarkers	biomarker	NOUN
ajird-1636	107	9	.	.	PUNCT
ajird-1636	108	1	galectin-3	galectin-3	PROPN
ajird-1636	108	2	and	and	CCONJ
ajird-1636	108	3	h	h	NOUN
ajird-1636	108	4	-	-	PUNCT
ajird-1636	108	5	fabras	fabra	NOUN
ajird-1636	108	6	factors	factor	NOUN
ajird-1636	108	7	predicting	predict	VERB
ajird-1636	108	8	the	the	DET
ajird-1636	108	9	outcomes	outcome	NOUN
ajird-1636	108	10	of	of	ADP
ajird-1636	108	11	the	the	DET
ajird-1636	108	12	course	course	NOUN
ajird-1636	108	13	of	of	ADP
ajird-1636	108	14	chf	chf	NOUN
ajird-1636	108	15	in	in	ADP
ajird-1636	108	16	type	type	NOUN
ajird-1636	108	17	2	2	NUM
ajird-1636	108	18	diabetes	diabetes	NOUN
ajird-1636	108	19	and	and	CCONJ
ajird-1636	108	20	without	without	ADP
ajird-1636	108	21	type	type	NOUN
ajird-1636	108	22	2	2	NUM
ajird-1636	108	23	diabetes	diabete	NOUN
ajird-1636	108	24	,	,	PUNCT
ajird-1636	108	25	as	as	SCONJ
ajird-1636	108	26	indicated	indicate	VERB
ajird-1636	108	27	in	in	ADP
ajird-1636	108	28	the	the	DET
ajird-1636	108	29	literature	literature	NOUN
ajird-1636	108	30	.	.	PUNCT
ajird-1636	109	1	further	far	ADV
ajird-1636	109	2	,	,	PUNCT
ajird-1636	109	3	the	the	DET
ajird-1636	109	4	relationship	relationship	NOUN
ajird-1636	109	5	between	between	ADP
ajird-1636	109	6	the	the	DET
ajird-1636	109	7	level	level	NOUN
ajird-1636	109	8	of	of	ADP
ajird-1636	109	9	galectin-3,h	galectin-3,h	NOUN
ajird-1636	109	10	-	-	PUNCT
ajird-1636	109	11	fabrand	fabrand	NOUN
ajird-1636	109	12	systolic	systolic	NOUN
ajird-1636	109	13	,	,	PUNCT
ajird-1636	109	14	diastolic	diastolic	ADJ
ajird-1636	109	15	function	function	NOUN
ajird-1636	109	16	in	in	ADP
ajird-1636	109	17	chf	chf	PROPN
ajird-1636	109	18	and	and	CCONJ
ajird-1636	109	19	dm2	dm2	PROPN
ajird-1636	109	20	were	be	AUX
ajird-1636	109	21	assessed	assess	VERB
ajird-1636	109	22	using	use	VERB
ajird-1636	109	23	the	the	DET
ajird-1636	109	24	study	study	NOUN
ajird-1636	109	25	of	of	ADP
ajird-1636	109	26	the	the	DET
ajird-1636	109	27	correlation	correlation	NOUN
ajird-1636	109	28	and	and	CCONJ
ajird-1636	109	29	student	student	NOUN
ajird-1636	109	30	's	's	PART
ajird-1636	109	31	test	test	NOUN
ajird-1636	109	32	of	of	ADP
ajird-1636	109	33	significance	significance	NOUN
ajird-1636	109	34	(	(	PUNCT
ajird-1636	109	35	table	table	NOUN
ajird-1636	109	36	7	7	NUM
ajird-1636	109	37	)	)	PUNCT
ajird-1636	109	38	..	..	PUNCT
ajird-1636	109	39	diastolic	diastolic	ADJ
ajird-1636	109	40	or	or	CCONJ
ajird-1636	109	41	systolic	systolic	ADJ
ajird-1636	109	42	dysfunction	dysfunction	NOUN
ajird-1636	109	43	has	have	AUX
ajird-1636	109	44	not	not	PART
ajird-1636	109	45	been	be	AUX
ajird-1636	109	46	associated	associate	VERB
ajird-1636	109	47	with	with	ADP
ajird-1636	109	48	galectin-3	galectin-3	PROPN
ajird-1636	109	49	in	in	ADP
ajird-1636	109	50	individuals	individual	NOUN
ajird-1636	109	51	without	without	ADP
ajird-1636	109	52	type	type	NOUN
ajird-1636	109	53	2	2	NUM
ajird-1636	109	54	diabetes	diabetes	NOUN
ajird-1636	109	55	.	.	PUNCT
ajird-1636	110	1	in	in	ADP
ajird-1636	110	2	t2	t2	PROPN
ajird-1636	110	3	dm	dm	PROPN
ajird-1636	110	4	,	,	PUNCT
ajird-1636	110	5	systolic	systolic	ADJ
ajird-1636	110	6	function	function	NOUN
ajird-1636	110	7	decreased	decrease	VERB
ajird-1636	110	8	with	with	ADP
ajird-1636	110	9	increasing	increase	VERB
ajird-1636	110	10	levels	level	NOUN
ajird-1636	110	11	of	of	ADP
ajird-1636	110	12	galectin-3	galectin-3	PROPN
ajird-1636	110	13	,	,	PUNCT
ajird-1636	110	14	regardless	regardless	ADV
ajird-1636	110	15	of	of	ADP
ajird-1636	110	16	age	age	NOUN
ajird-1636	110	17	,	,	PUNCT
ajird-1636	110	18	gender	gender	NOUN
ajird-1636	110	19	,	,	PUNCT
ajird-1636	110	20	comorbidities	comorbiditie	NOUN
ajird-1636	110	21	,	,	PUNCT
ajird-1636	110	22	and	and	CCONJ
ajird-1636	110	23	hf	hf	ADP
ajird-1636	110	24	medications	medication	NOUN
ajird-1636	110	25	.	.	PUNCT
ajird-1636	111	1	diastolic	diastolic	ADJ
ajird-1636	111	2	dysfunction	dysfunction	NOUN
ajird-1636	111	3	(	(	PUNCT
ajird-1636	111	4	e	e	NOUN
ajird-1636	111	5	/	/	SYM
ajird-1636	111	6	e	e	NOUN
ajird-1636	111	7	'	'	PART
ajird-1636	111	8	ratio	ratio	NOUN
ajird-1636	111	9	)	)	PUNCT
ajird-1636	111	10	was	be	AUX
ajird-1636	111	11	associated	associate	VERB
ajird-1636	111	12	with	with	ADP
ajird-1636	111	13	increased	increase	VERB
ajird-1636	111	14	levels	level	NOUN
ajird-1636	111	15	of	of	ADP
ajird-1636	111	16	galectin-3	galectin-3	PROPN
ajird-1636	111	17	in	in	ADP
ajird-1636	111	18	chf	chf	NOUN
ajird-1636	111	19	without	without	ADP
ajird-1636	111	20	dm	dm	PROPN
ajird-1636	111	21	2	2	NUM
ajird-1636	111	22	after	after	ADP
ajird-1636	111	23	adjusting	adjust	VERB
ajird-1636	111	24	for	for	ADP
ajird-1636	111	25	sex	sex	NOUN
ajird-1636	111	26	and	and	CCONJ
ajird-1636	111	27	age	age	NOUN
ajird-1636	111	28	was	be	AUX
ajird-1636	111	29	attenuated	attenuate	VERB
ajird-1636	111	30	.	.	PUNCT
ajird-1636	112	1	on	on	ADP
ajird-1636	112	2	the	the	DET
ajird-1636	112	3	contrary	contrary	NOUN
ajird-1636	112	4	,	,	PUNCT
ajird-1636	112	5	in	in	ADP
ajird-1636	112	6	t2	t2	PROPN
ajird-1636	112	7	dm	dm	PROPN
ajird-1636	112	8	,	,	PUNCT
ajird-1636	112	9	a	a	DET
ajird-1636	112	10	corresponding	corresponding	ADJ
ajird-1636	112	11	relationship	relationship	NOUN
ajird-1636	112	12	between	between	ADP
ajird-1636	112	13	diastolic	diastolic	ADJ
ajird-1636	112	14	dysfunction	dysfunction	NOUN
ajird-1636	112	15	and	and	CCONJ
ajird-1636	112	16	galectin-3	galectin-3	PROPN
ajird-1636	112	17	levels	level	NOUN
ajird-1636	112	18	was	be	AUX
ajird-1636	112	19	observed	observe	VERB
ajird-1636	112	20	significantly	significantly	ADV
ajird-1636	112	21	.	.	PUNCT
ajird-1636	113	1	in	in	ADP
ajird-1636	113	2	general	general	ADJ
ajird-1636	113	3	,	,	PUNCT
ajird-1636	113	4	an	an	DET
ajird-1636	113	5	increase	increase	NOUN
ajird-1636	113	6	in	in	ADP
ajird-1636	113	7	the	the	DET
ajird-1636	113	8	level	level	NOUN
ajird-1636	113	9	of	of	ADP
ajird-1636	113	10	galectin	galectin	ADJ
ajird-1636	113	11	american	american	PROPN
ajird-1636	113	12	journal	journal	PROPN
ajird-1636	113	13	of	of	ADP
ajird-1636	113	14	interdisciplinary	interdisciplinary	ADJ
ajird-1636	113	15	research	research	NOUN
ajird-1636	113	16	and	and	CCONJ
ajird-1636	113	17	development	development	NOUN
ajird-1636	113	18	issn	issn	PROPN
ajird-1636	113	19	online	online	NOUN
ajird-1636	113	20	:	:	PUNCT
ajird-1636	113	21	2771	2771	NUM
ajird-1636	113	22	-	-	SYM
ajird-1636	113	23	8948	8948	NUM
ajird-1636	113	24	website	website	NOUN
ajird-1636	113	25	:	:	PUNCT
ajird-1636	113	26	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-1636	113	27	volume	volume	NOUN
ajird-1636	113	28	46	46	NUM
ajird-1636	113	29	,	,	PUNCT
ajird-1636	113	30	november2025	november2025	PROPN
ajird-1636	113	31	45	45	NUM
ajird-1636	114	1	|	|	ADV
ajird-1636	114	2	p	p	ADP
ajird-1636	114	3	a	a	DET
ajird-1636	114	4	g	g	NOUN
ajird-1636	114	5	e	e	NOUN
ajird-1636	114	6	3	3	NUM
ajird-1636	114	7	was	be	AUX
ajird-1636	114	8	associated	associate	VERB
ajird-1636	114	9	with	with	ADP
ajird-1636	114	10	the	the	DET
ajird-1636	114	11	occurrence	occurrence	NOUN
ajird-1636	114	12	of	of	ADP
ajird-1636	114	13	disturbances	disturbance	NOUN
ajird-1636	114	14	in	in	ADP
ajird-1636	114	15	systolic	systolic	ADJ
ajird-1636	114	16	and	and	CCONJ
ajird-1636	114	17	diastolic	diastolic	ADJ
ajird-1636	114	18	function	function	NOUN
ajird-1636	114	19	of	of	ADP
ajird-1636	114	20	the	the	DET
ajird-1636	114	21	heart	heart	NOUN
ajird-1636	114	22	in	in	ADP
ajird-1636	114	23	t2	t2	PROPN
ajird-1636	114	24	dm	dm	PROPN
ajird-1636	114	25	,	,	PUNCT
ajird-1636	114	26	as	as	ADV
ajird-1636	114	27	well	well	ADV
ajird-1636	114	28	as	as	ADP
ajird-1636	114	29	with	with	ADP
ajird-1636	114	30	a	a	DET
ajird-1636	114	31	violation	violation	NOUN
ajird-1636	114	32	of	of	ADP
ajird-1636	114	33	systolic	systolic	ADJ
ajird-1636	114	34	heart	heart	NOUN
ajird-1636	114	35	function	function	NOUN
ajird-1636	114	36	in	in	ADP
ajird-1636	114	37	chf	chf	NOUN
ajird-1636	114	38	without	without	ADP
ajird-1636	114	39	type	type	NOUN
ajird-1636	114	40	2	2	NUM
ajird-1636	114	41	diabetes	diabetes	NOUN
ajird-1636	114	42	.	.	PUNCT
ajird-1636	115	1	table	table	NOUN
ajird-1636	115	2	7	7	NUM
ajird-1636	115	3	.	.	X
ajird-1636	115	4	relationship	relationship	NOUN
ajird-1636	115	5	between	between	ADP
ajird-1636	115	6	the	the	DET
ajird-1636	115	7	level	level	NOUN
ajird-1636	115	8	of	of	ADP
ajird-1636	115	9	galectin-3,h	galectin-3,h	NOUN
ajird-1636	115	10	-	-	PUNCT
ajird-1636	115	11	fabrand	fabrand	NOUN
ajird-1636	115	12	systolic	systolic	NOUN
ajird-1636	115	13	,	,	PUNCT
ajird-1636	115	14	diastolic	diastolic	ADJ
ajird-1636	115	15	function	function	NOUN
ajird-1636	115	16	indicators	indicator	NOUN
ajird-1636	115	17	r	r	NOUN
ajird-1636	115	18	p	p	X
ajird-1636	115	19	ef	ef	X
ajird-1636	115	20	lv	lv	PROPN
ajird-1636	115	21	0.56	0.56	NUM
ajird-1636	115	22	<	<	X
ajird-1636	115	23	0.005	0.005	NUM
ajird-1636	115	24	е	е	NOUN
ajird-1636	115	25	/	/	SYM
ajird-1636	115	26	е	е	NOUN
ajird-1636	115	27	’	'	PUNCT
ajird-1636	115	28	g̴	g̴	NUM
ajird-1636	115	29	al-3	al-3	PUNCT
ajird-1636	115	30	with	with	ADP
ajird-1636	115	31	sd2	sd2	PROPN
ajird-1636	115	32	0.65	0.65	PROPN
ajird-1636	115	33	*	*	PUNCT
ajird-1636	115	34	>	>	X
ajird-1636	115	35	0.005	0.005	NUM
ajird-1636	115	36	е	е	NOUN
ajird-1636	115	37	/	/	SYM
ajird-1636	115	38	е	е	NOUN
ajird-1636	115	39	’	'	PUNCT
ajird-1636	115	40	'	'	PUNCT
ajird-1636	115	41	̴g̴al-3	̴g̴al-3	VERB
ajird-1636	115	42	with	with	ADP
ajird-1636	115	43	chf	chf	NOUN
ajird-1636	115	44	0.33	0.33	NUM
ajird-1636	115	45	<	<	X
ajird-1636	115	46	0.005	0.005	NUM
ajird-1636	115	47	е	е	NOUN
ajird-1636	115	48	/	/	SYM
ajird-1636	115	49	е	е	NOUN
ajird-1636	115	50	’	'	PUNCT
ajird-1636	115	51	'	'	PUNCT
ajird-1636	115	52	̴h̴-fabr	̴h̴-fabr	PROPN
ajird-1636	115	53	for	for	ADP
ajird-1636	115	54	dm	dm	NUM
ajird-1636	115	55	2	2	NUM
ajird-1636	115	56	0.59	0.59	NUM
ajird-1636	115	57	*	*	PUNCT
ajird-1636	115	58	<	<	X
ajird-1636	115	59	0.005	0.005	NUM
ajird-1636	115	60	е	е	NOUN
ajird-1636	115	61	/	/	SYM
ajird-1636	115	62	е	е	NOUN
ajird-1636	115	63	’	'	PUNCT
ajird-1636	115	64	~	~	PUNCT
ajird-1636	115	65	0.38	0.38	NUM
ajird-1636	115	66	>	>	SYM
ajird-1636	115	67	0.005	0.005	NUM
ajird-1636	115	68	h	h	NOUN
ajird-1636	115	69	-	-	PUNCT
ajird-1636	115	70	fabr	fabr	NOUN
ajird-1636	115	71	for	for	ADP
ajird-1636	115	72	chf	chf	NOUN
ajird-1636	115	73	note	note	NOUN
ajird-1636	115	74	:	:	PUNCT
ajird-1636	115	75	r	r	NOUN
ajird-1636	115	76	correlation	correlation	NOUN
ajird-1636	115	77	,	,	PUNCT
ajird-1636	115	78	p	p	NOUN
ajird-1636	115	79	criterion	criterion	NOUN
ajird-1636	115	80	of	of	ADP
ajird-1636	115	81	significance	significance	NOUN
ajird-1636	115	82	when	when	SCONJ
ajird-1636	115	83	compared	compare	VERB
ajird-1636	115	84	with	with	ADP
ajird-1636	115	85	control	control	NOUN
ajird-1636	115	86	.	.	PUNCT
ajird-1636	116	1	all	all	DET
ajird-1636	116	2	the	the	DET
ajird-1636	116	3	above	above	ADJ
ajird-1636	116	4	data	datum	NOUN
ajird-1636	116	5	indicate	indicate	VERB
ajird-1636	116	6	the	the	DET
ajird-1636	116	7	need	need	NOUN
ajird-1636	116	8	for	for	ADP
ajird-1636	116	9	timelydiagnosing	timelydiagnose	VERB
ajird-1636	116	10	chf	chf	NOUN
ajird-1636	116	11	in	in	ADP
ajird-1636	116	12	patients	patient	NOUN
ajird-1636	116	13	with	with	ADP
ajird-1636	116	14	type	type	NOUN
ajird-1636	116	15	2	2	NUM
ajird-1636	116	16	diabetes	diabetes	NOUN
ajird-1636	116	17	mellitus	mellitus	NOUN
ajird-1636	116	18	,	,	PUNCT
ajird-1636	116	19	developing	develop	VERB
ajird-1636	116	20	measures	measure	NOUN
ajird-1636	116	21	to	to	PART
ajird-1636	116	22	prevent	prevent	VERB
ajird-1636	116	23	their	their	PRON
ajird-1636	116	24	development	development	NOUN
ajird-1636	116	25	and	and	CCONJ
ajird-1636	116	26	organizing	organize	VERB
ajird-1636	116	27	longterm	longterm	ADJ
ajird-1636	116	28	monitoring	monitoring	NOUN
ajird-1636	116	29	of	of	ADP
ajird-1636	116	30	patients	patient	NOUN
ajird-1636	116	31	with	with	ADP
ajird-1636	116	32	a	a	DET
ajird-1636	116	33	high	high	ADJ
ajird-1636	116	34	risk	risk	NOUN
ajird-1636	116	35	of	of	ADP
ajird-1636	116	36	developing	develop	VERB
ajird-1636	116	37	this	this	DET
ajird-1636	116	38	complication	complication	NOUN
ajird-1636	116	39	of	of	ADP
ajird-1636	116	40	diabetes	diabetes	NOUN
ajird-1636	116	41	.	.	PUNCT
ajird-1636	117	1	thus	thus	ADV
ajird-1636	117	2	,	,	PUNCT
ajird-1636	117	3	a	a	DET
ajird-1636	117	4	significant	significant	ADJ
ajird-1636	117	5	difference	difference	NOUN
ajird-1636	117	6	was	be	AUX
ajird-1636	117	7	found	find	VERB
ajird-1636	117	8	in	in	ADP
ajird-1636	117	9	the	the	DET
ajird-1636	117	10	parameters	parameter	NOUN
ajird-1636	117	11	of	of	ADP
ajird-1636	117	12	central	central	ADJ
ajird-1636	117	13	hemodynamics	hemodynamic	NOUN
ajird-1636	117	14	in	in	ADP
ajird-1636	117	15	all	all	DET
ajird-1636	117	16	the	the	DET
ajird-1636	117	17	studied	study	VERB
ajird-1636	117	18	groups	group	NOUN
ajird-1636	117	19	compared	compare	VERB
ajird-1636	117	20	with	with	ADP
ajird-1636	117	21	the	the	DET
ajird-1636	117	22	normal	normal	ADJ
ajird-1636	117	23	values	value	NOUN
ajird-1636	117	24	,	,	PUNCT
ajird-1636	117	25	but	but	CCONJ
ajird-1636	117	26	in	in	ADP
ajird-1636	117	27	patients	patient	NOUN
ajird-1636	117	28	with	with	ADP
ajird-1636	117	29	dm	dm	PROPN
ajird-1636	117	30	2	2	NUM
ajird-1636	117	31	and	and	CCONJ
ajird-1636	117	32	chf	chf	NOUN
ajird-1636	117	33	,	,	PUNCT
ajird-1636	117	34	these	these	DET
ajird-1636	117	35	changes	change	NOUN
ajird-1636	117	36	were	be	AUX
ajird-1636	117	37	most	most	ADV
ajird-1636	117	38	pronounced	pronounce	VERB
ajird-1636	117	39	.	.	PUNCT
ajird-1636	118	1	so	so	ADV
ajird-1636	118	2	,	,	PUNCT
ajird-1636	118	3	in	in	ADP
ajird-1636	118	4	the	the	DET
ajird-1636	118	5	groups	group	NOUN
ajird-1636	118	6	of	of	ADP
ajird-1636	118	7	patients	patient	NOUN
ajird-1636	118	8	with	with	ADP
ajird-1636	118	9	type	type	NOUN
ajird-1636	118	10	2	2	NUM
ajird-1636	118	11	diabetes	diabetes	NOUN
ajird-1636	118	12	and	and	CCONJ
ajird-1636	118	13	chf	chf	NOUN
ajird-1636	118	14	,	,	PUNCT
ajird-1636	118	15	we	we	PRON
ajird-1636	118	16	detected	detect	VERB
ajird-1636	118	17	echo	echo	NOUN
ajird-1636	118	18	-	-	PUNCT
ajird-1636	118	19	ecg	ecg	PROPN
ajird-1636	118	20	changes	change	NOUN
ajird-1636	118	21	according	accord	VERB
ajird-1636	118	22	to	to	ADP
ajird-1636	118	23	the	the	DET
ajird-1636	118	24	type	type	NOUN
ajird-1636	118	25	of	of	ADP
ajird-1636	118	26	lv	lv	PROPN
ajird-1636	118	27	diastolic	diastolic	ADJ
ajird-1636	118	28	dysfunction	dysfunction	NOUN
ajird-1636	118	29	of	of	ADP
ajird-1636	118	30	2	2	NUM
ajird-1636	118	31	-	-	SYM
ajird-1636	118	32	3	3	NUM
ajird-1636	118	33	degrees	degree	NOUN
ajird-1636	118	34	with	with	ADP
ajird-1636	118	35	a	a	DET
ajird-1636	118	36	tendency	tendency	NOUN
ajird-1636	118	37	to	to	PART
ajird-1636	118	38	increase	increase	VERB
ajird-1636	118	39	the	the	DET
ajird-1636	118	40	mean	mean	ADJ
ajird-1636	118	41	pressure	pressure	NOUN
ajird-1636	118	42	in	in	ADP
ajird-1636	118	43	the	the	DET
ajird-1636	118	44	pulmonary	pulmonary	ADJ
ajird-1636	118	45	artery	artery	NOUN
ajird-1636	118	46	.	.	PUNCT
ajird-1636	119	1	conclusion	conclusion	NOUN
ajird-1636	119	2	1	1	NUM
ajird-1636	119	3	)	)	PUNCT
ajird-1636	119	4	an	an	DET
ajird-1636	119	5	increase	increase	NOUN
ajird-1636	119	6	in	in	ADP
ajird-1636	119	7	the	the	DET
ajird-1636	119	8	concentration	concentration	NOUN
ajird-1636	119	9	of	of	ADP
ajird-1636	119	10	galectin-3	galectin-3	PROPN
ajird-1636	119	11	and	and	CCONJ
ajird-1636	119	12	h	h	NOUN
ajird-1636	119	13	-	-	PUNCT
ajird-1636	119	14	fabr	fabr	ADJ
ajird-1636	119	15	in	in	ADP
ajird-1636	119	16	all	all	DET
ajird-1636	119	17	patients	patient	NOUN
ajird-1636	119	18	with	with	ADP
ajird-1636	119	19	type	type	NOUN
ajird-1636	119	20	2	2	NUM
ajird-1636	119	21	dm	dm	NOUN
ajird-1636	119	22	with	with	ADP
ajird-1636	119	23	concomitant	concomitant	ADJ
ajird-1636	119	24	chf	chf	NOUN
ajird-1636	119	25	,	,	PUNCT
ajird-1636	119	26	as	as	ADV
ajird-1636	119	27	well	well	ADV
ajird-1636	119	28	as	as	ADP
ajird-1636	119	29	the	the	DET
ajird-1636	119	30	high	high	ADJ
ajird-1636	119	31	sensitivity	sensitivity	NOUN
ajird-1636	119	32	and	and	CCONJ
ajird-1636	119	33	specificity	specificity	NOUN
ajird-1636	119	34	of	of	ADP
ajird-1636	119	35	the	the	DET
ajird-1636	119	36	test	test	NOUN
ajird-1636	119	37	,	,	PUNCT
ajird-1636	119	38	prove	prove	VERB
ajird-1636	119	39	the	the	DET
ajird-1636	119	40	value	value	NOUN
ajird-1636	119	41	of	of	ADP
ajird-1636	119	42	this	this	DET
ajird-1636	119	43	marker	marker	NOUN
ajird-1636	119	44	for	for	ADP
ajird-1636	119	45	diagnosing	diagnose	VERB
ajird-1636	119	46	chf	chf	NOUN
ajird-1636	119	47	in	in	ADP
ajird-1636	119	48	patients	patient	NOUN
ajird-1636	119	49	with	with	ADP
ajird-1636	119	50	type	type	NOUN
ajird-1636	119	51	2	2	NUM
ajird-1636	119	52	dm	dm	NOUN
ajird-1636	119	53	.	.	PUNCT
ajird-1636	120	1	the	the	DET
ajird-1636	120	2	dynamics	dynamic	NOUN
ajird-1636	120	3	of	of	ADP
ajird-1636	120	4	their	their	PRON
ajird-1636	120	5	concentration	concentration	NOUN
ajird-1636	120	6	can	can	AUX
ajird-1636	120	7	help	help	VERB
ajird-1636	120	8	in	in	ADP
ajird-1636	120	9	assessing	assess	VERB
ajird-1636	120	10	the	the	DET
ajird-1636	120	11	effectiveness	effectiveness	NOUN
ajird-1636	120	12	of	of	ADP
ajird-1636	120	13	the	the	DET
ajird-1636	120	14	therapy	therapy	NOUN
ajird-1636	120	15	and	and	CCONJ
ajird-1636	120	16	the	the	DET
ajird-1636	120	17	need	need	NOUN
ajird-1636	120	18	to	to	PART
ajird-1636	120	19	titrate	titrate	VERB
ajird-1636	120	20	the	the	DET
ajird-1636	120	21	dose	dose	NOUN
ajird-1636	120	22	of	of	ADP
ajird-1636	120	23	drugs	drug	NOUN
ajird-1636	120	24	.	.	PUNCT
ajird-1636	121	1	2)an	2)an	NUM
ajird-1636	121	2	increase	increase	NOUN
ajird-1636	121	3	in	in	ADP
ajird-1636	121	4	the	the	DET
ajird-1636	121	5	level	level	NOUN
ajird-1636	121	6	of	of	ADP
ajird-1636	121	7	galectin-3	galectin-3	PROPN
ajird-1636	121	8	was	be	AUX
ajird-1636	121	9	associated	associate	VERB
ajird-1636	121	10	with	with	ADP
ajird-1636	121	11	the	the	DET
ajird-1636	121	12	occurrence	occurrence	NOUN
ajird-1636	121	13	of	of	ADP
ajird-1636	121	14	violations	violation	NOUN
ajird-1636	121	15	of	of	ADP
ajird-1636	121	16	systolic	systolic	ADJ
ajird-1636	121	17	and	and	CCONJ
ajird-1636	121	18	diastolic	diastolic	ADJ
ajird-1636	121	19	function	function	NOUN
ajird-1636	121	20	of	of	ADP
ajird-1636	121	21	the	the	DET
ajird-1636	121	22	heart	heart	NOUN
ajird-1636	121	23	in	in	ADP
ajird-1636	121	24	t2	t2	PROPN
ajird-1636	121	25	dm	dm	PROPN
ajird-1636	121	26	,	,	PUNCT
ajird-1636	121	27	as	as	ADV
ajird-1636	121	28	well	well	ADV
ajird-1636	121	29	as	as	ADP
ajird-1636	121	30	with	with	ADP
ajird-1636	121	31	a	a	DET
ajird-1636	121	32	violation	violation	NOUN
ajird-1636	121	33	of	of	ADP
ajird-1636	121	34	systolic	systolic	ADJ
ajird-1636	121	35	function	function	NOUN
ajird-1636	121	36	of	of	ADP
ajird-1636	121	37	the	the	DET
ajird-1636	121	38	heart	heart	NOUN
ajird-1636	121	39	in	in	ADP
ajird-1636	121	40	chf	chf	NOUN
ajird-1636	121	41	without	without	ADP
ajird-1636	121	42	type	type	NOUN
ajird-1636	121	43	2	2	NUM
ajird-1636	121	44	diabetes	diabetes	NOUN
ajird-1636	121	45	.	.	PUNCT
ajird-1636	122	1	references	reference	NOUN
ajird-1636	122	2	1	1	NUM
ajird-1636	122	3	.	.	PUNCT
ajird-1636	122	4	saeedi	saeedi	NOUN
ajird-1636	122	5	p	p	NOUN
ajird-1636	122	6	,	,	PUNCT
ajird-1636	122	7	et	et	PROPN
ajird-1636	122	8	al	al	PROPN
ajird-1636	122	9	.	.	PROPN
ajird-1636	123	1	global	global	ADJ
ajird-1636	123	2	and	and	CCONJ
ajird-1636	123	3	regional	regional	ADJ
ajird-1636	123	4	diabetes	diabetes	NOUN
ajird-1636	123	5	estimates	estimate	NOUN
ajird-1636	123	6	for	for	ADP
ajird-1636	123	7	2019	2019	NUM
ajird-1636	123	8	and	and	CCONJ
ajird-1636	123	9	projections	projection	NOUN
ajird-1636	123	10	for	for	ADP
ajird-1636	123	11	2030	2030	NUM
ajird-1636	123	12	and	and	CCONJ
ajird-1636	123	13	2045	2045	NUM
ajird-1636	123	14	:	:	PUNCT
ajird-1636	123	15	results	result	NOUN
ajird-1636	123	16	from	from	ADP
ajird-1636	123	17	the	the	DET
ajird-1636	123	18	international	international	ADJ
ajird-1636	123	19	diabetes	diabetes	NOUN
ajird-1636	123	20	federation	federation	PROPN
ajird-1636	123	21	diabetes	diabetes	PROPN
ajird-1636	123	22	atlas	atlas	PROPN
ajird-1636	123	23	,	,	PUNCT
ajird-1636	123	24	9(th	9(th	NOUN
ajird-1636	123	25	)	)	PUNCT
ajird-1636	123	26	edition	edition	NOUN
ajird-1636	123	27	.	.	PUNCT
ajird-1636	123	28	//diabetes	//diabete	VERB
ajird-1636	124	1	res	re	NOUN
ajird-1636	124	2	.	.	PUNCT
ajird-1636	125	1	clin	clin	PROPN
ajird-1636	125	2	.	.	PUNCT
ajird-1636	126	1	pract	pract	PROPN
ajird-1636	126	2	.	.	PUNCT
ajird-1636	127	1	2019;157:107843	2019;157:107843	NUM
ajird-1636	127	2	.	.	PUNCT
ajird-1636	127	3	doi	doi	PROPN
ajird-1636	127	4	:	:	PUNCT
ajird-1636	127	5	10.1016	10.1016	NUM
ajird-1636	127	6	/	/	SYM
ajird-1636	127	7	j.diabres.2019.107843	j.diabres.2019.107843	PROPN
ajird-1636	127	8	.	.	PUNCT
ajird-1636	128	1	american	american	ADJ
ajird-1636	128	2	journal	journal	PROPN
ajird-1636	128	3	of	of	ADP
ajird-1636	128	4	interdisciplinary	interdisciplinary	ADJ
ajird-1636	128	5	research	research	NOUN
ajird-1636	128	6	and	and	CCONJ
ajird-1636	128	7	development	development	NOUN
ajird-1636	128	8	issn	issn	PROPN
ajird-1636	128	9	online	online	NOUN
ajird-1636	128	10	:	:	PUNCT
ajird-1636	128	11	2771	2771	NUM
ajird-1636	128	12	-	-	SYM
ajird-1636	128	13	8948	8948	NUM
ajird-1636	128	14	website	website	NOUN
ajird-1636	128	15	:	:	PUNCT
ajird-1636	128	16	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-1636	128	17	volume	volume	NOUN
ajird-1636	128	18	46	46	NUM
ajird-1636	128	19	,	,	PUNCT
ajird-1636	128	20	november2025	november2025	PROPN
ajird-1636	128	21	46	46	NUM
ajird-1636	129	1	|	|	ADV
ajird-1636	129	2	p	p	X
ajird-1636	129	3	a	a	DET
ajird-1636	129	4	g	g	NOUN
ajird-1636	129	5	e	e	NOUN
ajird-1636	129	6	2	2	NUM
ajird-1636	129	7	.	.	PUNCT
ajird-1636	130	1	cho	cho	PROPN
ajird-1636	130	2	nh	nh	PROPN
ajird-1636	130	3	,	,	PUNCT
ajird-1636	130	4	et	et	PROPN
ajird-1636	130	5	al	al	PROPN
ajird-1636	130	6	.	.	PROPN
ajird-1636	130	7	idf	idf	PROPN
ajird-1636	131	1	diabetes	diabetes	PROPN
ajird-1636	131	2	atlas	atlas	PROPN
ajird-1636	131	3	:	:	PUNCT
ajird-1636	131	4	global	global	ADJ
ajird-1636	131	5	estimates	estimate	NOUN
ajird-1636	131	6	of	of	ADP
ajird-1636	131	7	diabetes	diabetes	NOUN
ajird-1636	131	8	prevalence	prevalence	NOUN
ajird-1636	131	9	for	for	ADP
ajird-1636	131	10	2017	2017	NUM
ajird-1636	131	11	and	and	CCONJ
ajird-1636	131	12	projections	projection	NOUN
ajird-1636	131	13	for	for	ADP
ajird-1636	131	14	2045	2045	NUM
ajird-1636	131	15	.	.	PUNCT
ajird-1636	132	1	//diabetes	//diabete	VERB
ajird-1636	133	1	res	re	NOUN
ajird-1636	133	2	.	.	PUNCT
ajird-1636	134	1	clin	clin	PROPN
ajird-1636	134	2	.	.	PUNCT
ajird-1636	135	1	pract	pract	PROPN
ajird-1636	135	2	.	.	PUNCT
ajird-1636	136	1	2017;138:271–281	2017;138:271–281	NUM
ajird-1636	136	2	.	.	PUNCT
ajird-1636	137	1	doi	doi	NOUN
ajird-1636	137	2	:	:	PUNCT
ajird-1636	137	3	10.1016	10.1016	NUM
ajird-1636	137	4	/	/	SYM
ajird-1636	137	5	j.diabres.2018.02.023	j.diabres.2018.02.023	PROPN
ajird-1636	137	6	.	.	PROPN
ajird-1636	138	1	3	3	X
ajird-1636	138	2	.	.	X
ajird-1636	138	3	supabphol	supabphol	NOUN
ajird-1636	138	4	s	s	PROPN
ajird-1636	138	5	,	,	PUNCT
ajird-1636	138	6	seubwai	seubwai	PROPN
ajird-1636	138	7	w	w	PROPN
ajird-1636	138	8	,	,	PUNCT
ajird-1636	138	9	wongkham	wongkham	PROPN
ajird-1636	138	10	s	s	PROPN
ajird-1636	138	11	,	,	PUNCT
ajird-1636	138	12	saengboonmee	saengboonmee	PROPN
ajird-1636	138	13	c.	c.	PROPN
ajird-1636	138	14	high	high	PROPN
ajird-1636	138	15	glucose	glucose	NOUN
ajird-1636	138	16	:	:	PUNCT
ajird-1636	138	17	an	an	DET
ajird-1636	138	18	emerging	emerge	VERB
ajird-1636	138	19	association	association	NOUN
ajird-1636	138	20	between	between	ADP
ajird-1636	138	21	diabetes	diabetes	NOUN
ajird-1636	138	22	mellitus	mellitus	NOUN
ajird-1636	138	23	and	and	CCONJ
ajird-1636	138	24	cancer	cancer	NOUN
ajird-1636	138	25	progression	progression	NOUN
ajird-1636	138	26	.	.	PUNCT
ajird-1636	139	1	//j	//j	PUNCT
ajird-1636	139	2	.	.	PUNCT
ajird-1636	140	1	mol	mol	PROPN
ajird-1636	140	2	.	.	PROPN
ajird-1636	140	3	med	med	PROPN
ajird-1636	140	4	.	.	PUNCT
ajird-1636	141	1	2021	2021	NUM
ajird-1636	141	2	doi	doi	NOUN
ajird-1636	141	3	:	:	PUNCT
ajird-1636	141	4	10.1007	10.1007	NUM
ajird-1636	141	5	/	/	SYM
ajird-1636	141	6	s00109	s00109	VERB
ajird-1636	141	7	-	-	PUNCT
ajird-1636	141	8	021	021	NUM
ajird-1636	141	9	-	-	PUNCT
ajird-1636	141	10	02096	02096	NUM
ajird-1636	141	11	-	-	PUNCT
ajird-1636	141	12	w.	w.	NOUN
ajird-1636	141	13	4	4	NUM
ajird-1636	141	14	.	.	PUNCT
ajird-1636	141	15	schmitt	schmitt	PROPN
ajird-1636	141	16	vh	vh	PROPN
ajird-1636	141	17	,	,	PUNCT
ajird-1636	141	18	et	et	PROPN
ajird-1636	141	19	al	al	PROPN
ajird-1636	141	20	.	.	PUNCT
ajird-1636	142	1	cardiovascular	cardiovascular	ADJ
ajird-1636	142	2	profiling	profiling	NOUN
ajird-1636	142	3	in	in	ADP
ajird-1636	142	4	the	the	DET
ajird-1636	142	5	diabetic	diabetic	ADJ
ajird-1636	142	6	continuum	continuum	NOUN
ajird-1636	142	7	:	:	PUNCT
ajird-1636	142	8	results	result	NOUN
ajird-1636	142	9	from	from	ADP
ajird-1636	142	10	the	the	DET
ajird-1636	142	11	population	population	NOUN
ajird-1636	142	12	-	-	PUNCT
ajird-1636	142	13	based	base	VERB
ajird-1636	142	14	gutenberg	gutenberg	PROPN
ajird-1636	142	15	health	health	PROPN
ajird-1636	142	16	study	study	PROPN
ajird-1636	142	17	.	.	PUNCT
ajird-1636	143	1	//	//	X
ajird-1636	144	1	clin	clin	PROPN
ajird-1636	144	2	.	.	PUNCT
ajird-1636	145	1	res	re	NOUN
ajird-1636	145	2	.	.	PUNCT
ajird-1636	146	1	cardiol	cardiol	NOUN
ajird-1636	146	2	.	.	PUNCT
ajird-1636	147	1	2021	2021	NUM
ajird-1636	147	2	doi	doi	NOUN
ajird-1636	147	3	:	:	PUNCT
ajird-1636	147	4	10.1007	10.1007	NUM
ajird-1636	147	5	/	/	SYM
ajird-1636	147	6	s00392	s00392	NOUN
ajird-1636	147	7	-	-	PUNCT
ajird-1636	147	8	021	021	NUM
ajird-1636	147	9	-	-	PUNCT
ajird-1636	147	10	01879	01879	NUM
ajird-1636	147	11	-	-	PUNCT
ajird-1636	147	12	y.	y.	NOUN
ajird-1636	147	13	5	5	NUM
ajird-1636	147	14	.	.	PUNCT
ajird-1636	147	15	schmitt	schmitt	PROPN
ajird-1636	147	16	vh	vh	PROPN
ajird-1636	147	17	,	,	PUNCT
ajird-1636	147	18	et	et	PROPN
ajird-1636	147	19	al	al	PROPN
ajird-1636	147	20	.	.	PROPN
ajird-1636	147	21	impact	impact	NOUN
ajird-1636	147	22	of	of	ADP
ajird-1636	147	23	diabetes	diabetes	NOUN
ajird-1636	147	24	mellitus	mellitus	NOUN
ajird-1636	147	25	on	on	ADP
ajird-1636	147	26	mortality	mortality	NOUN
ajird-1636	147	27	rates	rate	NOUN
ajird-1636	147	28	and	and	CCONJ
ajird-1636	147	29	outcomes	outcome	NOUN
ajird-1636	147	30	in	in	ADP
ajird-1636	147	31	myocardial	myocardial	ADJ
ajird-1636	147	32	infarction	infarction	NOUN
ajird-1636	147	33	.	.	PUNCT
ajird-1636	148	1	6	6	X
ajird-1636	148	2	.	.	PUNCT
ajird-1636	148	3	//diabetes	//diabete	VERB
ajird-1636	149	1	metab	metab	NOUN
ajird-1636	149	2	.	.	PUNCT
ajird-1636	150	1	2020;47:101211	2020;47:101211	NUM
ajird-1636	150	2	.	.	PUNCT
ajird-1636	151	1	doi	doi	NOUN
ajird-1636	151	2	:	:	PUNCT
ajird-1636	151	3	10.1016	10.1016	NUM
ajird-1636	151	4	/	/	SYM
ajird-1636	151	5	j.diabet.2020.11.003	j.diabet.2020.11.003	NOUN
ajird-1636	151	6	.	.	PROPN
ajird-1636	151	7	7	7	X
ajird-1636	151	8	.	.	X
ajird-1636	151	9	seshasai	seshasai	PROPN
ajird-1636	151	10	sr	sr	PROPN
ajird-1636	151	11	,	,	PUNCT
ajird-1636	151	12	et	et	PROPN
ajird-1636	151	13	al	al	PROPN
ajird-1636	151	14	.	.	PROPN
ajird-1636	152	1	diabetes	diabetes	PROPN
ajird-1636	152	2	mellitus	mellitus	NOUN
ajird-1636	152	3	,	,	PUNCT
ajird-1636	152	4	fasting	fast	VERB
ajird-1636	152	5	glucose	glucose	NOUN
ajird-1636	152	6	,	,	PUNCT
ajird-1636	152	7	and	and	CCONJ
ajird-1636	152	8	risk	risk	NOUN
ajird-1636	152	9	of	of	ADP
ajird-1636	152	10	cause	cause	NOUN
ajird-1636	152	11	-	-	PUNCT
ajird-1636	152	12	specific	specific	ADJ
ajird-1636	152	13	death	death	NOUN
ajird-1636	152	14	.	.	PUNCT
ajird-1636	153	1	//n	//n	PUNCT
ajird-1636	153	2	.	.	PUNCT
ajird-1636	154	1	english	english	PROPN
ajird-1636	154	2	j.	j.	PROPN
ajird-1636	154	3	med	med	PROPN
ajird-1636	154	4	.	.	PUNCT
ajird-1636	155	1	2011;364:829–841	2011;364:829–841	X
ajird-1636	155	2	.	.	PUNCT
ajird-1636	156	1	doi	doi	NOUN
ajird-1636	156	2	:	:	PUNCT
ajird-1636	156	3	10.1056	10.1056	NUM
ajird-1636	156	4	/	/	SYM
ajird-1636	156	5	nejmoa1008862	nejmoa1008862	NOUN
ajird-1636	156	6	.	.	PUNCT
ajird-1636	157	1	8	8	X
ajird-1636	157	2	.	.	X
ajird-1636	157	3	faulds	faulds	PROPN
ajird-1636	157	4	mh	mh	PROPN
ajird-1636	157	5	,	,	PUNCT
ajird-1636	157	6	dahlman	dahlman	PROPN
ajird-1636	157	7	-	-	PUNCT
ajird-1636	157	8	wright	wright	PROPN
ajird-1636	157	9	k.	k.	PROPN
ajird-1636	157	10	metabolic	metabolic	PROPN
ajird-1636	157	11	diseases	disease	NOUN
ajird-1636	157	12	and	and	CCONJ
ajird-1636	157	13	cancer	cancer	NOUN
ajird-1636	157	14	risk	risk	NOUN
ajird-1636	157	15	.	.	PUNCT
ajird-1636	158	1	//	//	PUNCT
ajird-1636	158	2	curr	curr	PROPN
ajird-1636	158	3	.	.	PUNCT
ajird-1636	159	1	opin	opin	NOUN
ajird-1636	159	2	.	.	PUNCT
ajird-1636	160	1	oncol	oncol	ADJ
ajird-1636	160	2	.	.	PUNCT
ajird-1636	161	1	2011;24:58–61	2011;24:58–61	NUM
ajird-1636	161	2	.	.	PUNCT
ajird-1636	162	1	doi	doi	NOUN
ajird-1636	162	2	:	:	PUNCT
ajird-1636	162	3	10.1097	10.1097	NUM
ajird-1636	162	4	/	/	SYM
ajird-1636	162	5	cco.0b013e32834e0582	cco.0b013e32834e0582	NOUN
ajird-1636	162	6	.	.	NOUN
ajird-1636	163	1	9	9	NUM
ajird-1636	163	2	.	.	NOUN
ajird-1636	163	3	8	8	NUM
ajird-1636	163	4	salvatore	salvatore	PROPN
ajird-1636	163	5	t	t	PROPN
ajird-1636	163	6	,	,	PUNCT
ajird-1636	163	7	et	et	PROPN
ajird-1636	163	8	al	al	PROPN
ajird-1636	163	9	.	.	PUNCT
ajird-1636	164	1	the	the	DET
ajird-1636	164	2	diabetic	diabetic	ADJ
ajird-1636	164	3	cardiomyopathy	cardiomyopathy	ADV
ajird-1636	164	4	:	:	PUNCT
ajird-1636	164	5	the	the	DET
ajird-1636	164	6	contributing	contribute	VERB
ajird-1636	164	7	pathophysiological	pathophysiological	ADJ
ajird-1636	164	8	mechanisms	mechanism	NOUN
ajird-1636	164	9	.	.	PUNCT
ajird-1636	165	1	//front	//front	PUNCT
ajird-1636	165	2	.	.	PUNCT
ajird-1636	166	1	med	med	PROPN
ajird-1636	166	2	.	.	PUNCT
ajird-1636	167	1	2021;8:695792	2021;8:695792	PROPN
ajird-1636	167	2	.	.	PUNCT
ajird-1636	168	1	doi	doi	NOUN
ajird-1636	168	2	:	:	PUNCT
ajird-1636	168	3	10.3389	10.3389	NUM
ajird-1636	168	4	/	/	SYM
ajird-1636	168	5	fmed.2021.695792	fmed.2021.695792	NOUN
ajird-1636	168	6	.	.	NOUN
ajird-1636	169	1	10	10	NUM
ajird-1636	169	2	.	.	PUNCT
ajird-1636	170	1	huang	huang	PROPN
ajird-1636	170	2	y	y	PROPN
ajird-1636	170	3	,	,	PUNCT
ajird-1636	170	4	cai	cai	PROPN
ajird-1636	170	5	x	x	PROPN
ajird-1636	170	6	,	,	PUNCT
ajird-1636	170	7	mai	mai	PROPN
ajird-1636	170	8	w	w	PROPN
ajird-1636	170	9	,	,	PUNCT
ajird-1636	170	10	li	li	PROPN
ajird-1636	170	11	m	m	PROPN
ajird-1636	170	12	,	,	PUNCT
ajird-1636	170	13	hu	hu	PROPN
ajird-1636	170	14	y.	y.	PROPN
ajird-1636	170	15	association	association	PROPN
ajird-1636	170	16	between	between	ADP
ajird-1636	170	17	prediabetes	prediabete	NOUN
ajird-1636	170	18	and	and	CCONJ
ajird-1636	170	19	risk	risk	NOUN
ajird-1636	170	20	of	of	ADP
ajird-1636	170	21	cardiovascular	cardiovascular	ADJ
ajird-1636	170	22	disease	disease	NOUN
ajird-1636	170	23	and	and	CCONJ
ajird-1636	170	24	all	all	DET
ajird-1636	170	25	cause	cause	VERB
ajird-1636	170	26	mortality	mortality	NOUN
ajird-1636	170	27	:	:	PUNCT
ajird-1636	170	28	systematic	systematic	ADJ
ajird-1636	170	29	review	review	NOUN
ajird-1636	170	30	and	and	CCONJ
ajird-1636	170	31	meta	meta	ADJ
ajird-1636	170	32	-	-	PUNCT
ajird-1636	170	33	analysis	analysis	NOUN
ajird-1636	170	34	.	.	PUNCT
ajird-1636	171	1	//bmj	//bmj	PROPN
ajird-1636	171	2	.	.	PUNCT
ajird-1636	172	1	2016;355	2016;355	NUM
ajird-1636	172	2	:	:	PUNCT
ajird-1636	172	3	i5953	i5953	NOUN
ajird-1636	172	4	.	.	PUNCT
ajird-1636	172	5	doi	doi	NOUN
ajird-1636	172	6	:	:	PUNCT
ajird-1636	172	7	10.1136	10.1136	NUM
ajird-1636	172	8	/	/	SYM
ajird-1636	172	9	bmj.i5953	bmj.i5953	NOUN
ajird-1636	172	10	.	.	PUNCT
ajird-1636	173	1	11	11	NUM
ajird-1636	173	2	.	.	X
ajird-1636	174	1	magnussen	magnussen	PROPN
ajird-1636	174	2	c	c	PROPN
ajird-1636	174	3	,	,	PUNCT
ajird-1636	174	4	blankenberg	blankenberg	PROPN
ajird-1636	174	5	s.	s.	PROPN
ajird-1636	174	6	biomarkers	biomarkers	PROPN
ajird-1636	174	7	for	for	ADP
ajird-1636	174	8	heart	heart	NOUN
ajird-1636	174	9	failure	failure	NOUN
ajird-1636	174	10	:	:	PUNCT
ajird-1636	174	11	small	small	ADJ
ajird-1636	174	12	molecules	molecule	NOUN
ajird-1636	174	13	with	with	ADP
ajird-1636	174	14	high	high	ADJ
ajird-1636	174	15	clinical	clinical	ADJ
ajird-1636	174	16	relevance	relevance	NOUN
ajird-1636	174	17	.	.	PUNCT
ajird-1636	174	18	//j	//j	PUNCT
ajird-1636	174	19	.	.	PUNCT
ajird-1636	175	1	intern	intern	PROPN
ajird-1636	175	2	.	.	PUNCT
ajird-1636	176	1	med	med	PROPN
ajird-1636	176	2	.	.	PUNCT
ajird-1636	177	1	2018;283:530–543	2018;283:530–543	X
ajird-1636	177	2	.	.	PUNCT
ajird-1636	178	1	doi	doi	NOUN
ajird-1636	178	2	:	:	PUNCT
ajird-1636	178	3	10.1111	10.1111	NUM
ajird-1636	178	4	/	/	SYM
ajird-1636	178	5	joim.12756	joim.12756	PROPN
ajird-1636	178	6	.	.	PROPN
ajird-1636	178	7	12	12	NUM
ajird-1636	178	8	.	.	PUNCT
ajird-1636	179	1	kanukurti	kanukurti	PROPN
ajird-1636	179	2	j	j	PROPN
ajird-1636	179	3	,	,	PUNCT
ajird-1636	179	4	et	et	PROPN
ajird-1636	179	5	al	al	PROPN
ajird-1636	179	6	.	.	PUNCT
ajird-1636	179	7	evaluation	evaluation	NOUN
ajird-1636	179	8	of	of	ADP
ajird-1636	179	9	galectin-3	galectin-3	PROPN
ajird-1636	179	10	as	as	ADP
ajird-1636	179	11	a	a	DET
ajird-1636	179	12	novel	novel	ADJ
ajird-1636	179	13	diagnostic	diagnostic	ADJ
ajird-1636	179	14	biomarker	biomarker	NOUN
ajird-1636	179	15	in	in	ADP
ajird-1636	179	16	patients	patient	NOUN
ajird-1636	179	17	with	with	ADP
ajird-1636	179	18	heart	heart	NOUN
ajird-1636	179	19	failure	failure	NOUN
ajird-1636	179	20	with	with	ADP
ajird-1636	179	21	preserved	preserve	VERB
ajird-1636	179	22	ejection	ejection	NOUN
ajird-1636	179	23	fraction	fraction	NOUN
ajird-1636	179	24	.	.	PUNCT
ajird-1636	180	1	//j	//j	PUNCT
ajird-1636	180	2	.	.	PUNCT
ajird-1636	181	1	lab	lab	NOUN
ajird-1636	181	2	.	.	PUNCT
ajird-1636	182	1	phys	phy	NOUN
ajird-1636	182	2	.	.	PUNCT
ajird-1636	183	1	2020;12:126–132	2020;12:126–132	X
ajird-1636	183	2	.	.	PUNCT
ajird-1636	184	1	doi	doi	NOUN
ajird-1636	184	2	:	:	PUNCT
ajird-1636	184	3	10.1055	10.1055	NUM
ajird-1636	184	4	/	/	SYM
ajird-1636	184	5	s-0040	s-0040	NOUN
ajird-1636	184	6	-	-	NOUN
ajird-1636	184	7	1716608	1716608	NUM
ajird-1636	184	8	.	.	PUNCT
ajird-1636	185	1	13	13	NUM
ajird-1636	185	2	.	.	X
ajird-1636	185	3	fu	fu	PROPN
ajird-1636	185	4	h	h	PROPN
ajird-1636	185	5	,	,	PUNCT
ajird-1636	185	6	et	et	PROPN
ajird-1636	185	7	al	al	PROPN
ajird-1636	185	8	.	.	PUNCT
ajird-1636	186	1	galectin-3	galectin-3	PROPN
ajird-1636	186	2	and	and	CCONJ
ajird-1636	186	3	acute	acute	ADJ
ajird-1636	186	4	heart	heart	NOUN
ajird-1636	186	5	failure	failure	NOUN
ajird-1636	186	6	:	:	PUNCT
ajird-1636	186	7	genetic	genetic	ADJ
ajird-1636	186	8	polymorphisms	polymorphism	NOUN
ajird-1636	186	9	,	,	PUNCT
ajird-1636	186	10	plasma	plasma	NOUN
ajird-1636	186	11	level	level	NOUN
ajird-1636	186	12	,	,	PUNCT
ajird-1636	186	13	myocardial	myocardial	ADJ
ajird-1636	186	14	fibrosis	fibrosis	NOUN
ajird-1636	186	15	and	and	CCONJ
ajird-1636	186	16	1	1	NUM
ajird-1636	186	17	-	-	PUNCT
ajird-1636	186	18	year	year	NOUN
ajird-1636	186	19	outcomes	outcome	NOUN
ajird-1636	186	20	.	.	PUNCT
ajird-1636	187	1	//biomark	//biomark	X
ajird-1636	187	2	.	.	PUNCT
ajird-1636	188	1	med	med	PROPN
ajird-1636	188	2	.	.	PUNCT
ajird-1636	188	3	2020;14:943–954	2020;14:943–954	PROPN
ajird-1636	188	4	.	.	PUNCT
ajird-1636	189	1	doi	doi	NOUN
ajird-1636	189	2	:	:	PUNCT
ajird-1636	189	3	10.2217	10.2217	NUM
ajird-1636	189	4	/	/	SYM
ajird-1636	189	5	bmm-2020	bmm-2020	NOUN
ajird-1636	189	6	-	-	PUNCT
ajird-1636	189	7	0269	0269	NUM
ajird-1636	189	8	.	.	PUNCT
ajird-1636	190	1	14	14	NUM
ajird-1636	190	2	.	.	PUNCT
ajird-1636	191	1	zhong	zhong	PROPN
ajird-1636	191	2	x	x	PROPN
ajird-1636	191	3	,	,	PUNCT
ajird-1636	191	4	qian	qian	PROPN
ajird-1636	191	5	x	x	PROPN
ajird-1636	191	6	,	,	PUNCT
ajird-1636	191	7	chen	chen	PROPN
ajird-1636	191	8	g	g	PROPN
ajird-1636	191	9	,	,	PUNCT
ajird-1636	191	10	song	song	NOUN
ajird-1636	191	11	x.	x.	NOUN
ajird-1636	191	12	the	the	DET
ajird-1636	191	13	role	role	NOUN
ajird-1636	191	14	of	of	ADP
ajird-1636	191	15	galectin-3	galectin-3	PROPN
ajird-1636	191	16	in	in	ADP
ajird-1636	191	17	heart	heart	NOUN
ajird-1636	191	18	failure	failure	NOUN
ajird-1636	191	19	and	and	CCONJ
ajird-1636	191	20	cardiovascular	cardiovascular	ADJ
ajird-1636	191	21	disease	disease	NOUN
ajird-1636	191	22	.	.	PUNCT
ajird-1636	192	1	//	//	X
ajird-1636	193	1	clin	clin	PROPN
ajird-1636	193	2	.	.	PUNCT
ajird-1636	194	1	exp	exp	PROPN
ajird-1636	194	2	.	.	PUNCT
ajird-1636	194	3	pharmacol	pharmacol	PROPN
ajird-1636	194	4	.	.	PUNCT
ajird-1636	194	5	physiol	physiol	PROPN
ajird-1636	194	6	.	.	PUNCT
ajird-1636	195	1	2019;46:197–203	2019;46:197–203	PROPN
ajird-1636	195	2	.	.	PUNCT
ajird-1636	196	1	doi	doi	NOUN
ajird-1636	196	2	:	:	PUNCT
ajird-1636	196	3	10.1111/1440	10.1111/1440	NUM
ajird-1636	196	4	-	-	SYM
ajird-1636	196	5	1681.13048	1681.13048	NOUN
ajird-1636	196	6	.	.	PUNCT
ajird-1636	197	1	15	15	NUM
ajird-1636	197	2	.	.	PUNCT
ajird-1636	197	3	schmitt	schmitt	PROPN
ajird-1636	197	4	vh	vh	PROPN
ajird-1636	197	5	,	,	PUNCT
ajird-1636	197	6	prochaska	prochaska	PROPN
ajird-1636	197	7	jh	jh	PROPN
ajird-1636	197	8	,	,	PUNCT
ajird-1636	197	9	föll	föll	NOUN
ajird-1636	197	10	as	as	ADP
ajird-1636	197	11	,	,	PUNCT
ajird-1636	197	12	schulz	schulz	PROPN
ajird-1636	197	13	a	a	PROPN
ajird-1636	197	14	,	,	PUNCT
ajird-1636	197	15	keller	keller	PROPN
ajird-1636	197	16	k	k	PROPN
ajird-1636	197	17	,	,	PUNCT
ajird-1636	197	18	hahad	hahad	ADJ
ajird-1636	197	19	o	o	NOUN
ajird-1636	197	20	,	,	PUNCT
ajird-1636	197	21	koeck	koeck	PROPN
ajird-1636	197	22	t	t	PROPN
ajird-1636	197	23	,	,	PUNCT
ajird-1636	197	24	tröbs	tröb	VERB
ajird-1636	197	25	so	so	ADV
ajird-1636	197	26	,	,	PUNCT
ajird-1636	197	27	rapp	rapp	PROPN
ajird-1636	197	28	s	s	PROPN
ajird-1636	197	29	,	,	PUNCT
ajird-1636	197	30	beutel	beutel	PROPN
ajird-1636	197	31	m	m	PROPN
ajird-1636	197	32	,	,	PUNCT
ajird-1636	197	33	pfeiffer	pfeiffer	PROPN
ajird-1636	197	34	n	n	CCONJ
ajird-1636	197	35	,	,	PUNCT
ajird-1636	197	36	strauch	strauch	ADJ
ajird-1636	197	37	k	k	PROPN
ajird-1636	197	38	,	,	PUNCT
ajird-1636	197	39	lackner	lackner	PROPN
ajird-1636	197	40	kj	kj	PROPN
ajird-1636	197	41	,	,	PUNCT
ajird-1636	197	42	münzel	münzel	PROPN
ajird-1636	197	43	t	t	PROPN
ajird-1636	197	44	,	,	PUNCT
ajird-1636	197	45	wild	wild	ADJ
ajird-1636	197	46	ps	ps	NOUN
ajird-1636	197	47	.	.	PUNCT
ajird-1636	198	1	galectin-3	galectin-3	PROPN
ajird-1636	198	2	for	for	ADP
ajird-1636	198	3	prediction	prediction	NOUN
ajird-1636	198	4	of	of	ADP
ajird-1636	198	5	cardiac	cardiac	ADJ
ajird-1636	198	6	function	function	NOUN
ajird-1636	198	7	compared	compare	VERB
ajird-1636	198	8	to	to	ADP
ajird-1636	198	9	nt	not	PART
ajird-1636	198	10	-	-	PUNCT
ajird-1636	198	11	probnp	probnp	NOUN
ajird-1636	198	12	in	in	ADP
ajird-1636	198	13	individuals	individual	NOUN
ajird-1636	198	14	with	with	ADP
ajird-1636	198	15	prediabetes	prediabete	NOUN
ajird-1636	198	16	and	and	CCONJ
ajird-1636	198	17	type	type	NOUN
ajird-1636	198	18	2	2	NUM
ajird-1636	198	19	diabetes	diabetes	NOUN
ajird-1636	198	20	mellitus.//sci	mellitus.//sci	PROPN
ajird-1636	198	21	rep	rep	PROPN
ajird-1636	198	22	.	.	PROPN
ajird-1636	198	23	2021	2021	NUM
ajird-1636	198	24	sep	sep	PROPN
ajird-1636	198	25	24;11(1):19012	24;11(1):19012	NUM
ajird-1636	198	26	.	.	PUNCT
ajird-1636	199	1	doi	doi	NOUN
ajird-1636	199	2	:	:	PUNCT
ajird-1636	199	3	10.1038	10.1038	NUM
ajird-1636	199	4	/	/	SYM
ajird-1636	199	5	s41598021	s41598021	NOUN
ajird-1636	199	6	-	-	PUNCT
ajird-1636	199	7	98227	98227	NUM
ajird-1636	199	8	-	-	PUNCT
ajird-1636	199	9	x.	x.	NOUN
ajird-1636	199	10	16	16	NUM
ajird-1636	199	11	.	.	PUNCT
ajird-1636	200	1	bae	bae	PROPN
ajird-1636	200	2	jc	jc	PROPN
ajird-1636	200	3	,	,	PUNCT
ajird-1636	200	4	cho	cho	PROPN
ajird-1636	200	5	nh	nh	PROPN
ajird-1636	200	6	,	,	PUNCT
ajird-1636	200	7	suh	suh	PROPN
ajird-1636	200	8	s	s	PROPN
ajird-1636	200	9	,	,	PUNCT
ajird-1636	200	10	kim	kim	PROPN
ajird-1636	200	11	jh	jh	PROPN
ajird-1636	200	12	,	,	PUNCT
ajird-1636	200	13	hur	hur	PROPN
ajird-1636	200	14	ky	ky	PROPN
ajird-1636	200	15	,	,	PUNCT
ajird-1636	200	16	jin	jin	PROPN
ajird-1636	200	17	sm	sm	PROPN
ajird-1636	200	18	,	,	PUNCT
ajird-1636	200	19	et	et	PROPN
ajird-1636	200	20	al	al	PROPN
ajird-1636	200	21	.	.	PUNCT
ajird-1636	201	1	cardiovascular	cardiovascular	ADJ
ajird-1636	201	2	disease	disease	NOUN
ajird-1636	201	3	incidence	incidence	NOUN
ajird-1636	201	4	,	,	PUNCT
ajird-1636	201	5	mortality	mortality	NOUN
ajird-1636	201	6	and	and	CCONJ
ajird-1636	201	7	case	case	NOUN
ajird-1636	201	8	fatality	fatality	NOUN
ajird-1636	201	9	related	relate	VERB
ajird-1636	201	10	to	to	ADP
ajird-1636	201	11	diabetes	diabetes	NOUN
ajird-1636	201	12	and	and	CCONJ
ajird-1636	201	13	metabolic	metabolic	NOUN
ajird-1636	201	14	syndrome	syndrome	NOUN
ajird-1636	201	15	:	:	PUNCT
ajird-1636	201	16	a	a	DET
ajird-1636	201	17	american	american	ADJ
ajird-1636	201	18	journal	journal	NOUN
ajird-1636	201	19	of	of	ADP
ajird-1636	201	20	interdisciplinary	interdisciplinary	ADJ
ajird-1636	201	21	research	research	NOUN
ajird-1636	201	22	and	and	CCONJ
ajird-1636	201	23	development	development	NOUN
ajird-1636	201	24	issn	issn	PROPN
ajird-1636	201	25	online	online	NOUN
ajird-1636	201	26	:	:	PUNCT
ajird-1636	201	27	2771	2771	NUM
ajird-1636	201	28	-	-	SYM
ajird-1636	201	29	8948	8948	NUM
ajird-1636	201	30	website	website	NOUN
ajird-1636	201	31	:	:	PUNCT
ajird-1636	201	32	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-1636	201	33	volume	volume	NOUN
ajird-1636	201	34	46	46	NUM
ajird-1636	201	35	,	,	PUNCT
ajird-1636	201	36	november2025	november2025	PROPN
ajird-1636	201	37	47	47	NUM
ajird-1636	202	1	|	|	ADV
ajird-1636	202	2	p	p	X
ajird-1636	202	3	a	a	DET
ajird-1636	202	4	g	g	NOUN
ajird-1636	202	5	e	e	NOUN
ajird-1636	202	6	community	community	NOUN
ajird-1636	202	7	-	-	PUNCT
ajird-1636	202	8	based	base	VERB
ajird-1636	202	9	prospective	prospective	ADJ
ajird-1636	202	10	study	study	NOUN
ajird-1636	202	11	(	(	PUNCT
ajird-1636	202	12	ansungansan	ansungansan	ADJ
ajird-1636	202	13	cohort	cohort	NOUN
ajird-1636	202	14	2001	2001	NUM
ajird-1636	202	15	-	-	SYM
ajird-1636	202	16	12	12	NUM
ajird-1636	202	17	)	)	PUNCT
ajird-1636	202	18	//j	//j	PUNCT
ajird-1636	203	1	diabetes	diabetes	NOUN
ajird-1636	203	2	.	.	PUNCT
ajird-1636	204	1	2015;7:791–799	2015;7:791–799	X
ajird-1636	204	2	.	.	PUNCT
ajird-1636	205	1	doi	doi	NOUN
ajird-1636	205	2	:	:	PUNCT
ajird-1636	205	3	10.1111/1753	10.1111/1753	NUM
ajird-1636	205	4	-	-	PUNCT
ajird-1636	205	5	0407.12248	0407.12248	PROPN
ajird-1636	205	6	.	.	PUNCT
ajird-1636	206	1	17	17	NUM
ajird-1636	206	2	.	.	PUNCT
ajird-1636	207	1	udell	udell	PROPN
ajird-1636	207	2	ja	ja	PROPN
ajird-1636	207	3	,	,	PUNCT
ajird-1636	207	4	steg	steg	PROPN
ajird-1636	207	5	pg	pg	PROPN
ajird-1636	207	6	,	,	PUNCT
ajird-1636	207	7	scirica	scirica	PROPN
ajird-1636	207	8	bm	bm	PROPN
ajird-1636	207	9	,	,	PUNCT
ajird-1636	207	10	eagle	eagle	PROPN
ajird-1636	207	11	ka	ka	PROPN
ajird-1636	207	12	,	,	PUNCT
ajird-1636	207	13	ohman	ohman	NOUN
ajird-1636	207	14	em	em	PRON
ajird-1636	207	15	,	,	PUNCT
ajird-1636	207	16	goto	goto	NOUN
ajird-1636	207	17	s	s	NOUN
ajird-1636	207	18	,	,	PUNCT
ajird-1636	207	19	reduction	reduction	NOUN
ajird-1636	207	20	of	of	ADP
ajird-1636	207	21	atherothrombosis	atherothrombosis	NOUN
ajird-1636	207	22	for	for	ADP
ajird-1636	207	23	continued	continue	VERB
ajird-1636	207	24	health	health	NOUN
ajird-1636	207	25	(	(	PUNCT
ajird-1636	207	26	reach	reach	VERB
ajird-1636	207	27	)	)	PUNCT
ajird-1636	207	28	registry	registry	NOUN
ajird-1636	207	29	investigators	investigator	NOUN
ajird-1636	207	30	et	et	PROPN
ajird-1636	207	31	al	al	PROPN
ajird-1636	207	32	.	.	PROPN
ajird-1636	207	33	metabolic	metabolic	PROPN
ajird-1636	207	34	syndrome	syndrome	PROPN
ajird-1636	207	35	,	,	PUNCT
ajird-1636	207	36	diabetes	diabetes	NOUN
ajird-1636	207	37	mellitus	mellitus	NOUN
ajird-1636	207	38	,	,	PUNCT
ajird-1636	207	39	or	or	CCONJ
ajird-1636	207	40	both	both	PRON
ajird-1636	207	41	and	and	CCONJ
ajird-1636	207	42	cardiovascular	cardiovascular	ADJ
ajird-1636	207	43	risk	risk	NOUN
ajird-1636	207	44	in	in	ADP
ajird-1636	207	45	outpatients	outpatient	NOUN
ajird-1636	207	46	with	with	ADP
ajird-1636	207	47	or	or	CCONJ
ajird-1636	207	48	at	at	ADP
ajird-1636	207	49	risk	risk	NOUN
ajird-1636	207	50	for	for	ADP
ajird-1636	207	51	atherothrombosis	atherothrombosis	NOUN
ajird-1636	207	52	.	.	PUNCT
ajird-1636	208	1	//	//	PUNCT
ajird-1636	209	1	eur	eur	PROPN
ajird-1636	209	2	j	j	PROPN
ajird-1636	209	3	prev	prev	PROPN
ajird-1636	209	4	cardiol	cardiol	NOUN
ajird-1636	209	5	.	.	PUNCT
ajird-1636	210	1	2014;21:1531	2014;21:1531	NUM
ajird-1636	210	2	–	–	PUNCT
ajird-1636	210	3	1540	1540	NUM
ajird-1636	210	4	.	.	PUNCT
ajird-1636	211	1	doi	doi	NOUN
ajird-1636	211	2	:	:	PUNCT
ajird-1636	211	3	10.1177/2047487313500541	10.1177/2047487313500541	NUM
ajird-1636	211	4	.	.	NOUN
ajird-1636	211	5	18	18	NUM
ajird-1636	211	6	.	.	PUNCT
ajird-1636	212	1	church	church	NOUN
ajird-1636	212	2	ts	ts	PROPN
ajird-1636	212	3	,	,	PUNCT
ajird-1636	212	4	thompson	thompson	PROPN
ajird-1636	212	5	am	am	NOUN
ajird-1636	212	6	,	,	PUNCT
ajird-1636	212	7	katzmarzyk	katzmarzyk	PROPN
ajird-1636	212	8	pt	pt	PROPN
ajird-1636	212	9	,	,	PUNCT
ajird-1636	212	10	sui	sui	PROPN
ajird-1636	212	11	x	x	PROPN
ajird-1636	212	12	,	,	PUNCT
ajird-1636	212	13	johannsen	johannsen	PROPN
ajird-1636	212	14	n	n	CCONJ
ajird-1636	212	15	,	,	PUNCT
ajird-1636	212	16	earnest	earnest	ADJ
ajird-1636	212	17	cp	cp	NOUN
ajird-1636	212	18	,	,	PUNCT
ajird-1636	212	19	et	et	PROPN
ajird-1636	212	20	al	al	PROPN
ajird-1636	212	21	.	.	PROPN
ajird-1636	212	22	metabolic	metabolic	PROPN
ajird-1636	212	23	syndrome	syndrome	NOUN
ajird-1636	212	24	and	and	CCONJ
ajird-1636	212	25	diabetes	diabetes	NOUN
ajird-1636	212	26	,	,	PUNCT
ajird-1636	212	27	alone	alone	ADJ
ajird-1636	212	28	and	and	CCONJ
ajird-1636	212	29	in	in	ADP
ajird-1636	212	30	combination	combination	NOUN
ajird-1636	212	31	,	,	PUNCT
ajird-1636	212	32	as	as	ADP
ajird-1636	212	33	predictors	predictor	NOUN
ajird-1636	212	34	of	of	ADP
ajird-1636	212	35	cardiovascular	cardiovascular	ADJ
ajird-1636	212	36	disease	disease	NOUN
ajird-1636	212	37	mortality	mortality	NOUN
ajird-1636	212	38	among	among	ADP
ajird-1636	212	39	men	man	NOUN
ajird-1636	212	40	.	.	PUNCT
ajird-1636	213	1	//	//	NUM
ajird-1636	213	2	diabetes	diabetes	NOUN
ajird-1636	213	3	care	care	NOUN
ajird-1636	213	4	.	.	PUNCT
ajird-1636	214	1	2009;32:1289–1294	2009;32:1289–1294	NUM
ajird-1636	214	2	.	.	PUNCT
ajird-1636	214	3	doi	doi	NOUN
ajird-1636	214	4	:	:	PUNCT
ajird-1636	214	5	10.2337	10.2337	NUM
ajird-1636	214	6	/	/	SYM
ajird-1636	214	7	dc08	dc08	PROPN
ajird-1636	214	8	-	-	PUNCT
ajird-1636	214	9	1871	1871	NUM
ajird-1636	214	10	.	.	PUNCT
ajird-1636	215	1	19	19	NUM
ajird-1636	215	2	.	.	PUNCT
ajird-1636	216	1	cosentino	cosentino	PROPN
ajird-1636	216	2	f	f	PROPN
ajird-1636	216	3	,	,	PUNCT
ajird-1636	216	4	grant	grant	PROPN
ajird-1636	216	5	pj	pj	PROPN
ajird-1636	216	6	,	,	PUNCT
ajird-1636	216	7	aboyans	aboyan	VERB
ajird-1636	216	8	v	v	ADP
ajird-1636	216	9	,	,	PUNCT
ajird-1636	216	10	bailey	bailey	PROPN
ajird-1636	216	11	cj	cj	PROPN
ajird-1636	216	12	,	,	PUNCT
ajird-1636	216	13	ceriello	ceriello	AUX
ajird-1636	216	14	a	a	PRON
ajird-1636	216	15	,	,	PUNCT
ajird-1636	216	16	delgado	delgado	VERB
ajird-1636	216	17	v	v	ADP
ajird-1636	216	18	,	,	PUNCT
ajird-1636	216	19	esc	esc	NOUN
ajird-1636	216	20	scientific	scientific	ADJ
ajird-1636	216	21	document	document	NOUN
ajird-1636	216	22	group	group	NOUN
ajird-1636	216	23	et	et	PROPN
ajird-1636	216	24	al	al	PROPN
ajird-1636	216	25	.	.	PROPN
ajird-1636	216	26	esc	esc	PROPN
ajird-1636	216	27	guidelines	guideline	VERB
ajird-1636	216	28	on	on	ADP
ajird-1636	216	29	diabetes	diabetes	NOUN
ajird-1636	216	30	,	,	PUNCT
ajird-1636	216	31	pre	pre	ADJ
ajird-1636	216	32	-	-	NOUN
ajird-1636	216	33	diabetes	diabetes	ADJ
ajird-1636	216	34	,	,	PUNCT
ajird-1636	216	35	and	and	CCONJ
ajird-1636	216	36	cardiovascular	cardiovascular	ADJ
ajird-1636	216	37	diseases	disease	NOUN
ajird-1636	216	38	developed	develop	VERB
ajird-1636	216	39	in	in	ADP
ajird-1636	216	40	collaboration	collaboration	NOUN
ajird-1636	216	41	with	with	ADP
ajird-1636	216	42	the	the	DET
ajird-1636	216	43	easd	easd	NOUN
ajird-1636	216	44	.	.	PUNCT
ajird-1636	217	1	eur	eur	PROPN
ajird-1636	217	2	heart	heart	NOUN
ajird-1636	217	3	j.	j.	PROPN
ajird-1636	217	4	2019	2019	NUM
ajird-1636	217	5	doi	doi	NOUN
ajird-1636	217	6	:	:	PUNCT
ajird-1636	217	7	10.1093	10.1093	NUM
ajird-1636	217	8	/	/	SYM
ajird-1636	217	9	eurheartj	eurheartj	ADJ
ajird-1636	217	10	/	/	SYM
ajird-1636	217	11	ehz486	ehz486	PROPN
ajird-1636	217	12	.	.	PUNCT
ajird-1636	218	1	20	20	NUM
ajird-1636	218	2	.	.	PUNCT
ajird-1636	219	1	åkerblom	åkerblom	VERB
ajird-1636	219	2	a	a	PRON
ajird-1636	219	3	,	,	PUNCT
ajird-1636	219	4	wojdyla	wojdyla	NOUN
ajird-1636	219	5	d	d	NOUN
ajird-1636	219	6	,	,	PUNCT
ajird-1636	219	7	steg	steg	PROPN
ajird-1636	219	8	pg	pg	PROPN
ajird-1636	219	9	,	,	PUNCT
ajird-1636	219	10	wallentin	wallentin	ADJ
ajird-1636	219	11	l	l	PROPN
ajird-1636	219	12	,	,	PUNCT
ajird-1636	219	13	james	james	PROPN
ajird-1636	219	14	sk	sk	PROPN
ajird-1636	219	15	,	,	PUNCT
ajird-1636	219	16	budaj	budaj	NOUN
ajird-1636	219	17	a	a	PRON
ajird-1636	219	18	,	,	PUNCT
ajird-1636	219	19	plato	plato	PROPN
ajird-1636	219	20	investigators	investigator	NOUN
ajird-1636	219	21	et	et	PROPN
ajird-1636	219	22	al	al	PROPN
ajird-1636	219	23	.	.	PUNCT
ajird-1636	220	1	prevalence	prevalence	NOUN
ajird-1636	220	2	and	and	CCONJ
ajird-1636	220	3	relevance	relevance	NOUN
ajird-1636	220	4	of	of	ADP
ajird-1636	220	5	abnormal	abnormal	ADJ
ajird-1636	220	6	glucose	glucose	NOUN
ajird-1636	220	7	metabolism	metabolism	NOUN
ajird-1636	220	8	in	in	ADP
ajird-1636	220	9	acute	acute	ADJ
ajird-1636	220	10	coronary	coronary	ADJ
ajird-1636	220	11	syndromes	syndrome	NOUN
ajird-1636	220	12	:	:	PUNCT
ajird-1636	220	13	insights	insight	NOUN
ajird-1636	220	14	from	from	ADP
ajird-1636	220	15	the	the	DET
ajird-1636	220	16	platelet	platelet	NOUN
ajird-1636	220	17	inhibition	inhibition	NOUN
ajird-1636	220	18	and	and	CCONJ
ajird-1636	220	19	patient	patient	ADJ
ajird-1636	220	20	outcomes	outcome	NOUN
ajird-1636	220	21	(	(	PUNCT
ajird-1636	220	22	plato	plato	PROPN
ajird-1636	220	23	)	)	PUNCT
ajird-1636	220	24	trial	trial	NOUN
ajird-1636	220	25	.	.	PUNCT
ajird-1636	221	1	j	j	PROPN
ajird-1636	221	2	thromb	thromb	PROPN
ajird-1636	221	3	thrombolysis	thrombolysis	NOUN
ajird-1636	221	4	.	.	PUNCT
ajird-1636	222	1	2019;48(4):563–569	2019;48(4):563–569	X
ajird-1636	222	2	.	.	PUNCT
ajird-1636	222	3	doi	doi	NOUN
ajird-1636	222	4	:	:	PUNCT
ajird-1636	222	5	10.1007	10.1007	NUM
ajird-1636	222	6	/	/	SYM
ajird-1636	222	7	s11239019	s11239019	PROPN
ajird-1636	222	8	-	-	PUNCT
ajird-1636	222	9	01938	01938	NUM
ajird-1636	222	10	-	-	PUNCT
ajird-1636	222	11	2	2	NUM
ajird-1636	222	12	.	.	NUM
ajird-1636	222	13	21	21	NUM
ajird-1636	222	14	.	.	PUNCT
ajird-1636	223	1	berezin	berezin	PROPN
ajird-1636	223	2	ae	ae	PROPN
ajird-1636	223	3	,	,	PUNCT
ajird-1636	223	4	berezin	berezin	PROPN
ajird-1636	223	5	aa	aa	PROPN
ajird-1636	223	6	.	.	PUNCT
ajird-1636	224	1	circulating	circulate	VERB
ajird-1636	224	2	cardiac	cardiac	ADJ
ajird-1636	224	3	biomarkers	biomarker	NOUN
ajird-1636	224	4	in	in	ADP
ajird-1636	224	5	diabetes	diabetes	NOUN
ajird-1636	224	6	mellitus	mellitus	NOUN
ajird-1636	224	7	:	:	PUNCT
ajird-1636	224	8	a	a	DET
ajird-1636	224	9	new	new	ADJ
ajird-1636	224	10	dawn	dawn	NOUN
ajird-1636	224	11	for	for	ADP
ajird-1636	224	12	risk	risk	NOUN
ajird-1636	224	13	stratification	stratification	NOUN
ajird-1636	224	14	-	-	PUNCT
ajird-1636	224	15	a	a	DET
ajird-1636	224	16	narrative	narrative	NOUN
ajird-1636	224	17	review	review	NOUN
ajird-1636	224	18	.	.	PUNCT
ajird-1636	225	1	diabetes	diabetes	NOUN
ajird-1636	225	2	ther	ther	ADV
ajird-1636	225	3	.	.	PUNCT
ajird-1636	226	1	jun	jun	PROPN
ajird-1636	226	2	2020;11(6):12711291	2020;11(6):12711291	PROPN
ajird-1636	226	3	.	.	PUNCT
ajird-1636	227	1	doi:10.1007	doi:10.1007	VERB
ajird-1636	227	2	/	/	SYM
ajird-1636	228	1	s13300	s13300	NUM
ajird-1636	228	2	-	-	PUNCT
ajird-1636	228	3	02000835	02000835	NUM
ajird-1636	228	4	-	-	SYM
ajird-1636	228	5	9	9	NUM
ajird-1636	228	6	.	.	NOUN
ajird-1636	229	1	22	22	NUM
ajird-1636	229	2	.	.	PUNCT
ajird-1636	230	1	suthahar	suthahar	PROPN
ajird-1636	230	2	n	n	CCONJ
ajird-1636	230	3	,	,	PUNCT
ajird-1636	230	4	meijers	meijers	PROPN
ajird-1636	230	5	wc	wc	PROPN
ajird-1636	230	6	,	,	PUNCT
ajird-1636	230	7	silljé	silljé	NOUN
ajird-1636	230	8	hhw	hhw	NOUN
ajird-1636	230	9	,	,	PUNCT
ajird-1636	230	10	ho	ho	PROPN
ajird-1636	230	11	je	je	PROPN
ajird-1636	230	12	,	,	PUNCT
ajird-1636	230	13	liu	liu	PROPN
ajird-1636	230	14	ft	ft	PROPN
ajird-1636	230	15	,	,	PUNCT
ajird-1636	230	16	de	de	PROPN
ajird-1636	230	17	boer	boer	PROPN
ajird-1636	230	18	ra	ra	PROPN
ajird-1636	230	19	.	.	PUNCT
ajird-1636	231	1	galectin-3	galectin-3	PROPN
ajird-1636	231	2	activation	activation	NOUN
ajird-1636	231	3	and	and	CCONJ
ajird-1636	231	4	inhibition	inhibition	NOUN
ajird-1636	231	5	in	in	ADP
ajird-1636	231	6	heart	heart	NOUN
ajird-1636	231	7	failure	failure	NOUN
ajird-1636	231	8	and	and	CCONJ
ajird-1636	231	9	cardiovascular	cardiovascular	ADJ
ajird-1636	231	10	disease	disease	NOUN
ajird-1636	231	11	:	:	PUNCT
ajird-1636	231	12	an	an	DET
ajird-1636	231	13	update	update	NOUN
ajird-1636	231	14	.	.	PUNCT
ajird-1636	232	1	theranostics	theranostic	NOUN
ajird-1636	232	2	.	.	PUNCT
ajird-1636	233	1	2018;8(3):593–609	2018;8(3):593–609	X
ajird-1636	233	2	.	.	PUNCT
ajird-1636	233	3	doi	doi	NOUN
ajird-1636	233	4	:	:	PUNCT
ajird-1636	233	5	10.7150	10.7150	NUM
ajird-1636	233	6	/	/	SYM
ajird-1636	233	7	thno.22196	thno.22196	PROPN
ajird-1636	233	8	.	.	PROPN
ajird-1636	233	9	23	23	NUM
ajird-1636	233	10	.	.	PUNCT
ajird-1636	234	1	tan	tan	PROPN
ajird-1636	234	2	kcb	kcb	PROPN
ajird-1636	234	3	,	,	PUNCT
ajird-1636	234	4	cheung	cheung	PROPN
ajird-1636	234	5	cl	cl	PROPN
ajird-1636	234	6	,	,	PUNCT
ajird-1636	234	7	lee	lee	PROPN
ajird-1636	234	8	ach	ach	PROPN
ajird-1636	234	9	,	,	PUNCT
ajird-1636	234	10	lam	lam	PROPN
ajird-1636	234	11	jky	jky	PROPN
ajird-1636	234	12	,	,	PUNCT
ajird-1636	234	13	wong	wong	PROPN
ajird-1636	234	14	y	y	PROPN
ajird-1636	234	15	,	,	PUNCT
ajird-1636	234	16	shiu	shiu	PROPN
ajird-1636	234	17	swm	swm	PROPN
ajird-1636	234	18	.	.	PUNCT
ajird-1636	235	1	galectin-3	galectin-3	PROPN
ajird-1636	235	2	is	be	AUX
ajird-1636	235	3	independently	independently	ADV
ajird-1636	235	4	associated	associate	VERB
ajird-1636	235	5	with	with	ADP
ajird-1636	235	6	progression	progression	NOUN
ajird-1636	235	7	of	of	ADP
ajird-1636	235	8	nephropathy	nephropathy	NOUN
ajird-1636	235	9	in	in	ADP
ajird-1636	235	10	type	type	NOUN
ajird-1636	235	11	2	2	NUM
ajird-1636	235	12	diabetes	diabetes	NOUN
ajird-1636	235	13	mellitus	mellitus	NOUN
ajird-1636	235	14	.	.	PUNCT
ajird-1636	236	1	diabetology	diabetology	NOUN
ajird-1636	236	2	.	.	PUNCT
ajird-1636	237	1	2018;61(5):1212–1219	2018;61(5):1212–1219	PROPN
ajird-1636	237	2	.	.	PUNCT
ajird-1636	238	1	doi	doi	NOUN
ajird-1636	238	2	:	:	PUNCT
ajird-1636	238	3	10.1007	10.1007	NUM
ajird-1636	238	4	/	/	SYM
ajird-1636	238	5	s00125	s00125	NUM
ajird-1636	238	6	-	-	PUNCT
ajird-1636	238	7	018	018	NUM
ajird-1636	238	8	-	-	PUNCT
ajird-1636	238	9	4552	4552	NUM
ajird-1636	238	10	-	-	PUNCT
ajird-1636	238	11	z.	z.	PROPN
ajird-1636	238	12	24	24	NUM
ajird-1636	238	13	.	.	PUNCT
ajird-1636	239	1	hernández	hernández	PROPN
ajird-1636	239	2	-	-	PUNCT
ajird-1636	239	3	romero	romero	PROPN
ajird-1636	239	4	d	d	PROPN
ajird-1636	239	5	,	,	PUNCT
ajird-1636	239	6	vílchez	vílchez	PROPN
ajird-1636	239	7	ja	ja	PROPN
ajird-1636	239	8	,	,	PUNCT
ajird-1636	239	9	lahoz	lahoz	PROPN
ajird-1636	239	10	á	á	PROPN
ajird-1636	239	11	,	,	PUNCT
ajird-1636	239	12	romero	romero	PROPN
ajird-1636	239	13	-	-	PUNCT
ajird-1636	239	14	aniorte	aniorte	PROPN
ajird-1636	239	15	ai	ai	NOUN
ajird-1636	239	16	,	,	PUNCT
ajird-1636	239	17	jover	jover	PROPN
ajird-1636	239	18	e	e	PROPN
ajird-1636	239	19	,	,	PUNCT
ajird-1636	239	20	garcíaalberola	garcíaalberola	PROPN
ajird-1636	239	21	a	a	PROPN
ajird-1636	239	22	,	,	PUNCT
ajird-1636	239	23	et	et	PROPN
ajird-1636	239	24	al	al	PROPN
ajird-1636	239	25	.	.	PUNCT
ajird-1636	240	1	galectin-3	galectin-3	PROPN
ajird-1636	240	2	as	as	ADP
ajird-1636	240	3	a	a	DET
ajird-1636	240	4	marker	marker	NOUN
ajird-1636	240	5	of	of	ADP
ajird-1636	240	6	interstitial	interstitial	ADJ
ajird-1636	240	7	atrial	atrial	ADJ
ajird-1636	240	8	remodeling	remodeling	NOUN
ajird-1636	240	9	involved	involve	VERB
ajird-1636	240	10	in	in	ADP
ajird-1636	240	11	atrial	atrial	ADJ
ajird-1636	240	12	fibrillation	fibrillation	NOUN
ajird-1636	240	13	.	.	PUNCT
ajird-1636	241	1	sci	sci	PROPN
ajird-1636	241	2	rep	rep	PROPN
ajird-1636	241	3	.	.	PROPN
ajird-1636	241	4	2017;7:40378	2017;7:40378	NUM
ajird-1636	241	5	.	.	PUNCT
ajird-1636	242	1	doi	doi	NOUN
ajird-1636	242	2	:	:	PUNCT
ajird-1636	242	3	10.1038	10.1038	NUM
ajird-1636	242	4	/	/	SYM
ajird-1636	242	5	srep40378	srep40378	PROPN
ajird-1636	242	6	.	.	PUNCT
ajird-1636	243	1	25	25	NUM
ajird-1636	243	2	.	.	PUNCT
ajird-1636	244	1	holmager	holmager	PROPN
ajird-1636	244	2	p	p	X
ajird-1636	244	3	,	,	PUNCT
ajird-1636	244	4	egstrup	egstrup	NOUN
ajird-1636	244	5	m	m	PROPN
ajird-1636	244	6	,	,	PUNCT
ajird-1636	244	7	gustafsson	gustafsson	PROPN
ajird-1636	244	8	i	i	PROPN
ajird-1636	244	9	,	,	PUNCT
ajird-1636	244	10	schou	schou	PROPN
ajird-1636	244	11	m	m	PROPN
ajird-1636	244	12	,	,	PUNCT
ajird-1636	244	13	dahl	dahl	PROPN
ajird-1636	244	14	js	js	PROPN
ajird-1636	244	15	,	,	PUNCT
ajird-1636	244	16	rasmussen	rasmussen	PROPN
ajird-1636	244	17	lm	lm	PROPN
ajird-1636	244	18	,	,	PUNCT
ajird-1636	244	19	et	et	PROPN
ajird-1636	244	20	al	al	PROPN
ajird-1636	244	21	.	.	PUNCT
ajird-1636	245	1	galectin-3	galectin-3	PROPN
ajird-1636	245	2	and	and	CCONJ
ajird-1636	245	3	fibulin-1	fibulin-1	PROPN
ajird-1636	245	4	in	in	ADP
ajird-1636	245	5	systolic	systolic	ADJ
ajird-1636	245	6	heart	heart	NOUN
ajird-1636	245	7	failure	failure	NOUN
ajird-1636	245	8	relation	relation	NOUN
ajird-1636	245	9	to	to	PART
ajird-1636	245	10	glucose	glucose	VERB
ajird-1636	245	11	metabolism	metabolism	NOUN
ajird-1636	245	12	and	and	CCONJ
ajird-1636	245	13	left	leave	VERB
ajird-1636	245	14	ventricular	ventricular	ADJ
ajird-1636	245	15	contractile	contractile	NOUN
ajird-1636	245	16	reserve	reserve	NOUN
ajird-1636	245	17	.	.	PUNCT
ajird-1636	246	1	bmc	bmc	PROPN
ajird-1636	246	2	cardiovasc	cardiovasc	PROPN
ajird-1636	246	3	discord	discord	NOUN
ajird-1636	246	4	.	.	PUNCT
ajird-1636	247	1	2017;17(1):22	2017;17(1):22	X
ajird-1636	247	2	.	.	PUNCT
ajird-1636	247	3	doi:10.1186	doi:10.1186	PROPN
ajird-1636	247	4	/	/	SYM
ajird-1636	247	5	s12872	s12872	PROPN
ajird-1636	247	6	-	-	PUNCT
ajird-1636	247	7	016	016	NUM
ajird-1636	247	8	-	-	PUNCT
ajird-1636	247	9	0437	0437	NUM
ajird-1636	247	10	-	-	SYM
ajird-1636	247	11	6	6	NUM
ajird-1636	247	12	26	26	NUM
ajird-1636	247	13	.	.	PUNCT
ajird-1636	247	14	januzzi	januzzi	PROPN
ajird-1636	247	15	jl	jl	PROPN
ajird-1636	247	16	,	,	PUNCT
ajird-1636	247	17	jr	jr	PROPN
ajird-1636	247	18	,	,	PUNCT
ajird-1636	247	19	butler	butler	PROPN
ajird-1636	247	20	j	j	PROPN
ajird-1636	247	21	,	,	PUNCT
ajird-1636	247	22	jarolim	jarolim	PROPN
ajird-1636	247	23	p	p	X
ajird-1636	247	24	,	,	PUNCT
ajird-1636	247	25	sattar	sattar	PROPN
ajird-1636	247	26	n	n	PROPN
ajird-1636	247	27	,	,	PUNCT
ajird-1636	247	28	vijapurkar	vijapurkar	PROPN
ajird-1636	247	29	u	u	PROPN
ajird-1636	247	30	,	,	PUNCT
ajird-1636	247	31	desai	desai	PROPN
ajird-1636	247	32	m	m	PROPN
ajird-1636	247	33	,	,	PUNCT
ajird-1636	247	34	et	et	PROPN
ajird-1636	247	35	al	al	PROPN
ajird-1636	247	36	.	.	PUNCT
ajird-1636	247	37	effects	effect	NOUN
ajird-1636	247	38	of	of	ADP
ajird-1636	247	39	canagliflozin	canagliflozin	NOUN
ajird-1636	247	40	on	on	ADP
ajird-1636	247	41	cardiovascular	cardiovascular	ADJ
ajird-1636	247	42	biomarkers	biomarker	NOUN
ajird-1636	247	43	in	in	ADP
ajird-1636	247	44	older	old	ADJ
ajird-1636	247	45	adults	adult	NOUN
ajird-1636	247	46	with	with	ADP
ajird-1636	247	47	type	type	NOUN
ajird-1636	247	48	2	2	NUM
ajird-1636	247	49	diabetes	diabetes	NOUN
ajird-1636	247	50	.	.	PUNCT
ajird-1636	248	1	j	j	PROPN
ajird-1636	248	2	am	be	AUX
ajird-1636	248	3	call	call	NOUN
ajird-1636	248	4	cardiol	cardiol	NOUN
ajird-1636	248	5	.	.	PUNCT
ajird-1636	249	1	2017;70(6):704–712	2017;70(6):704–712	X
ajird-1636	249	2	.	.	PUNCT
ajird-1636	249	3	doi	doi	NOUN
ajird-1636	249	4	:	:	PUNCT
ajird-1636	249	5	10.1016	10.1016	NUM
ajird-1636	249	6	/	/	SYM
ajird-1636	249	7	j.jacc.2017.06.016	j.jacc.2017.06.016	PROPN
ajird-1636	249	8	.	.	PUNCT